Table of Contents


 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549 
FORM 10-Q
xQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2017March 31, 2018
 
OR
oTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Commission File Number 1-815 
E. I. du Pont de Nemours and Company
(Exact Name of Registrant as Specified in Its Charter)
Delaware 51-0014090
(State or other Jurisdiction of (I.R.S. Employer
Incorporation or Organization) Identification No.)
974 Centre Road, Wilmington, Delaware 19805
(Address of Principal Executive Offices)
 
(302) 774-1000
(Registrant’s Telephone Number)
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes  x   No  o
 
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that registrant was required to submit and post such files.)  Yes  x   No  o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company.  See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large Accelerated Filer x
 
Accelerated Filer o
   
Non-Accelerated Filer o
 
Smaller reporting company o
   
  
Emerging growth company o
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  o
Indicate by check mark whether the registrant is a shell company (as defined by Rule 12b-2 of the Exchange Act).  Yes  o   No  x
The Registrant had 867,806,000100 shares (excludes 87,041,000 shares of treasury stock) of common stock, $0.30$0.30 par value, outstanding at July 17, 2017.March 31, 2018, all of which are held by DowDuPont Inc.



The Registrant meets the conditions set forth in General Instruction H(1)(a) and (b) of Form 10-Q (as modified by a grant of no-action relief dated February 12, 2018) and is therefore filing this form with reduced disclosure format.


Table of Contents


E. I. DU PONT DE NEMOURS AND COMPANY

Table of Contents
 
The terms “DuPont” or the “company” as used herein refer to E. I. du Pont de Nemours and Company and its consolidated subsidiaries, or to E. I. du Pont de Nemours and Company, as the context may indicate. 
  Page
 
   
 
 
 
 
 
 
   
 
 
 
 
 
 
   
   
 
   
 
 


1

Table of Contents


PART I.  FINANCIAL INFORMATION

Item 1.CONSOLIDATED FINANCIAL STATEMENTS

E. I. du Pont de Nemours and Company
Consolidated Income Statements of Operations (Unaudited)
(Dollars in millions, except per share)
 
Three Months EndedSix Months EndedSuccessorPredecessor
June 30,June 30,
2017201620172016
(In millions, except per share amounts)Three Months Ended March 31, 2018Three Months Ended March 31, 2017
Net sales$7,424
$7,061
$15,167
$14,466
$6,699
$7,319
Cost of goods sold4,192
3,990
8,563
8,232
4,847
4,152
Other operating charges176
143
380
328
 200
Research and development expense382
368
Selling, general and administrative expenses1,348
1,211
2,608
2,339
959
1,190
Research and development expense441
432
857
850
Other (loss) income, net(21)51
285
423
Amortization of intangibles315
 
Restructuring and asset related charges - net97
152
Integration and separation costs255
 
Sundry income - net47
202
Interest expense99
93
183
185
80
84
Employee separation / asset related charges, net160
(90)312
(13)
Income from continuing operations before income taxes987
1,333
2,549
2,968
(Loss) income from continuing operations before income taxes(189)1,375
Provision for income taxes on continuing operations128
306
352
712
27
197
Income from continuing operations after income taxes859
1,027
2,197
2,256
Income (loss) from discontinued operations after income taxes10
(3)(207)
Net income869
1,024
1,990
2,256
Less: Net income attributable to noncontrolling interests7
4
15
10
Net income attributable to DuPont$862
$1,020
$1,975
$2,246
(Loss) income from continuing operations after income taxes(216)1,178
Loss from discontinued operations after income taxes(5)(57)
Net (loss) income(221)1,121
Net income attributable to noncontrolling interests7
8
Net (loss) income attributable to DuPont$(228)$1,113
Basic earnings (loss) per share of common stock:      
Basic earnings per share of common stock from continuing operations$0.98
$1.17
$2.51
$2.56

$1.35
Basic earnings (loss) per share of common stock from discontinued operations0.01

(0.24)
Basic loss per share of common stock from discontinued operations
(0.07)
Basic earnings per share of common stock$0.99
$1.16
$2.27
$2.56

$1.28
Diluted earnings (loss) per share of common stock:    

Diluted earnings per share of common stock from continuing operations$0.97
$1.16
$2.50
$2.55

$1.34
Diluted earnings (loss) per share of common stock from discontinued operations0.01

(0.24)
Diluted loss per share of common stock from discontinued operations
(0.07)
Diluted earnings per share of common stock$0.99
$1.16
$2.26
$2.55

$1.27
Dividends per share of common stock$0.38
$0.38
$0.76
$0.76
Dividends declared per share of common stock
$0.38

See Notes to the Consolidated Financial Statements beginning on page 7.6.

2

Table of Contents


E. I. du Pont de Nemours and Company
Consolidated Statements of Comprehensive Income (Unaudited)
(Dollars in millions)

 Three Months EndedSix Months Ended
 June 30,June 30,
 2017201620172016
Net income$869
$1,024
$1,990
$2,256
Other comprehensive income (loss), net of tax:    
      Cumulative translation adjustment275
(97)653
73
      Adjustments to pension benefit plans88
(636)197
(1,255)
      Adjustments to other benefit plans3
(104)7
(219)
      Net change in unrealized losses on securities
14

6
      Net gains (losses) on cash flow hedging derivative instruments(8)17
(11)34
      Total other comprehensive income (loss)358
(806)846
(1,361)
Comprehensive income1,227
218
2,836
895
      Comprehensive income attributable to noncontrolling interests, net of tax7
4
15
10
Comprehensive income attributable to DuPont$1,220
$214
$2,821
$885
 SuccessorPredecessor
(In millions)Three Months Ended March 31, 2018Three Months Ended March 31, 2017
Net (loss) income$(221)$1,121
Other comprehensive income (loss) - net of tax:  
Cumulative translation adjustments957
378
Adjustments to pension benefit plans4
109
Adjustments to other benefit plans
4
Derivative instruments11
(3)
Total other comprehensive income972
488
Comprehensive income751
1,609
Comprehensive income attributable to noncontrolling interests - net of tax7
8
Comprehensive income attributable to DuPont$744
$1,601

See Notes to the Consolidated Financial Statements beginning on page 7.6.

3

Table of Contents



E. I. du Pont de Nemours and Company
Condensed Consolidated Balance Sheets (Unaudited)
(Dollars in millions, except per share)
June 30,
2017
December 31,
2016
Successor
(In millions, except share amounts)March 31, 2018December 31, 2017
Assets 
 
 
 
Current assets 
 
 
 
Cash and cash equivalents$3,254
$4,605
$5,095
$7,250
Marketable securities2,974
1,362
246
952
Accounts and notes receivable, net8,562
4,971
Accounts and notes receivable - net7,147
5,239
Inventories4,856
5,673
7,901
8,633
Prepaid expenses476
506
Other current assets1,287
981
Total current assets20,122
17,117
21,676
23,055
Property, plant and equipment, net of accumulated depreciation
(June 30, 2017 - $15,294; December 31, 2016 - $14,736)
8,959
9,231
Investment in nonconsolidated affiliates1,479
1,595
Property, plant and equipment - net of accumulated depreciation (March 31, 2018 - $769; December 31, 2017 - $443)12,362
12,435
Goodwill4,232
4,180
46,446
45,589
Other intangible assets3,623
3,664
27,493
27,726
Investment in affiliates698
649
Deferred income taxes2,841
3,308
330
480
Other assets2,731
1,815
2,102
2,084
Total$43,206
$39,964
Total Assets$111,888
$112,964
Liabilities and Equity 
 
 
 
Current liabilities 
 
 
 
Short-term borrowings and capital lease obligations$3,406
$2,779
Accounts payable$2,756
$3,705
4,293
4,831
Short-term borrowings and capital lease obligations3,473
429
Income taxes153
101
Other accrued liabilities4,060
4,662
Income taxes payable133
149
Accrued and other current liabilities4,133
4,384
Total current liabilities10,442
8,897
11,965
12,143
Long-term borrowings and capital lease obligations10,086
8,107
Other liabilities9,718
12,333
Deferred income taxes366
431
Total liabilities30,612
29,768
Long-Term Debt9,747
10,291
Other Noncurrent Liabilities 
Deferred income tax liabilities5,669
5,836
Pension and other post employment benefits - noncurrent7,650
7,787
Other noncurrent obligations1,891
1,975
Total noncurrent liabilities24,957
25,889
Commitments and contingent liabilities



 
Stockholders’ equity 
 
 
 
Preferred stock237
237
Common stock, $0.30 par value; 1,800,000,000 shares authorized;
Issued at June 30, 2017 - 954,703,000; December 31, 2016 - 950,044,000
286
285
Preferred stock, without par value – cumulative; 23,000,000 shares authorized;
issued at March 31, 2018 and December 31, 2017:
 
$4.50 Series – 1,673,000 shares (callable at $120)169
169
$3.50 Series – 700,000 shares (callable at $102)70
70
Common stock, $.30 par value; 1,800,000,000 shares authorized;
issued at March 31, 2018 and December 31, 2017 - 100


Additional paid-in capital11,424
11,190
74,783
74,727
Reinvested earnings16,233
14,924
Accumulated other comprehensive loss(9,065)(9,911)
Common stock held in treasury, at cost
(87,041,000 shares at June 30, 2017 and December 31, 2016)
(6,727)(6,727)
(Accumulated deficit) Retained earnings(881)175
Accumulated other comprehensive income (loss)591
(381)
Total DuPont stockholders’ equity12,388
9,998
74,732
74,760
Noncontrolling interests206
198
234
172
Total equity12,594
10,196
74,966
74,932
Total$43,206
$39,964
Total Liabilities and Equity$111,888
$112,964

See Notes to the Consolidated Financial Statements beginning on page 7.6.

4

Table of Contents


E. I. du Pont de Nemours and Company
Condensed Consolidated Statements of Cash Flows (Unaudited)
(Dollars in millions)

 Six Months Ended
 June 30,
 20172016
Operating activities  
Net income$1,990
$2,256
Adjustments to reconcile net income to cash used for operating activities: 
 
Depreciation462
473
Amortization of intangible assets108
226
Net periodic pension benefit cost219
320
Contributions to pension plans(2,994)(237)
Gain on sale of businesses and other assets(202)(385)
Asset related charges279
78
Other operating activities - net279
300
Change in operating assets and liabilities - net(4,196)(4,491)
Cash used for operating activities(4,055)(1,460)
Investing activities 
 
Purchases of property, plant and equipment(524)(507)
Investments in affiliates(22)(2)
Proceeds from sale of businesses and other assets - net296
212
Purchases of short-term financial instruments(4,243)(509)
Proceeds from maturities and sales of short-term financial instruments2,633
683
Foreign currency exchange contract settlements(29)(280)
Other investing activities - net(43)(15)
Cash used for investing activities(1,932)(418)
Financing activities 
 
Dividends paid to stockholders(664)(669)
Net increase in short-term (less than 90 days) borrowings3,011
1,670
Long-term and other borrowings:  
Receipts2,234
717
Payments(204)(755)
Proceeds from exercise of stock options203
70
Other financing activities - net(49)(39)
Cash provided by financing activities4,531
994
Effect of exchange rate changes on cash105
(5)
Decrease in cash and cash equivalents$(1,351)$(889)
Cash and cash equivalents at beginning of period4,605
5,300
Cash and cash equivalents at end of period$3,254
$4,411
 SuccessorPredecessor
(In millions)Three Months Ended March 31, 2018Three Months Ended March 31, 2017
Operating activities  
Net (loss) income$(221)$1,121
Adjustments to reconcile net income to cash used for operating activities:



Depreciation and amortization647
281
Provision for deferred income tax35


Net periodic pension (benefit) cost(79)109
Pension contributions(70)(82)
Net gain on sales of property, businesses, consolidated companies, and investments(2)(192)
Restructuring and asset related charges - net97


Asset related charges

119
Amortization of inventory step-up703


Other net loss258
78
Changes in operating assets and liabilities - net(3,343)(3,058)
Cash used for operating activities(1,975)(1,624)
Investing activities 
 
Capital expenditures(355)(330)
Proceeds from sales of property, businesses, and consolidated companies - net of cash divested18
283
Investments in and loans to nonconsolidated affiliates
(22)
Purchases of investments(201)(2,073)
Proceeds from sales and maturities of investments922
868
Foreign currency exchange contract settlements

(15)
Other investing activities - net(2)(46)
Cash provided by (used for) investing activities382
(1,335)
Financing activities 
 
Change in short-term (less than 90 days) borrowings(97)1,681
Proceeds from issuance of long-term debt253
197
Payments on long-term debt(31)(34)
Proceeds from exercise of stock options45
160
Dividends paid to stockholders(2)(331)
Distributions to DowDuPont(830)

Other financing activities(32)(32)
Cash (used for) provided by financing activities(694)1,641
Effect of exchange rate changes on cash, cash equivalents and restricted cash108
60
Change in cash classified as held for sale
(13)
Decrease in cash, cash equivalents and restricted cash(2,179)(1,271)
Cash, cash equivalents and restricted cash at beginning of period7,808
4,548
Cash, cash equivalents and restricted cash at end of period$5,629
$3,277

See Notes to the Consolidated Financial Statements beginning on page 7.6.


5

Table of Contents
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)


E.I. du Pont de Nemours and Company

Notes to the Consolidated Financial Statements (Unaudited)


Table of Contents

Note Page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18



6

Table of Contents
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(Dollars in millions, except per share)


NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Note 1.  Summary of Significant Accounting Policies
Interim Financial Statements
The accompanying unaudited consolidated financial statementsinterim Consolidated Financial Statements have been prepared in accordance with generally accepted accounting principles in the United States of America (GAAP)("GAAP") for interim financial information and the instructions to Form 10-Q and Rule 10-01 of Regulation S-X.  In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair statement of the results for interim periods have been included.  Results for interim periods should not be considered indicative of results for a full year.  These interim Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and Notes thereto contained in the company’s Annual Report on Form 10-K for the year ended December 31, 2016,2017, collectively referred to as the “2016“2017 Annual Report.”Report”.  The interim Consolidated Financial Statements include the accounts of the company and all of its subsidiaries in which a controlling interest is maintained.

Principles of Consolidation and Basis of Presentation
DowDuPont Inc. ("DowDuPont") was formed on December 9, 2015 to effect an all-stock, merger of equals strategic combination between The Dow Chemical Company ("Dow") and DuPont (the "Merger Transaction"). On JulyAugust 31, 2017 at 11:59 pm ET, (the "Merger Effectiveness Time") pursuant to the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017 (the "Merger Agreement"), Dow and DuPont each merged with wholly owned subsidiaries of DowDuPont ("Mergers") and, as a result of the Mergers, Dow and DuPont became subsidiaries of DowDuPont (collectively, the "Merger"). Prior to the Merger, DowDuPont did not conduct any business activities other than those required for its formation and matters contemplated by the Merger Agreement. DowDuPont intends to pursue, subject to certain customary conditions, including, among others, the effectiveness of registration statements filed with the Securities and Exchange Commission and approval by the Board of Directors of DowDuPont, the separation of the combined company's agriculture business, specialty products business and materials science business through a series of tax-efficient transactions (collectively, the "Intended Business Separations").

For purposes of DowDuPont's financial statement presentation, Dow was determined to be the accounting acquirer in the Merger and DuPont's assets and liabilities are reflected at fair value as of the Merger Effectiveness Time. In connection with the Merger and the related accounting determination, DuPont has elected to apply push-down accounting and reflect in its financial statements the fair value of its assets and liabilities. DuPont's interim Consolidated Financial Statements for periods following the close of the Merger are labeled “Successor” and reflect DowDuPont’s basis in the fair values of the assets and liabilities of DuPont. All periods prior to the closing of the Merger reflect the historical accounting basis in DuPont's assets and liabilities and are labeled “Predecessor.” The interim Consolidated Financial Statements and footnotes include a black line division between the columns titled "Predecessor" and "Successor" to signify that the amounts shown for the periods prior to and following the Merger are not comparable. See Note 3 for additional information on the Merger.

Transactions between DuPont and DowDuPont, Dow and their affiliates and other associated companies are reflected in the Successor consolidated financial statements and disclosed as related party transactions when material. Related party transactions with Dow and DowDuPont are included in Note 7.

As a condition of the regulatory approval for the Merger Transaction, the company was required to divest certain assets related to its crop protection business and research and development ("R&D") organization, specifically the company’s Cereal Broadleaf Herbicides and Chewing Insecticides portfolios, including Rynaxypyr®, Cyazypyr® and Indoxacarb as well as the crop protection R&D pipeline and organization, excluding seed treatment, nematicides, and late-stage R&D programs. On March 31, 2017, the company entered into a definitive agreement (the "FMC Transaction Agreement") with FMC Corporation ("FMC"). Under the FMC Transaction Agreement, FMC would acquire the crop protection business and R&D assets that DuPont was required to divest in order to obtain European Commission ("EC") approval of the Merger Transaction as described above, (the "Divested Ag Business") and DuPont agreed to acquire certain assets relating to FMC’s Health and Nutrition segment, excluding its Omega-3 products (the "H&N Business") (collectively, the "FMC Transactions").

On November 1, 2015,2017, the company completed the separation of its Performance Chemicals segmentFMC Transactions through the spin-off of alldisposition of the issuedDivested Ag Business and outstanding stockthe acquisition of the H&N Business. The Chemours Company (Chemours). In accordance with GAAP,sale of the Divested Ag Business meets the criteria for discontinued operations and as such, results of operations of the Performance Chemicals segment are presented as discontinued operations and as such, have been excluded from continuing operations and segment results for all periods presented. The sum of the individual earnings per share amounts from continuing operations and discontinued operations may not equal the total company earnings per share amounts due to rounding.

Certain reclassifications of prior year's data have been made to conform to current year's presentation. As noted below under “Recent Accounting Pronouncements,” effective January 1, 2017, the company adopted the Financial Accounting Standards Board (FASB) Accounting Standards Update (ASU) No. 2016-09, Compensation - Stock Compensation (Topic 718), Improvements to Employee Share-Based Payment Accounting. In conjunction with the adoption of this ASU, the company retrospectively reclassified The comprehensive income and cash flows related to income tax impacts associated with employee share-based paymentsthe Divested Ag Business have not been segregated and are included in the interim Consolidated Statements of Comprehensive Income and interim Condensed Consolidated Statements of Cash Flows, as described below.

Recent Accounting Pronouncements
Accounting Pronouncements Implemented in 2017
In March 2016, the FASB issued ASU No. 2016-09, Compensation - Stock Compensation (Topic 718), Improvements to Employee Share-Based Payment Accounting, which modifies the accountingrespectively, for certain aspects of share-based payments to employees. The new guidance requires excess tax benefits and tax deficiencies to be recorded in the income statement when stock awards vest or are settled. In addition, cash flowsall periods presented. Amounts related to excess tax benefits will no longer be separately classified as a financing activity apartthe Divested Ag Business are consistently included or excluded from other income tax cash flows. The standard also allows the company to repurchase more of an employee’s vested shares for tax withholding purposes without triggering liability accounting, and clarifies that all cash payments made to tax authorities on an employee’s behalf for withheld shares should be presented as a financing activity on the statement of cash flows. The company adopted this standard as of January 1, 2017.
The primary impact of adoption was the recognition of excess tax benefits in the company's provision for income taxes rather than additional paid-in capital, which is applied prospectively in accordance with the guidance. Adoption of the new standard resulted in the recognition of $5 and $25 of excess tax benefits in the company's provision for income taxes rather than additional paid-in capital for the three and six months ended June 30, 2017, respectively.
The company elected to apply the presentation requirements for cash flows related to excess tax benefits retrospectively to all periods presented which resulted in a decrease to both net cash used for operating activities and net cash provided by financing activities of $18 for the six months ended June 30, 2016. The presentation requirements for cash flows related to employee taxes paid for withheld shares resulted in a decrease to both net cash used for operating activities and net cash provided by financing activities of $25 for the six months ended June 30, 2016.
The remaining updates required by this standard did not have a material impactNotes to the company’s interim Consolidated Financial Statements.Statements based on the respective financial statement line item. See Note 4 for additional information.


7

Table of Contents
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(Dollars in millions, except per share)

NewCertain reclassifications of prior year's data have been made to conform to current year's presentation. As described in Note 2, effective January 1, 2018, the company adopted Financial Accounting PronouncementsStandards Board ("FASB") Accounting Standards Update ("ASU") No. 2017-07, Compensation - Retirement Benefits (Topic 715), Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost. In conjunction with the adoption of this ASU, the company retrospectively reclassified the non-service components of net periodic benefit cost in the interim Consolidated Statements of Operations, as described in Note 2.

Significant Accounting Policies
The company has updated it revenue recognition policy since issuance of its 2017 Annual Report as a result of the adoption of ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606) in the first quarter 2018. See Notes 2 and 5 for additional information. See Note 1, "Summary of Significant Accounting Policies," in the 2017 Annual Report for more information on DuPont's other significant accounting policies.

Revenue
The company recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration which the company expects to receive in exchange for those goods or services. To determine revenue recognition for the arrangements that the company determines are within the scope of Topic 606, the company performs the following five steps: (1) identify the contract(s) with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when (or as) the entity satisfies a performance obligation. See Note 5 for additional information on revenue recognition.

Changes in Accounting and Reporting
Within the Successor period, DuPont made the following changes in accounting and reporting to harmonize its accounting and reporting with DowDuPont.

Within the Successor period of the interim Consolidated Statements of Operations:
Included royalty income within net sales. In the Predecessor periods, royalty income is included within sundry income - net.
Eliminated the other operating charges line item. In the Successor period, a majority of these costs are included within cost of goods sold. These costs are also included in selling, general and administrative expenses and amortization of intangibles in the Successor period.
Presented amortization of intangibles as a separate line item. In the Predecessor periods, amortization is included within selling, general and administrative expenses, other operating charges, and research and development expenses.
Presented integration and separation costs as a separate line item. In the Predecessor periods, these costs are included within selling, general and administrative expenses.
Included interest accrued related to unrecognized tax benefits within the provision for income taxes on continuing operations. In the Predecessor period, interest accrued related to unrecognized tax benefits is included within sundry income - net.

Within the Successor period of the interim Condensed Consolidated Statements of Cash Flows:
Included foreign currency exchange contract settlements within cash flows from operating activities, regardless of hedge accounting qualification. In the Predecessor period, DuPont reflected non-qualified hedge programs, specifically forward contracts, options and cash collateral activity, within cash flows from investing activities. In the Predecessor period, DuPont reflected cash flows from qualified hedge programs within the line item to which the program related (i.e., revenue hedge cash flows presented within changes from accounts receivable).


8

Table of Contents
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)


NOTE 2 - RECENT ACCOUNTING GUIDANCE

Recently Adopted Accounting Guidance
In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606) which was further updated in March, April, May and December 2016, as well as September and November 2017.  The new guidance clarifies the principles for recognizing revenue and develops a common revenue standard for GAAP.  The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be Implementedentitled in exchange for those goods and services.  The new standard resulted in additional disclosure requirements to describe the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. The standard permits the use of either the retrospective or modified retrospective (cumulative-effect) transition method of adoption. 

The company adopted this standard in the first quarter of 2018 and applied the modified retrospective transition method to contracts not completed at the date of initial application. Results for reporting periods beginning after January 1, 2018 are presented under Topic 606, while prior period amounts are not adjusted and continue to be reported in accordance with historic accounting under Topic 605 (Revenue Recognition). The company recognized the cumulative effect of applying the new revenue standard as an adjustment to the opening balance of retained earnings in the beginning of 2018. See Note 5 for additional disclosures regarding the company's contracts with customers.

In accordance with Topic 606, the disclosure of the impact of adoption to the company's interim Condensed Consolidated Balance Sheet was as follows:
(In millions, except per share amounts)
As Reported
December 31, 2017
Effect of Adoption of ASU 2014-09
Updated
January 1, 2018
Current assets   
  Accounts and notes receivable - net$5,239
$65
$5,304
Inventories8,633
(53)8,580
Other current assets981
115
1,096
 





Deferred income taxes$480
$1
$481
    
Liabilities and Equity   
Current liabilities   
Accounts payable$4,831
$(3)$4,828
Accrued and other current liabilities4,384
120
4,504
 





Deferred income tax liabilities$5,836
$3
$5,839
 





Retained earnings$175
$8
$183

The most significant changes as a result of adopting ASU No. 2014-09 relate to the reclassification of the company's return assets and refund liabilities in the agriculture product line on the interim Condensed Consolidated Balance Sheets. Under previous guidance, the company accrued the amount of expected product returns as a reduction of net sales and a reduction of accounts and notes receivable - net, and the value associated with the products expected to be recovered in inventory along with a corresponding reduction in cost of goods sold. Under Topic 606, the company now separately presents the amount of expected product returns as refund liabilities, included in accrued and other current liabilities, and the products expected to be recovered as return assets, included in other current assets in the consolidated balance sheets. The reclassification of return assets and refund liabilities was $61 million and $119 million, respectively, at January 1, 2018.


9

Table of Contents
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)


The effect on the interim Consolidated Statements of Operations and the interim Condensed Consolidated Statement of Cash Flows was not material. The following table summarizes the effects of adopting the new accounting standard related to revenue recognition on the company's interim Condensed Consolidated Balance Sheet:
 March 31, 2018
(In millions, except per share amounts)As ReportedEffect of ChangeBalance without Adoption of Topic 606
Current assets   
  Accounts and notes receivable - net$7,147
$(205)$6,942
Inventories7,901
111
8,012
Other current assets1,287
(168)1,119
 





Deferred income taxes$330
$(1)$329
    
Liabilities and Equity   
Current liabilities   
Accrued and other current liabilities$4,133
$(258)$3,875
 





Deferred income tax liabilities$5,669
$(2)$5,667
 





Accumulated deficit$(881)$(3)$(884)

In August 2016, the FASB issued ASU No. 2016-15, Statement of Cash Flows (Topic 230), Classification of Certain Cash Receipts and Cash Payments. The new guidance makes eight targeted changes to how cash receipts and cash payments are presented and classified in the statement of cash flows. The guidance is effective for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. The new guidance requires adoption on a retrospective basis unless it is impracticable to apply, in which case the company would be required to apply the amendments prospectively as of the earliest date practicable. The company adopted this standard on January 1, 2018 and there was no material impact.

In October 2016, the FASB issued ASU No. 2016-16, Income Taxes (Topic 740), Intra-Entity Transfers of Assets Other Than Inventory. The new guidance requires that entities recognize the income tax consequences of an intra-entity transfer of an asset other than inventory when the transfer occurs, rather than when the asset is sold to an outside party. The guidance is effective for annual reporting periods beginning after December 15, 2017, including interim periods within those annual reporting periods. Early adoption is permitted as of the beginning of an annual reporting period. The new guidance requires adoption on a modified retrospective basis through a cumulative-effect adjustment directly to retained earnings as of the beginning of the period of adoption. The company adopted this standard on January 1, 2018 and there was no adjustment to retained earnings.

In November 2016, the FASB issued ASU No. 2016-18, Statement of Cash Flows (Topic 230), Restricted Cash (a consensus of the FASB Emerging Issues Task Force), which clarifies how entities should present restricted cash and restricted cash equivalents in the statement of cash flows, and, as a result, entities will no longer present transfers between cash and cash equivalents and restricted cash and restricted cash equivalents in the statement of cash flows. An entity with a material balance of restricted cash and restricted cash equivalents must disclose information about the nature of the restrictions. The company adopted this standard on January 1, 2018. See the interim Condensed Consolidated Statement of Cash Flows for the new presentation of restricted cash as well as Note 8 for a reconciliation of cash, cash equivalents and restricted cash (included in other current assets) presented on the interim Condensed Consolidated Balance Sheets to the total cash, cash equivalents and restricted cash presented in the interim Condensed Consolidated Statements of Cash Flows.

10

Table of Contents
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)


In January 2017, the FASB issued ASU No. 2017-01, Business Combinations (Topic 805), Clarifying the Definition of a Business. The new guidance narrows the existing definition of a business and provides a framework for evaluating whether a transaction should be accounted for as an acquisition (or disposal) of assets or a business. The guidance requires an entity to evaluate if substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable asset or a group of similar identifiable assets; if so, the set of transferred assets and activities (collectively, the "set") is not a business. To be considered a business, the set would need to include an input and a substantive process that together significantly contribute to the ability to create outputs, as defined by the ASU. The guidance is effective for annual reporting periods beginning after December 15, 2017, including interim periods within those annual reporting periods, and should be applied prospectively. Early adoption is permitted. The company adopted this standard on January 1, 2018 and will apply it prospectively to all applicable transactions after the adoption date.

In March 2017, the FASB issued ASU No. 2017-07, Compensation - Retirement Benefits (Topic 715), Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost. The new guidance requires registrants to present the service cost component of net periodic benefit cost in the same income statement line item or items as other employee compensation costs arising from services rendered during the period. In addition, only the service cost component will be eligible for capitalization in assets. Registrants will present the other components of net periodic benefit cost separately from the service cost component; and, the line item or items used in the income statement to present the other components of net periodic benefit cost must be disclosed. The guidance is effective for annual reporting periods beginning after December 15, 2017, including interim periods within those fiscal years. Early adoption is permitted as of the beginning of an annual period. The new standard must be adopted retrospectively for the presentation of the service cost component and the other components of net periodic benefit cost in the income statement, and prospectively for the capitalization of the service cost component of net periodic benefit cost in assets. The company plans to adoptadopted this guidance in the first quarter ofon January 1, 2018, and is currently evaluatingwill record the impact on the Consolidated Financial Statements and related disclosures. See Note 14 for theother components of net periodic benefit cost.cost in sundry income - net. The following table summarizes the reclassification of those costs from cost of goods sold, research and development expense, and selling, general and administrative expenses to sundry income - net in the interim Consolidated Statements of Operations:
Summary of Changes to the interim Consolidated Statement of OperationsFor the Three Months Ended March 31, 2017 (Predecessor)
(in millions)
As reported 1
Effect of ChangeUpdated
Cost of goods sold$4,209
$(57)$4,152
Research and development expense$384
$(16)$368
Selling, general and administrative expenses$1,221
$(31)$1,190
Sundry income - net$306
$(104)$202
1.Includes adjustments for discontinued operations.

Accounting Guidance Issued But Not Adopted as of March 31, 2018
In JanuaryAugust 2017, the FASB issued ASU No. 2017-04, Intangibles - Goodwill2017-12, Derivatives and OtherHedging (Topic 350)815), Simplifying the TestTargeted Improvements to Accounting for Goodwill Impairment.Hedging Activities. The new guidance eliminatesexpands and refines hedge accounting for both nonfinancial and financial risk components and aligns the requirement to determinerecognition and presentation of the fair valueeffects of individual assetsthe hedging instrument and liabilities of a reporting unit to measure goodwill impairment. Under the amendmentshedged items in the new ASU, goodwill impairment testing will be performed by comparing the fair value of the reporting unit with its carrying amountfinancial statements. For cash flow and recognizing an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value. The new standard is effective for annual and interim goodwill impairment tests in fiscal years beginning after December 15, 2019, and should be applied on a prospective basis. Early adoption is permitted for annual or interim goodwill impairment testing performed after January 1, 2017. The company is currently evaluating the timing of adoption.

In January 2017, the FASB issued ASU No. 2017-01, Business Combinations (Topic 805), Clarifying the Definition of a Business. The new guidance narrows thenet investment hedges existing definition of a business and provides a framework for evaluating whether a transaction should be accounted for as an acquisition (or disposal) of assets or a business. The guidance requires an entity to evaluate if substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable asset or a group of similar identifiable assets; if so, the set of transferred assets and activities (collectively, the set) is not a business. To be considered a business, the set would need to include an input and a substantive process that together significantly contribute to the ability to create outputs, as defined by the ASU. The guidance is effective for annual reporting periods beginning after December 15, 2017, including interim periods within those annual reporting periods, and should be applied prospectively. Early adoption is permitted. The company will apply this guidance to applicable transactions after the adoption date.

In October 2016, the FASB issued ASU No. 2016-16, Income Taxes (Topic 740), Intra-Entity Transfers of Assets Other Than Inventory. The new guidance requires that entities recognize the income tax consequences of an intra-entity transfer of an asset other than inventory when the transfer occurs, rather than when the asset is sold to an outside party. The guidance is effective for annual reporting periods beginning after December 15, 2017, including interim periods within those annual reporting periods. Early adoption is permitted as of the beginningdate of adoption, an annual reporting period. The new guidance requires adoption on a modified retrospective basis throughentity should apply a cumulative-effect adjustment directlyrelated to eliminating the separate measurement of ineffectiveness to accumulated other comprehensive income with a corresponding adjustment to the opening balance of retained earnings as of the beginning of the period of adoption. The company plansfiscal year in which an entity adopts. Presentation and disclosure guidance is required to adopt this guidance in the first quarter of 2018 and is currently evaluating the impact this guidance will have on the Consolidated Financial Statements and related disclosures.

In August 2016, the FASB issued ASU No. 2016-15, Statement of Cash Flows (Topic 230), Classification of Certain Cash Receipts and Cash Payments.be adopted prospectively. The new guidance makes eight targeted changes to how cash receipts and cash payments are presented and classified in the statement of cash flows. The guidancestandard is effective for fiscal years beginning after December 15, 2017,2018 and interim periods within those fiscal years. Early adoption is permitted including adoption in anany interim period. If anAll transition requirements and elections should be applied to hedging relationships existing (that is, hedging relationships in which the hedging instrument has not expired, been sold, terminated, or exercised or the entity early adoptshas not removed the amendments in an interim period, any adjustmentsdesignation of the hedging relationship) on the date of adoption. The effect of adoption should be reflected as of the beginning of the fiscal year that includes that interim period. An entity that electsof adoption. The company will early adoption must adopt all of the amendmentsnew guidance in the same period. The new guidance requires adoption on a retrospective basis unless it is impracticable to apply, in which case the company would be required to apply the amendments prospectively assecond quarter of the earliest date practicable. The company is currently evaluating the impact this guidance will have on the Consolidated Financial Statements and related disclosures, but does not expect there to be a significant impact.2018.


811

Table of Contents
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(Dollars in millions, except per share)

In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842). The amendments under the new guidance will require lessees to recognize almost all leases on their balance sheet as a right-of-use asset and a lease liability, other than leases that meet the definition of a short-term lease. For income statement purposes, the FASB retained a dual model, requiring leases to be classified as either operating or finance. Classification will be based on criteria that are largely similar to those applied in current lease accounting. Lessor accounting is similar to the current model, but updated to align with certain changes to the lessee model and the new revenue recognition standard. The new leasing standard will be effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption is permitted. The new standard must be adopted using a modified retrospective transition, requiring application at the beginning of the earliest comparative period presented. The company is currently evaluating the impact of adopting this guidance on the Consolidated Financial Statements and related disclosures. The company is the lessee under various agreements for facilities and equipment that are currently accounted for as operating leases. A complete discussion of these leases is included in the company's 20162017 Annual Report in Note 15,14, "Commitments and Contingent Liabilities."

In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts
Note 3 - BUSINESS COMBINATIONS

Merger with Customers (Topic 606), which was further updated in March, April, May and December 2016. The new guidance clarifies the principles for recognizing revenue and develops a common revenue standard for GAAP. The core principleDow
Upon completion of the guidanceMerger, (i) each share of common stock, par value $0.30 per share, of the company (the "DuPont Common Stock") was converted into the right to receive 1.2820 fully paid and non-assessable shares of DowDuPont common stock, par value $0.01 per share, ("DowDuPont Common Stock"), in addition to cash in lieu of any fractional shares of DowDuPont Common Stock, and (ii) each share of DuPont Preferred Stock— $4.50 Series and DuPont Preferred Stock— $3.50 Series (collectively "DuPont Preferred Stock") issued and outstanding immediately prior to the Merger Effectiveness Time remains issued and outstanding and was unaffected by the Merger.

As provided in the Merger Agreement, at the Merger Effectiveness Time, all options relating to shares of DuPont Common Stock that were outstanding immediately prior to the effective time of the Merger were generally automatically converted into options relating to shares of DowDuPont Common Stock and all restricted stock units and performance based restricted stock units relating to shares of DuPont Common Stock that were outstanding immediately prior to the effective time of the Mergers were generally automatically converted into restricted stock units relating to shares of DowDuPont Common Stock, in each case, after giving effect to appropriate adjustments to reflect the Mergers and otherwise generally on the same terms and conditions as applied under the applicable plans and award agreements immediately prior to the Merger Effectiveness Time.

Prior to the Merger, shares of DuPont Common Stock were registered pursuant to Section 12(b) of the Securities Exchange Act of 1934, as amended and listed on the New York Stock Exchange (the “NYSE”). As a result of the Merger, on August 31, 2017, the company requested that the NYSE withdraw the shares of DuPont Common Stock from listing on the NYSE and filed a Form 25 with the U.S. Securities and Exchange Commission ("SEC") to report that DuPont Common Stock is thatno longer listed on the NYSE. DuPont continues to have preferred stock outstanding and it remains listed on the NYSE. DowDuPont Common Stock is listed and trades on the NYSE, ticker symbol DWDP.

As a condition of the regulatory approval of the Merger, DuPont was required to divest a portion of its crop protection product line, including certain research and development capabilities. See Note 4 for additional information.

Preliminary Allocation of Purchase Price
Based on an entity should recognize revenue to depictevaluation of the transferprovisions of promised goods or services to customers in an amount that reflects the consideration to which the entity expectsAccounting Standards Codification ("ASC") 805, "Business Combinations" ("ASC 805"), Dow was determined to be entitledthe accounting acquirer in the Merger. DowDuPont has applied the acquisition method of accounting with respect to the assets and liabilities of DuPont, which have been measured at fair value as of the date of the Merger. In connection with the Merger and the related accounting determination, DuPont has elected to apply push-down accounting and reflect in its financial statements the fair value of assets and liabilities. Such fair values have been reflected in the Successor Consolidated Financial Statements.

DuPont's assets and liabilities were measured at estimated fair values as of the Merger Effectiveness Time, primarily using Level 3 inputs. Estimates of fair value represent management's best estimate which require a complex series of judgments about future events and uncertainties. Third-party valuation specialists were engaged to assist in the valuation of these assets and liabilities.

The total fair value of consideration transferred for the Merger was $74,680 million. Total consideration is comprised of the equity value of the DowDuPont shares as of the Merger Effectiveness Time that were issued in exchange for those goodsDuPont shares, the cash value for fractional shares, and services. the portion of DuPont's share awards and share options earned as of the Merger Effectiveness Time.


12

Table of Contents
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)


The new standard also willfollowing table summarizes the fair value of consideration exchanged as a result in additional disclosure requirementsof the Merger:
(In millions, except exchange ratio) 
DuPont Common Stock outstanding as of the Merger Effectiveness Time868.3
DuPont exchange ratio1.2820
DowDuPont Common Stock issued in exchange for DuPont Common Stock1,113.2
Fair value of DowDuPont Common Stock issued 1
$74,195
Fair value of DowDuPont equity awards issued in exchange for outstanding DuPont equity awards 2
485
Total consideration$74,680
1.Amount was determined based on the price per share of Dow Common Stock of $66.65 on August 31, 2017.
2.Represents the fair value of replacement awards issued for DuPont's equity awards outstanding immediately before the Merger and attributable to the service periods prior to the Merger. The previous DuPont equity awards were converted into the right to receive 1.2820 shares of DowDuPont Common Stock.

The acquisition method of accounting requires, among other things, that identifiable assets acquired and liabilities assumed be recognized on the balance sheet at their respective fair value as of the acquisition date. In determining the fair value, DowDuPont utilized various forms of the income, cost and market approaches depending on the asset or liability being fair valued. The estimation of fair value required significant judgments related to describe the nature, amount, timing and uncertainty of revenue andfuture net cash flows arising from contracts with customers. In July 2015,(including net sales, cost of products sold, selling and marketing costs, and working capital/contributory asset charges), discount rates reflecting the FASB approved a deferralrisk inherent in each cash flow stream, competitive trends, market comparables and other factors. Inputs were generally determined by taking into account historical data, supplemented by current and anticipated market conditions, and growth rates.


13

Table of Contents
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)


The table below presents the preliminary fair value that was allocated to DuPont's assets and liabilities based upon fair values as determined by DowDuPont. The valuation process to determine the fair values is not yet complete. DuPont estimated the preliminary fair value of acquired assets and liabilities as of the ASU effective date from annualMerger Effectiveness Time based on information currently available and interim periods beginning after December 15, 2016 to annual and interim periods beginning after December 15, 2017. The company continues to evaluateadjust those estimates upon refinement of market participant assumptions for integrating businesses, finalization of tax returns in the impactpre-merger period and application of push-down accounting at the new standard on the Consolidated Financial Statements and related disclosures.  Based on the analysis conducted to date, the company does not believe the impact upon adoption will be material to its Consolidated Financial Statements.  The company plans to adopt the standard insubsidiary level. In the first quarter of 2018, underDowDuPont made measurement period adjustments to reflect facts and circumstances in existence as of the modified retrospective transition method.Merger Effectiveness Time. These adjustments primarily included a $282 million increase in goodwill, a $98 million decrease in property, plant, and equipment, an $80 million decrease in indefinite-lived trademarks and trade names and customer-related assets, a $56 million increase in noncontrolling interests, a $28 million decrease in investments in nonconsolidated affiliates and a $16 million decrease in assets held for sale. The preliminary fair values are substantially complete with the exception of identifiable intangible assets, property, plant, and equipment, income taxes and goodwill. As DuPont finalizes the fair values of assets acquired and liabilities assumed, additional purchase price adjustments may be recorded during the measurement period, but no later than one year from the date of the Merger. DuPont will reflect measurement period adjustments, if any, in the period in which the adjustments are recognized. Final determination of the fair values may result in further adjustments to the values presented in the following table.
 Estimated fair value as adjusted
(In millions)
Fair Value of Assets as of the Merger Effectiveness Time 
Cash and cash equivalents$4,005
Marketable securities2,849
Accounts and notes receivable7,847
Inventories8,807
Other current assets360
Investment in nonconsolidated affiliates1,626
Assets held for sale - current3,732
Property, plant and equipment11,843
Goodwill45,387
Other intangible assets27,141
Deferred income tax assets284
Other assets2,076
Total Assets$115,957
Fair Value of Liabilities 
Short-term borrowings and capital lease obligations$5,319
Accounts payable3,285
Income taxes payable261
Accrued and other current liabilities3,517
Liabilities held for sale - current125
Long-term debt9,878
Deferred income tax liabilities8,419
Pension and other post employment benefits - noncurrent8,056
  Other noncurrent obligations1,944
Total Liabilities$40,804
Noncontrolling interests234
Preferred stock239
Fair Value of Net Assets (Consideration for the Merger)$74,680


14

Table of Contents
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)


Integration and Separation Costs
Integration and separation costs have been and are expected to be significant. These costs to date primarily have consisted of financial advisory, information technology, legal, accounting, consulting, and other professional advisory fees associated with the preparation and execution of activities related to the Merger and the Intended Business Separations. These costs are recorded within integration and separation costs in the Successor period and within selling, general and administrative expenses in the Predecessor period within the interim Consolidated Statements of Operations.
 SuccessorPredecessor
(In millions)Three Months Ended March 31, 2018Three Months Ended March 31, 2017
Integration and separation costs$255
 
Selling, general and administrative expenses $170

H&N Business
On November 1, 2017, the company completed the FMC Transactions through the acquisition of the H&N Business and the divestiture of the Divested Ag Business. The acquisition is being integrated into the nutrition and health product line to enhance DuPont’s position as a leading provider of sustainable, bio-based food ingredients and allow for expanded capabilities in the pharma excipients space. The company accounted for the acquisition in accordance with ASC 805, which requires the assets acquired and liabilities assumed to be recognized on the balance sheet at their fair values as of the acquisition date. The purchase accounting and purchase price allocation for the H&N Business are substantially complete. However, the company continues to refine the preliminary valuation of certain acquired assets, such as intangibles, deferred income taxes, and property, plant and equipment, which could impact the amount of residual goodwill recorded. The company will finalize the amounts recognized as it obtains the information necessary to complete the analysis, but no later than one year from the date of the acquisition. The preliminary fair value allocated to the assets acquired and liabilities assumed for the H&N Business at November 1, 2017 was $1,970 million. There were no material updates to the purchase accounting and purchase price allocation for the three months ended March 31, 2018.  For additional information regarding the acquisition of the H&N Business, see Note 3, "Business Combinations," in the 2017 Annual Report. 

Note 2. Planned Merger with Dow Chemical
On December 11, 2015, DuPont and The Dow Chemical Company (Dow) announced entry into an Agreement and Plan of Merger, as amended on March 31, 2017, (the Merger Agreement), under which the companies will combine in an all-stock merger of equals (the Merger Transaction) subject to satisfaction of customary closing conditions, including receipt of regulatory approval. The combined company will be named DowDuPont Inc. (DowDuPont). The Merger Transaction will be accomplished through the merger of separate DowDuPont subsidiaries with and into each of Dow and DuPont with Dow and DuPont surviving as subsidiaries of DowDuPont (the Mergers). Following the consummation of the Merger Transaction, DuPont and Dow intend to pursue, subject to the receipt of approval by the Board of Directors of DowDuPont, the separation of the combined company’s agriculture business, specialty products business and material science business through a series of tax-efficient transactions (collectively, the Intended Business Separations).

On March 27, 2017, DuPont and Dow announced that the European Commission (EC) granted conditional regulatory clearance in Europe for the Merger Transaction conditional on DuPont and Dow fulfilling certain commitments. Dow is required to divest its global Ethylene Acrylic Acid copolymers and ionomers business and has entered a definitive agreement with SK Global Chemical Co., LTD, (the EAA Transaction) subject to the closing of the Merger Transaction in addition to customary closing conditions, including regulatory approval.

DuPont is required to sell certain assets related to its Crop Protection business and research and development (R&D) organization, specifically the company’s Cereal Broadleaf Herbicides and Chewing Insecticides portfolios, including RynaxypyrNOTE ®, Cyazypyr®4 and Indoxacarb as well as the Crop Protection R&D pipeline and organization, excluding seed treatment, nematicides, and late-stage R&D programs. The company will continue to develop and bring to market its late-stage Crop Protection R&D programs and retain the personnel needed to support the Crop Protection marketed products and R&D programs not required to be divested per the EC's conditional approval.- DIVESTITURES AND OTHER TRANSACTIONS

Merger Remedy - Divested Ag Business
On March 31, 2017, DuPontthe company and FMC entered into a definitive agreement (thethe FMC Transaction Agreement) with FMC Corporation (FMC).Agreement. Under the FMC Transaction Agreement, and effective upon the closing of the transaction on November 1, 2017, FMC will acquireacquired the Crop Protection business and R&D assetsDivested Ag Business that DuPont iswas required to divest in order to obtain EC approval of the Merger Transaction as described above, (the Divested Ag Business) and DuPont has agreed to acquire certain assets relating to FMC’s Health and Nutrition segment, excluding its Omega-3 products, (the Acquiredacquired the H&N Business) (collectively,Business. See further discussion of the FMC Transactions)Transactions in Note 1. Additionally, FMC will pay DuPont $1,200 in cash, subject to certain adjustments as set forth in the FMC Transaction Agreement, which reflects the difference in value betweenThe sale of the Divested Ag Business meets the criteria for discontinued operations and as such, earnings are included within (loss) income from discontinued operations after income taxes for all periods presented.

For the Acquired H&N Business. DuPont will retain accounts receivable and accounts payable associated withthree months ended March 31, 2018, the company recorded a loss from discontinued operations before income taxes related to the Divested Ag Business with an expected net value of $425 at closing.$10 million ($5 million after tax). The following table summarizes the results of operations of the Divested Ag Business presented as discontinued operations for the three months ended March 31, 2017:
 Predecessor
(In millions)Three Months Ended March 31, 2017
Net sales$424
Cost of goods sold162
Other operating charges4
Research and development expenses32
Selling, general and administrative expenses39
Income from discontinued operations before income taxes187
Provision for income taxes27
Income from discontinued operations after income taxes$160

The following table presents depreciation and capital expenditures of the discontinued operations related to the Divested Ag Business:

915

Table of Contents
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(Dollars in millions, except per share)


The divestiture will satisfy DuPont’s commitments to the EC in connection with its conditional regulatory clearance of the merger with Dow. The FMC Transaction is expected to close in the fourth quarter of 2017, subject to the closing of the Merger Transaction, in addition to customary closing conditions, including regulatory approval of the FMC Transactions. Under the FMC Transaction Agreement, DuPont is not required to take certain specified actions to obtain regulatory approval with respect to the acquisition of the Acquired H&N Business (Divestiture Actions) that would reasonably be likely to result in the one-year loss of revenues to DuPont, Dow, DowDuPont Inc., their respective subsidiaries or the Acquired H&N Business in excess of $350 in the aggregate (based on fiscal year 2016 annual revenues).
 Predecessor
(In millions)Three Months Ended March 31, 2017
Depreciation$8
Capital expenditures$4

To accommodate the requirements of the FMC Transaction Agreement, DuPont and Dow entered into Amendment No. 1 to the Merger Agreement which, among other things, extends the termination date of the Merger Agreement from June 15, 2017 to August 31, 2017, and sets forth the companies' current intention, subject to approval of the DowDuPont Board of Directors, that the first step in the Intended Business Separation process will be the spin-off of the post-merger material science business, assuming that such sequencing would allow for the completion of all of the Intended Business Separations, through spin-offs as currently anticipated, within 18 months following closing of the merger and would not adversely impact the value of the intended spin-off transactions to DowDuPont's shareholders.

In the second quarter 2017, Dow and DuPont obtained conditional approval for the Merger Transaction from the antitrust regulatory authorities in the United States, Brazil, Canada and China, among others. The conditional approval was granted based on the companies fulfilling their commitments to the EC and, in the case of Brazil and China, certain local remedies. The local remedies in Brazil include the divestiture of a select portion of Dow’s corn seed business in Brazil for which Dow has entered a definitive agreement with CITIC Henan Agriculture Industrial Investment Fund, subject to the closing of the Merger Transaction in addition to customary closing conditions, including regulatory approval, (the Brazil Seeds Transaction). In China, DuPont and Dow have made commitments related to the supply and distribution in China of certain herbicide and insecticide ingredients and formulations for rice crops for five years after the closing of the Merger Transaction.

Additional information about the Merger Agreement and the Intended Business Separations is set forth in the company’s Current Reports on Form 8-K filed with the U.S. Securities and Exchange Commission (the SEC) on March 31, 2017, March 27, 2017 and December 11, 2015; the company’s 2015 and 2016 Annual Reports filed with the SEC on February 4, 2016 and February 2, 2017, respectively, and the registration statement on Form S-4 (File No. 333-209869) (as amended, the Registration Statement) filed by DowDuPont and declared effective by the SEC on June 9, 2016. The Registration Statement constitutes a prospectus of DowDuPont and includes a joint proxy statement of Dow and DuPont. The joint proxy statement relates to the separate special meetings of the companies’ respective common stock shareholders of record as of the close of business on June 2, 2016, to adopt the Merger Agreement and related matters. DuPont's special meeting of stockholders was held on July 20, 2016, which resulted in a vote for adoption of the Merger Agreement and approval of related matters.

Dow and DuPont continue to work constructively with regulators to address questions and obtain regulatory approval, primarily related to the FMC Transactions, the EAA Transaction and the Brazil Seeds Transaction, and to prepare for closing as soon as possible after closing conditions have been met. Subject to satisfaction of these customary closing conditions, including the receipt of regulatory approvals, closing is anticipated to occur no earlier than August 1, 2017.

During the three and six months ended June 30, 2017, and the three and six months ended June 30, 2016, the company incurred $216 and $386, and $76 and $100, respectively, of costs in connection with the planned merger with Dow and the Intended Business Separations, including costs relating to integration and separation planning. These costs were recorded in selling, general and administrative expenses in the company's interim Consolidated Income Statements and primarily include financial advisory, information technology, legal, accounting, consulting and other advisory fees and expenses.


10

Table of Contents
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Dollars in millions, except per share)

Note 3. Divestitures and Other Transactions
Food Safety Diagnostic Sale
In February 2017, the company completed the sale of its global food safety diagnostic business, a part of the Nutrition & Health segment,diagnostics to Hygiena LLC.  The sale resulted in a pre-tax gain of $162 million ($86 million net of tax). The gain was recorded in other (loss)sundry income - net in the company's interim Consolidated Income Statement of Operations for the sixthree months ended June 30,March 31, 2017.

DuPont (Shenzhen) Manufacturing Limited
In March 2016, the company recognized the sale of its 100 percent ownership interest in DuPont (Shenzhen) Manufacturing Limited to the Feixiang Group. The sale of the entity, which held certain buildings and other assets, resulted in a pre-tax gain of $369 ($214 net of tax). The gain was recorded in other (loss) income, net in the company's interim Consolidated Income Statement for the six months ended June 30, 2016 and was reflected as a Corporate item.
Performance Chemicals
On July 1, 2015, DuPont completed the separation of its Performance Chemicals segment through the spin-off of all of the issued and outstanding stock of The Chemours Company (the Separation)"Separation"). In connection with the Separation, the company and The Chemours Company (Chemours)("Chemours") entered into a Separation Agreement discussed below, and a Tax Matters Agreement and certain ancillary agreements, including an employee matters agreement, agreements related(the "Separation Agreement"). Pursuant to transition and site services, and intellectual property cross licensing arrangements. In addition, the companies have entered into certain supply agreements.

Separation Agreement
The company and Chemours entered into a Separation Agreement that sets forth, among other things, the agreements between the company and Chemours regarding the principal transactions necessary to effect the Separation and also sets forth ancillary agreements that govern certain aspects of the company’s relationship with Chemours after the separation. Among other matters, the Separation Agreement and the ancillary agreements provide for the allocation between DuPont and Chemours of assets, employees, liabilities and obligations (including investments, property and employee benefits and tax-related assets and liabilities) attributable to periods prior to, at and after the completion of the Separation.

Pursuantamendment to the Separation Agreement, as discussed below, Chemours indemnifies DuPont against certain litigation, environmental, workers' compensation and other liabilities that arose prior to the distribution. The term of this indemnification is generally indefinite and includes defense costs and expenses, as well as monetary and non-monetary settlements and judgments. In 2017, DuPont and Chemours amended the Separation Agreement to provide for a limited sharing of potential future perfluorooctanoic acid (“PFOA”) liabilities for a period of five years beginning July 6, 2017. In connection with the recognition of liabilities related to these matters, the company records an indemnification asset when recovery is deemed probable. At June 30, 2017,March 31, 2018, the indemnified assets are $412$82 million within accounts and notes receivable - net and $343$332 million within other assets onalong with the corresponding liabilities of $82 million within accrued and other current liabilities and $332 million within other noncurrent obligations in the interim Condensed Consolidated Balance Sheet. See Note 1114 for further discussion of the amendment to the Separation Agreement and certain litigation and environmental matters indemnified by Chemours.

Income (loss)Loss from discontinued operations after taxes in the company's interim Consolidated Income Statements during the three and six months ended June 30, 2017 reflects a tax benefit of $10 associated with an adjustment to the tax benefit recognized in the first quarter of 2017 related to the charge for the perfluorooctanoic acid (PFOA) multi-district litigation settlement. Income (loss) from discontinued operations afterincome taxes for the sixthree months ended June 30,March 31, 2017 includes a charge of $335 million ($214224 million net of tax) in connection with the PFOA multi-district litigation settlement. See Note 1114 for further discussion. Income (loss)

NOTE 5 - REVENUE

Revenue Recognition
Products
Substantially all of DuPont's revenue is derived from discontinued operationsproduct sales. Product sales consist of sales of DuPont's products to supply manufacturers, distributors, and farmers. DuPont considers purchase orders, which in some cases are governed by master supply agreements, to be a contract with a customer. Contracts with customers are considered to be short-term when the time between order confirmation and satisfaction of the performance obligations is equal to or less than one year.

Revenue from product sales is recognized when the customer obtains control of the company's product, which occurs at a point in time according to shipping terms. Payment terms for contracts related to product lines other than agriculture generally average 30 to 60 days after taxesinvoicing, depending on business and geography. Payment terms for agriculture product line contracts are generally less than one year from invoicing. The company elected the practical expedient and will not adjust the promised amount of consideration for the effects of a significant financing component when DuPont expects it will be one year or less between when a customer obtains control of the company's product and when payment is due. The company has elected to recognize shipping and handling activities when control has transferred to the customer as an expense in cost of goods sold. Taxes collected from customers relating to product sales and remitted to governmental authorities are excluded from revenues. In addition, DuPont elected the practical expedient to expense any costs to obtain contracts as incurred, as the amortization period for these costs would have been one year or less.


16

Table of Contents
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)


The transaction price includes estimates of variable consideration, such as rights of return, rebates, and discounts, that are reductions in revenue. All estimates are based on the company's historical experience, anticipated performance, and the company's best judgment at the time the estimate is made. Estimates for variable consideration are reassessed each reporting period and are included in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur upon resolution of uncertainty associated with the variable consideration. The majority of contracts have a single performance obligation satisfied at a point in time and the transaction price is stated in the contract, usually as quantity times price per unit. For contracts with multiple performance obligations, DuPont allocates the transaction price to each performance obligation based on the relative standalone selling price. The standalone selling price is the observable price which depicts the price as if sold to a similar customer in similar circumstances.

Licenses of Intellectual Property
DuPont enters into licensing arrangements with customers under which it licenses its intellectual property, such as patents and trademarks. Revenue from the majority of intellectual property licenses is derived from sales-based royalties. The company estimates the expected amount of sales-based royalties based on historical sales by customer. Revenue for licensing agreements that contain sales-based royalties is recognized at the later of (i) when the subsequent sale occurs or (ii) when the performance obligation to which some or all of the royalty has been allocated is satisfied.

Contract Balances
Contract liabilities primarily reflect deferred revenue from prepayments under agriculture product line contracts with customers where the company receives advance payments for products to be delivered in future periods. DuPont classifies deferred revenue as current or noncurrent based on the timing of when the company expects to recognize revenue. Contract assets primarily include amounts related to contractual rights to consideration for completed performance not yet invoiced within the industrial biosciences product line. Accounts receivable are recorded when the right to consideration becomes unconditional.

Contract BalancesMarch 31, 2018
Topic 606 Adjustments
January 1, 2018
December 31, 2017
(In millions)
Accounts and notes receivable - trade1
$5,699
$87
$3,976
Contract assets - current2
$57
$54
$
Deferred revenue - current3
$1,904
$2
$2,014
Deferred revenue - noncurrent4
$49
$
$48
1.
Included in accounts and notes receivable - net in the Consolidated Balance Sheets.
2.
Included in other current assets in the Consolidated Balance Sheets.
3.
Included in accrued and other current liabilities in the Consolidated Balance Sheets.
4.
Included in other noncurrent obligations in the Consolidated Balance Sheets.

The decrease in deferred revenue from December 31, 2017 to March 31, 2018 was primarily due to the timing of agriculture product line seed deliveries to customers for the North America growing season. Revenue recognized during the three and six months ended June 30, 2016, includes $13 and $20, respectively,March 31, 2018 from amounts included in deferred revenue at the beginning of costs in connection with the separation transaction primarily related to professional fees associated with preparation of regulatory filings and separation activities within finance, tax, legal, and information system functions.period was $563 million.


1117

Table of Contents
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)


Disaggregation of Revenue
Effective with the Merger, DuPont’s business activities are components of its parent company’s business operations. DuPont’s business activities, including the assessment of performance and allocation of resources, are reviewed and managed by DowDuPont. Information used by the chief operating decision maker of DuPont relates to the company in its entirety. Accordingly, there are no separate reportable business segments for DuPont under ASC Topic 280 “Segment Reporting” and DuPont's business results are reported in this Form 10-Q as a single operating segment.

The company has one reportable segment with the following principal product lines: agriculture, packaging and specialty plastics, electronics and imaging, nutrition and health, industrial biosciences, transportation and advanced polymers and safety and construction. The company believes disaggregation of revenue by principal product line best depicts the nature, amount, timing, and uncertainty of its revenue and cash flows. Net sales by principal product line are included below:

(In millions)For the Three Months Ended March 31, 2018
Agriculture$2,343
Packaging and Specialty Plastics419
Electronics and Imaging527
Nutrition and Health1,024
Industrial Biosciences406
Transportation and Advanced Polymers1,121
Safety and Construction855
Other4
Total$6,699

Sales are attributed to geographic areas based on customer location. Net sales by geographic region are included below:

(In millions)For the Three Months Ended March 31, 2018
U.S. & Canada$2,515
EMEA1
2,166
Asia Pacific1,535
Latin America483
Total$6,699
1.
Europe, Middle East, and Africa (EMEA).


18

Table of Contents
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(Dollars in millions, except per share)

Note 4. Employee Separation / Asset Related Charges, NetNOTE 6 - RESTRUCTURING AND ASSET RELATED CHARGES - NET
2017 Restructuring
DowDuPont Cost Synergy Program
DuringIn September and November 2017, DowDuPont and the first quarter 2017,company approved post-merger restructuring actions under the DowDuPont Cost Synergy Program (the “Synergy Program”), adopted by the DowDuPont Board of Directors. The plan is designed to integrate and optimize the organization following the Merger and in preparation for the Intended Business Separations.  Based on all actions approved to date under the Synergy Program, DuPont committedexpects to takerecord total pre-tax restructuring charges of $430 million to $600 million, comprised of approximately $320 million to $360 million of severance and related benefits costs; $110 million to $140 million of costs related to contract terminations; and up to $100 million of asset related charges. The Synergy Program includes certain asset actions to improve plant productivity and better position its businesses for productivity and growth before and afterthat are reflected in the anticipated closingpreliminary fair value measurement of DuPont’s assets as of the Merger Transaction (the 2017merger date. Current estimated total pre-tax restructuring program). In connection withcharges could be impacted by future adjustments to the preliminary fair value of DuPont’s assets.

As a result of these actions, the company incurredrecorded pre-tax restructuring charges of $160$187 million for the period September 1 through December 31, 2017, consisting of severance and $312, during the threerelated benefit costs of $153 million, contract termination costs of $31 million and six months ended June 30, 2017, respectively, recognized in employee separation / asset related charges net inof $3 million.

For the company's interim Consolidated Income Statements.three months ended March 31, 2018, DuPont recorded a pre-tax charge of $97 million, consisting of severance and related benefit costs of $68 million and contract termination costs of $29 million. The charge for the three months ended June 30, 2017 is comprised of $160 ofMarch 31, 2018 was recognized in restructuring and asset related charges. The charge forcharges - net in the six months ended June 30, 2017 is comprisedcompany's interim Consolidated Statements of $279 of asset-related charges and $33 in severance and related benefit costs. The charges primarily relate to the second quarter closureOperations. Substantially all of the Protection Solutions segment's Cooper River manufacturing site located near Charleston, South Carolina. The asset-relatedremaining restructuring charges mainly consist of accelerated depreciation associated withare expected to be incurred in 2018 and the closure. Therelated actions, including employee separations, associated with this plan are expected to be substantially complete by the end of 2017.
The 2017 restructuring program charge related to the segments, as well as corporate expenses, was as follows:
 
Three Months Ended
June 30, 2017
Six Months Ended
June 30, 2017
Electronics & Communications$1
$6
Industrial Biosciences
6
Nutrition & Health
2
Performance Materials2
13
Protection Solutions157
281
Corporate expenses
4
 $160
$312
2019.

AccountDuPont account balances and activity for the 2017 restructuring programSynergy Program in the Successor period are summarized below:
 Severance and Related Benefit Costs
Asset Related Charges1
Total
Charges to income from continuing operations for the six months ended June 30, 2017$33
$279
$312
Payments(5)
(5)
Asset write-offs
(279)(279)
Balance as of June 30, 2017$28
$
$28
1.
Includesaccelerated depreciation related to site closure. Charge for accelerated depreciation represents the difference between the depreciation expense to be recognized over the revised useful life of the site, based upon the anticipated date the site will be closed and depreciation expense as determined utilizing the useful life prior to the restructuring action.

La Porte Plant, La Porte, Texas
In March 2016, DuPont announced its decision to not re-start the Agriculture segment’s insecticide manufacturing facility at the La Porte site located in La Porte, Texas.  The facility manufactured Lannate® and Vydate® insecticides and has been shut down since November 2014.  As a result of this decision, during the six months ended June 30, 2016, a pre-tax charge of $75 was recorded in employee separation / asset related charges, net in the company's interim Consolidated Income Statement which included $41 of asset related charges, $18 of contract termination costs, and $16 of employee severance and related benefit costs.                
(In millions)Severance and Related Benefit CostsContract Termination ChargesTotal
Balance as of December 31, 2017$133
$28
$161
Charges to loss from continuing operations for the three months ended March 31, 201868
29
97
Payments(31)(16)(47)
Net translation adjustment1

1
Balance as of March 31, 2018$171
$41
$212

2016 Global Cost Savings and2017 Restructuring PlanProgram
At June 30, 2017,March 31, 2018, total liabilities related to the program were $44.$15 million. The restructuring actions associated with the chargethis plan were substantially completedcomplete in 2016.2017. A complete discussion of restructuring initiatives is included in the company's 20162017 Annual Report in Note 4, "Employee Separation /5, "Restructuring and Asset Related Charges - Net."
During the three months ended March 31, 2017, a net charge of $152 million was recorded, consisting of $119 million of asset related charges and $33 million of severance and related benefit costs. The asset related charges mainly consist of accelerated depreciation associated with the closure of the safety and construction product line at the Cooper River manufacturing site located near Charleston, South Carolina.


1219

Table of Contents
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)


NOTE 7 - RELATED PARTIES

Services Provided by and to Dow and its affiliates
Following the Merger, DuPont reports transactions with Dow and its affiliates as related party transactions. The table below presents revenue earned and expenses incurred in transactions with Dow and its affiliates following the Merger. DuPont sells to and procures from Dow and its affiliates certain feedstocks and raw materials that are consumed in each company's manufacturing process, as well as finished goods.
 Successor
(In millions)Three Months Ended March 31, 2018
Net sales$44
Cost of goods sold 
$24

Purchases from Dow and its affiliates were $43 million in the first quarter of 2018.

Transactions with DowDuPont
DowDuPont relies on distributions and other intercompany transfers from DuPont and Dow to fund payment of its costs and expenses. In November 2017, DowDuPont's Board of Directors authorized an initial $4,000 million share repurchase program to buy back shares of DowDuPont common stock. In February 2018, the Board declared a first quarter dividend per share of DowDuPont common stock payable on March 15, 2018. In the first quarter of 2018, DuPont declared and paid distributions to DowDuPont of about $830 million, primarily to fund a portion of DowDuPont's first quarter share repurchases and dividend payment.

In addition, at March 31, 2018 and December 31, 2017, DuPont had a payable to DowDuPont of $354 million, included in accounts payable in the Consolidated Balance Sheets related to its estimated 2017 tax liability. See Note 9 for additional information.

NOTE 8 - SUPPLEMENTARY INFORMATION

Sundry Income - NetSuccessorPredecessor
(In millions)Three Months Ended March 31, 2018Three Months Ended March 31, 2017
Royalty income1


$45
Interest income$28
25
Equity in earnings of affiliates - net14
18
Net gain on sales of businesses and other assets2
2
192
Net exchange losses(132)(59)
Non-operating pension and other post employment benefit credit (cost)3
92
(104)
Miscellaneous income and expenses - net4
43
85
Sundry income - net$47
$202
1.
In the Successor period, royalty income of $40 million is included in Net Sales.
2. 
Includes a pre-tax gain of $162 million ($86 million net of tax) for the three months ended March 31, 2017 related to the sale of global food safety diagnostics. See Note 4 for additional information.
3.
Includes non-service related components of net periodic benefit credits (costs) (interest cost, expected return on plan assets, amortization of unrecognized loss, and amortization of prior service benefit).  See Note 2 for discussion of the retrospective adoption of ASU No. 2017-07.
4.
Miscellaneous income and expenses - net, includes interest items (Predecessor period only), gains related to litigation settlements, and other items.



20

Table of Contents
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Dollars in millions, except per share)
(UNAUDITED)

Account balances and activity for the restructuring plan, which reflect timing of payments, are summarized below:
 Severance and Related Benefit Costs
Other Non-Personnel Charges1
Total
Balance at December 31, 2016$100
$22
$122
Payments(69)(11)(80)
Net translation adjustment2

2
Balance as of June 30, 2017$33
$11
$44
1.
Other non-personnel charges consist of contractual obligation costs.

During the three and six months ended June 30, 2016, a net benefit of $(90) and $(88) was recorded associated with the 2016 global cost savings and restructuring plan in employee separation / asset related charges, net in the company's interim Consolidated Income Statements. This was primarily due to a reduction in severance and related benefit costs partially offset by the identification of additional projects in certain segments.  The reduction in severance and related benefit costs was driven by the elimination of positions at a lower cost than expected as a result of redeployments and attrition as well as lower than estimated individual severance costs.

The net (benefit) charge related to the segments for the three and six months ended June 30, 2016 as follows:
 
Three Months Ended
June 30, 2016
Six Months Ended
June 30, 2016
Agriculture$(5)$16
Electronics & Communications(8)(15)
Industrial Biosciences(3)(4)
Nutrition & Health(12)(13)
Performance Materials(9)(5)
Protection Solutions(7)(10)
Other
3
Corporate expenses(46)(60)
 $(90)$(88)
Note 5.  Other (Loss) Income, Net
 Three Months EndedSix Months Ended
 June 30,June 30,
 2017201620172016
Royalty income$28
$24
$73
$81
Interest income33
27
58
43
Equity in earnings of affiliates, net24
28
42
38
Net gain on sales of businesses and other assets1,2
10
11
202
384
Net exchange losses(140)(15)(199)(136)
Miscellaneous income and expenses, net3
24
(24)109
13
Other (loss) income, net$(21)$51
$285
$423
1.
Includes a pre-tax gain of $162 ($86 net of tax) for the six months ended June 30, 2017 related to the sale of the global food safety diagnostic business. See Note 3 for additional information.
2. 
Includes a pre-tax gain of $369 ($214 net of tax) for the six months ended June 30, 2016 related to the sale of DuPont (Shenzhen) Manufacturing Limited. See Note 3 for additional information.
3.
Miscellaneous income and expenses, net, includes interest items, gains (losses) on available for sale securities, gains related to litigation settlements, licensing income, and other items. For the six months ended June 30, 2017, the amount includes a $47 benefit associated with accrued interest reversals related to a reduction in the company's unrecognized tax benefits due to the closure of various tax statutes of limitations. See Note 6 for additional information.


13

Table of Contents
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Dollars in millions, except per share)

The following table summarizes the impacts of the company's foreign currency hedging program on the company's results of operations for the three and six months ended June 30, 2017 and 2016.operations. The company routinely uses foreign currency exchange contracts to offset its net exposures, by currency, related to the foreign currency-denominated monetary assets and liabilities. The objective of this program is to maintain an approximately balanced position in foreign currencies in order to minimize, on an after-tax basis, the effects of exchange rate changes on net monetary asset positions. The hedging program gains (losses) are largely taxable (tax deductible) in the U.S.United States (U.S.), whereas the offsetting exchange gains (losses) on the re-measurementremeasurement of certainthe net monetary asset positions are often not taxable (tax deductible) in their local jurisdictions. The net pre-tax exchange gains (losses) are recorded in other (loss)sundry income - net and the related tax impact is recorded in provision for income taxes on continuing operations in the interim Consolidated Income Statements.Statements of Operations.
 SuccessorPredecessor
(In millions)Three Months Ended March 31, 2018Three Months Ended March 31, 2017
Subsidiary Monetary Position (Loss) Gain  
Pre-tax exchange gain$49
$26
Local tax benefits32
36
Net after-tax impact from subsidiary exchange gain$81
$62
   
Hedging Program Gain (Loss)  
Pre-tax exchange loss1
$(181)$(85)
Tax benefits42
30
Net after-tax impact from hedging program exchange loss$(139)$(55)
   
Total Exchange Gain (Loss)  
Pre-tax exchange loss$(132)$(59)
Tax benefits74
66
Net after-tax exchange (loss) gain$(58)$7
1.
Includes a $(50) million foreign exchange loss related to adjustments to foreign currency exchange contracts as a result of U.S. tax reform.

Cash, cash equivalents and restricted cash
The following table provides a reconciliation of cash and cash equivalents and restricted cash (included in other current assets) presented in the interim Condensed Consolidated Balance Sheets to the total cash, cash equivalents and restricted cash presented in the interim Condensed Consolidated Statements of Cash Flows.

 Three Months EndedSix Months Ended
 June 30,June 30,
 2017201620172016
Subsidiary Monetary Position Gain (Loss)    
Pre-tax exchange (losses) gains$(54)$146
$(28)$179
Local tax benefits (expenses)94
(60)130
(47)
Net after-tax impact from subsidiary exchange gains$40
$86
$102
$132
     
Hedging Program Gain (Loss)    
Pre-tax exchange losses$(86)$(161)$(171)$(315)
Tax benefits31
58
61
113
Net after-tax impact from hedging program exchange losses$(55)$(103)$(110)$(202)
     
Total Exchange Gain (Loss)    
Pre-tax exchange losses$(140)$(15)$(199)$(136)
Tax benefits (expenses)125
(2)191
66
Net after-tax exchange losses$(15)$(17)$(8)$(70)
 Successor
(In millions)March 31, 2018December 31, 2017
Cash and cash equivalents$5,095
$7,250
Restricted cash534
558
Total cash, cash equivalents and restricted cash$5,629
$7,808

DuPont entered into a trust agreement in 2013 (as amended and restated in 2017), establishing and requiring DuPont to fund a trust (the "Trust") for cash obligations under certain non-qualified benefit and deferred compensation plans upon a change in control event as defined in the Trust agreement. Under the Trust agreement, the consummation of the Merger was a change in control event. Restricted cash at March 31, 2018 and December 31, 2017 is related to the Trust.


21

Table of Contents
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)


Note 6.  Income TaxesNOTE 9 - INCOME TAXES

On December 22, 2017, the Tax Cuts and Jobs Act (“The Act”) was enacted. The Act reduces the U.S. federal corporate income tax rate from 35 percent to 21 percent, requires companies to pay a one-time transition tax (“transition tax”) on earnings of foreign subsidiaries that were previously tax deferred, creates new provisions related to foreign sourced earnings, eliminates the domestic manufacturing deduction and moves towards a territorial system. At March 31, 2018, the company had not completed its accounting for the tax effects of The Act; however, as described below, the company has made reasonable estimates of the effects on its existing deferred tax balances and the one-time transition tax. In accordance with Staff Accounting Bulletin 118 ("SAB 118"), during the measurement period, income tax effects of the Act may be refined upon obtaining, preparing, or analyzing additional information, and such changes could be material. During the measurement period, provisional amounts may also be adjusted for the effects, if any, of interpretive guidance issued by U.S. regulatory and standard-setting bodies.

As a result of The Act, the company remeasured its U.S. federal deferred tax assets and liabilities based on the rates at which they are expected to reverse in the future, which is generally 21 percent. However, the company is still analyzing certain aspects of The Act and refining its calculations. In the first quarter 2018, a $48 million charge was recorded to provision for income taxes on continuing operations in the company's interim Consolidated Statements of Operations to adjust the provisional amount related to the remeasurement of the company's deferred tax balance, resulting in a benefit of $(2,668) million since the enactment of The Act.

The Act requires a mandatory deemed repatriation of post-1986 undistributed foreign earnings and profits (“E&P”), which results in a one-time transition tax. The company has not yet completed its calculation of the total post-1986 foreign E&P for its foreign subsidiaries as E&P will not be finalized until the Federal income tax return is filed. The company has not recorded a change to the $715 million provisional charge recorded during the fourth quarter 2017 with respect to the one-time transition tax.

In the first quarter 2018, the company recognized a charge of $16 million to provision for income taxes on continuing operations in the company's interim Consolidated Statements of Operations as a result of an indirect impact of the Act related to certain inventory.

For tax years beginning after December 31, 2017, The Act introduces new provisions for U.S. taxation of certain global intangible low-taxed income ("GILTI"). The company is evaluating the policy election on whether the additional liability will be recorded in the period in which it is incurred or recognized for the basis differences that would be expected to reverse in future years.

DuPont and its subsidiaries are included in DowDuPont's consolidated federal income tax group and consolidated tax return.  Generally, the consolidated tax liability of the DowDuPont U.S. tax group for each year will be apportioned among the members of the consolidated group based on each member’s separate taxable income.  DuPont and Dow intend that to the extent Federal and/or State corporate income tax liabilities are reduced through the utilization of tax attributes of the other, settlement of any receivable and payable generated from the use of the other party’s sub-group attributes will be in accordance with a tax sharing agreement and/or tax matters agreement.

Each year the company files hundreds of tax returns in the various national, state and local income taxing jurisdictions in which it operates. These tax returns are subject to examination and possible challenge by the tax authorities. Positions challenged by the tax authorities may be settled or appealed by the company. As a result, there is an uncertainty in income taxes recognized in the company’scompany's financial statements in accordance with accounting for income taxes and accounting for uncertainty in income taxes. ItThe ultimate resolution of such uncertainties is reasonably possible that changesnot expected to have a material impact on the company's global unrecognized tax benefits could be significant; however, due to the uncertainty regarding the timingresults of completion of audits and possible outcomes, a current estimate of the range of increases or decreases that may occur within the next twelve months cannot be made.operations.

During the three months ended June 30, 2017, the company recognized tax expense of $29 associated with the elimination of the U.S. domestic manufacturing deduction recorded in 2016 due to taxable income limitations triggered by the Company's decision to deduct the second quarter 2017 principal U.S. pension plan contribution on its 2016 consolidated U.S. tax return.

Additionally, during the six months ended June 30,March 31, 2017, the company recognized a tax benefit of $57 million, as well as a $50 million pre-tax benefit of $50 on associated accrued interest reversals, related to a reduction in the company's unrecognized tax benefits due to the closure of various tax statutes of limitations. Income from continuing operations during the sixthree months ended June 30,March 31, 2017 includes a tax benefit of $53 million and a pre-tax benefit of $47 million for accrued interest reversals (recorded in other (loss)sundry income - net). Income (loss)Loss from discontinued operations after taxes during the sixthree months ended June 30,March 31, 2017 includes a tax benefit of $4 million and a pre-tax benefit of $3 million for the accrued interest reversal.  


1422

Table of Contents
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(Dollars in millions, except per share)

Note 7.  Earnings Per ShareNOTE 10 - EARNINGS PER SHARE OF COMMON STOCK

Upon completion of the Merger, each share of DuPont Common Stock was converted into the right to receive 1.2820 fully paid and non-assessable shares of DowDuPont Common Stock, in addition to cash in lieu of any fractional shares of DowDuPont Common Stock issued and therefore earnings per share of common stock information is not presented for the Successor period.

Set forth below is a reconciliation of the numerator and denominator for basic and diluted earnings per share calculations for the periods indicated:Predecessor period indicated below:
Three Months EndedSix Months EndedPredecessor
June 30,June 30,
2017201620172016
(In millions, except share amounts)Three Months Ended March 31, 2017
Numerator:  
Income from continuing operations after income taxes attributable to DuPont$852
$1,023
$2,182
$2,246
$1,171
Preferred dividends(3)(3)(5)(5)(2)
Income from continuing operations after income taxes available to DuPont common stockholders$849
$1,020
$2,177
$2,241
$1,169
   
Income (loss) from discontinued operations after income taxes available to DuPont common stockholders$10
$(3)$(207)$
Loss from discontinued operations after income taxes available to DuPont common stockholders(58)
  

Net income available to common stockholders$859
$1,017
$1,970
$2,241
$1,111
   
Denominator:   
Weighted-average number of common shares outstanding - Basic868,481,000
875,013,000
867,496,000
874,269,000
866,516,000
Dilutive effect of the company’s employee compensation plans4,269,000
4,166,000
4,424,000
3,945,000
4,567,000
Weighted-average number of common shares outstanding - Diluted872,750,000
879,179,000
871,920,000
878,214,000
871,083,000

The following average number of stock options were antidilutive, and therefore not included in the dilutive earnings per share calculations:
 Three Months EndedSix Months Ended
 June 30,June 30,
 2017201620172016
Average number of stock options
4,994,000
3,000
5,049,000

The change in the average number of stock options that were antidilutive in the three and six months ended June 30, 2017, compared to the same period last year was due to changes in the company's average stock price.
Predecessor
Three Months Ended March 31, 2017
Average number of stock options6,000

Note 8. InventoriesNOTE 11 - INVENTORIES

June 30,
2017
December 31,
2016
Successor
(In millions)March 31,
2018
December 31,
2017
Finished products$2,880
$3,113
$5,058
$4,500
Semi-finished products1,424
2,009
1,502
2,769
Raw materials, stores and supplies713
719
5,017
5,841
Adjustment of inventories to a last-in, first-out (LIFO) basis(161)(168)
Raw materials450
371
Stores and supplies342
447
Total$4,856
$5,673
$7,352
$8,087
Adjustment of inventories to a LIFO basis549
546
Total inventories$7,901
$8,633


1523

Table of Contents
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(Dollars in millions, except per share)

Note 9.  NOTE 12 - GOODWILL AND OTHER INTANGIBLE ASSETS

Goodwill
The following table summarizes changes in the carrying amount of goodwill for the three months ended March 31, 2018 (Successor period):
(In millions) 
Balance as of December 31, 2017$45,589
Currency translation adjustment569
Measurement period adjustments - Merger282
Measurement period adjustments - H&N Business6
Balance as of March 31, 2018$46,446

Other Intangible Assets
The gross carrying amounts and accumulated amortization of other intangible assets by major class are as follows: 
June 30, 2017December 31, 2016Successor
(In millions)March 31, 2018December 31, 2017
Gross
Accumulated
Amortization
NetGross
Accumulated
Amortization
NetGross
Accumulated
Amortization
NetGross
Accumulated
Amortization
Net
Intangible assets subject to amortization (Definite-lived): 
 
 
 
 
 
 
 
 
 
 
 
Customer lists$1,633
$(643)$990
$1,574
$(586)$988
Patents458
(287)171
446
(259)187
Purchased and licensed technology920
(589)331
964
(579)385
Trademarks / trade names54
(17)37
53
(15)38
Customer-related$9,590
$(332)$9,258
$9,502
$(186)$9,316
Developed technology4,479
(265)4,214
4,364
(144)4,220
Trademarks/trade names1,112
(48)1,064
1,117
(26)1,091
Favorable supply contracts475
(40)435
495
(17)478
Microbial cell factories407
(7)400
397
(6)391
Other1
173
(89)84
171
(82)89
386
(14)372
459
(10)449
3,238
(1,625)1,613
3,208
(1,521)1,687
Total other intangible assets with finite lives16,449
(706)15,743
16,334
(389)15,945
    
Intangible assets not subject to amortization (Indefinite-lived): 
 
 
 
 
 
 
 
 
 
 
 
In-process research and development74

74
73

73
Microbial cell factories306

306
306

306
Pioneer germplasm1,057

1,057
1,053

1,053
In-process research and development ("IPR&D")660

660
660

660
Germplasm2
6,265

6,265
6,265

6,265
Trademarks / trade names573

573
545

545
4,825

4,825
4,856

4,856
2,010

2,010
1,977

1,977
Total other intangible assets11,750

11,750
11,781

11,781
Total$5,248
$(1,625)$3,623
$5,185
$(1,521)$3,664
$28,199
$(706)$27,493
$28,115
$(389)$27,726
1. 
Primarily consists of sales and farmer networks, marketing and manufacturing alliances and non-competitionnoncompetition agreements.
2.
Pioneer germplasm is the pool of genetic source material and body of knowledge gained from the development and delivery stage of plant breeding. The company recognized germplasm as an intangible asset upon the acquisition of Pioneer. This intangible asset is expected to contribute to cash flows beyond the foreseeable future and there are no legal, regulatory, contractual, or other factors which limit its useful life.

The aggregate pre-tax amortization expense from continuing operations for definite-lived intangible assets was $57$315 million and $108$51 million for the three and six months ended June 30,March 31, 2018 and 2017, and $104 and $226 for the three and six months ended June 30, 2016, respectively. The estimated aggregate pre-tax amortization expense from continuing operations for the remainder of 20172018 and each of the next five years is approximately $95, $211, $210, $194, $141$950 million, $1,254 million, $1,244 million, $1,228 million, $1,221 million and $115,$1,207 million, respectively.


24

Note 10.  Short-Term and Long-Term Borrowings
Table of Contents
Debt OfferingNOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
In May 2017, the company completed an underwritten public offering of $1,250 of the company's 2.20 percent Notes due 2020 and $750 of the company's Floating Rate Notes due 2020 (the May 2017 Debt Offering). The proceeds of this offering were used to make a discretionary pension contribution to the company's principal U.S. pension plan. See Note 14 for further discussion regarding this contribution.

NOTE 13 - SHORT-TERM BORROWINGS, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES

Repurchase Facility
In January 2017,February 2018, the company entered into a new committed receivable repurchase agreementfacility of up to $1,300 million (the "2018 Repurchase Facility). TheFacility") which expires in December 2018. From time to time, the company and the banks modify the monthly commitment amounts to better align with working capital requirements. Under the 2018 Repurchase Facility, is structured to account for the seasonality of the agriculture business and expires on November 30, 2017. Under the Repurchase Facility, the companyDuPont may sell a portfolio of available and eligible outstanding agriculture product line customer notes receivables within the Agriculture segment to participating institutions and simultaneously must agree to repurchase such notes receivable at a future date. The 2018 Repurchase Facility is considered a secured borrowing with the customer notes receivables utilized as collateral. The amountinclusive of collateral required equalsthose that are sold and repurchased, equal to 105 percent of the outstanding borrowing amounts.amounts borrowed utilized as collateral. Borrowings under the 2018 Repurchase Facility will have an interest rate of the London interbank offered rate (LIBOR) plusLIBOR + 0.75 percent.

As of June 30, 2017, $1,365March 31, 2018, $42 million of notes receivable, recorded in accounts and notes receivable - net, were pledged as collateral against outstanding borrowings under the Repurchase Facility of $1,300,$40 million, recorded in short-term borrowings and capital lease obligations on the interim Condensed Consolidated Balance Sheet.


16

Table of Contents
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Dollars in millions, except per share)

Term Loan Facilityand Revolving Credit Facilities
In March 2016, the company entered into a credit agreement that provides for a three-year, senior unsecured term loan facility in the aggregate principal amount of $4,500 million (as may be amended, from time to time, the Term"Term Loan Facility). In the first quarter of 2017, the Term Loan Facility was amended to extend the date onFacility") under which the commitment to lend terminates. As a result, DuPont may make up to seven term loan borrowings through July 27, 2018;and amounts repaid or prepaid are not available for subsequent borrowings. The proceeds from the borrowings under the Term Loan Facility matureswill be used for the company's general corporate purposes including debt repayment, working capital and funding a portion of DowDuPont's costs and expenses. The Term Loan Facility was amended in March 20192018 to extend the maturity date to June 2020, at which time all outstanding borrowings, including accrued but unpaid interest, become immediately due and payable. As ofpayable, and to extend the date on which the commitment to lend terminates to June 30, 2017,2019. At March 31, 2018, the company had borrowed $500made three term loan borrowings in an aggregate principal amount of $1,500 million and had unused commitments of $4,000$3,000 million under the Term Loan Facility.

In addition, in 2018 the company amended its $3,000 million revolving credit facility to extend the maturity date to June 2020.

Note 11.  Commitments and Contingent LiabilitiesNOTE 14 - COMMITMENTS AND CONTINGENT LIABILITIES

Guarantees
Indemnifications
In connection with acquisitions and divestitures as of June 30, 2017,March 31, 2018, the company has indemnified respective parties against certain liabilities that may arise in connection with these transactions and business activities prior to the completion of the transactions. The term of these indemnifications, which typically pertain to environmental, tax and product liabilities, is generally indefinite. In addition, the company indemnifies its duly elected or appointed directors and officers to the fullest extent permitted by Delaware law, against liabilities incurred as a result of their activities for the company, such as adverse judgments relating to litigation matters. If the indemnified party were to incur a liability or have a liability increase as a result of a successful claim, pursuant to the terms of the indemnification, the company would be required to reimburse the indemnified party. The maximum amount of potential future payments is generally unlimited.

Obligations for Equity Affiliates & Others
The company has directly guaranteed various debt obligations under agreements with third parties related to equity affiliates, customers and suppliers. Additionally, in connection with the Separation, the company has directly guaranteed Chemours' purchase obligations under an agreement with a third party supplier. At June 30, 2017March 31, 2018 and December 31, 2016,2017, the company had directly guaranteed $298$284 million and $354,$297 million, respectively, of such obligations. These amounts represent the maximum potential amount of future (undiscounted) payments that the company could be required to make under the guarantees. The company would be required to perform on these guarantees in the event of default by the guaranteed party.

The company assesses the payment/performance risk by assigning default rates based on the duration of the guarantees. These default rates are assigned based on the external credit rating of the counterparty or through internal credit analysis and historical default history for counterparties that do not have published credit ratings. For counterparties without an external rating or available credit history, a cumulative average default rate is used.

In certain cases, the company has recourse to assets held as collateral, as well as personal guarantees from customers and suppliers. Assuming liquidation, these assets are estimated to cover approximately 20 percent of the $119$80 million of guaranteed obligations of customers and suppliers.

Set forth below are the company's guaranteed obligations at June 30, 2017March 31, 2018:.

25

Table of Contents
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)



The following tables provide a summary of the final expiration year and maximum future payments for each type of guarantee:
 Short-TermLong-TermTotal
Obligations for customers and suppliers1:
 
 
 
Bank borrowings (terms up to 5 years)$112
$7
$119
Obligations for equity affiliates2:
 
 
 
Bank borrowings (terms up to 1 year)168

168
Obligations for Chemours3:
   
Chemours' purchase obligations (final expiration - 2018)11

11
Total$291
$7
$298
Guarantees at March 31, 2018 (Successor)Final Expiration YearMaximum Future Payments
(In millions)
Obligations for customers and suppliers1:
  
Bank borrowings2022$80
Obligations for non-consolidated affiliates2:



Bank borrowings2018168
Residual value guarantees3
202936
Total guarantees $284
1.
Existing guarantees for customers and suppliers, as part of contractual agreements.
2.
Existing guarantees for equitynon-consolidated affiliates' liquidity needs in normal operations.
3.
Guarantee for Chemours' raw material purchase obligations under agreement withThe company provides guarantees related to leased assets specifying the residual value that will be available to the lessor at lease termination through sale of the assets to the lessee or third party supplier.parties.


17

Table of Contents
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Dollars in millions, except per share)

Litigation
The company is subject to various legal proceedings arising out of the normal course of its current and former business operations, including product liability, intellectual property, commercial, environmental and antitrust lawsuits. It is not possible to predict the outcome of these various proceedings. Although considerable uncertainty exists, management does not anticipate that the ultimate disposition of these matters will have a material adverse effect on the company's results of operations, consolidated financial position or liquidity.  However, the ultimate liabilities could be material to results of operations in the period recognized.

PFOA Matters
DuPont used PFOA (collectively, perfluorooctanoic acids and its salts, including the ammonium salt), as a processing aid to manufacture some fluoropolymer resins at various sites around the world including its Washington WorksWorks' plant in West Virginia. At June 30, 2017, DuPont has a total accrual balance of $656 relatedPursuant to the Separation Agreement discussed in Note 4, the company is indemnified by Chemours for the PFOA matters discussed below and has recorded a total indemnification asset of $335,$14 million.

U.S. Environmental Protection Agency (“EPA") and New Jersey Department of Environmental Protection (“NJDEP”)
DuPont is obligated under agreements with the EPA, including indemnificationsa 2009 consent decree to which Chemours was added in 2017, and has made voluntary commitments to the NJDEP. These obligations and voluntary commitments include surveying, sampling and testing drinking water in and around certain company sites and offering treatment or an alternative supply of drinking water if tests indicate the presence of PFOA in drinking water at or greater than the national health advisory level established from time to time by the EPA. At March 31, 2018, the company had an accrual of $14 million related to the MDL Settlementthese obligations and additional actions described below, from Chemours pursuantvoluntary commitments. The company recorded an indemnification asset corresponding to the Separation Agreement discussed in Note 3 and the first quarter 2017 agreement between Chemours and DuPont.accrual balance at March 31, 2018.

Leach v. DuPont
In August 2001, a class action, captioned Leach v. DuPont, was filed in West Virginia state court alleging that residents living near the Washington Works facility had suffered, or may suffer, deleterious health effects from exposure to PFOA in drinking water.

DuPont and attorneys for the class A settlement was reached a settlement in 2004 that binds aboutapproximately 80,000 residents, (the Leach Settlement)"Leach Settlement"). In 2005, DuPont paid the plaintiffs’ attorneys’addition to paying $23 million to plaintiff’s attorneys for fees and expenses of $23 and made a payment of $70 which class counsel designatedmillion to fund a community health project. The company funded a series of health studies which were completed in October 2012 by an independent science panel of experts (the C8 Science Panel). The studies were conducted in communities exposed to PFOA to evaluate available scientific evidence on whether any probable link exists, as defined in the Leach Settlement Agreement, between exposure to PFOA and human disease. The C8 Science Panel found probable links, as defined in the Leach Settlement Agreement, between exposure to PFOA and pregnancy-induced hypertension, including preeclampsia; kidney cancer; testicular cancer; thyroid disease; ulcerative colitis; and diagnosed high cholesterol.

In May 2013, a panel of three independent medical doctors released its initial recommendations for screening and diagnostic testing of eligible class members for the six human diseases for which the C8 Science Panel determined a probable link exists. In September 2014, the medical panel recommended follow-up screening and diagnostic testing three years after initial testing, based on individual results. The medical panel has not communicated its anticipated schedule for completion of its protocol. Under the Leach Settlement Agreement,project, the company is obligated to fund up to $235 million for a medical monitoring program for eligible class members and in addition,to pay administrative costs and fees associated with the program, including class counsel fees. In Januaryprogram. Since the establishment in 2012 the company established and put $1 intoof an escrow account to fund medical monitoring as required by the settlement agreement. The balance inagreement, approximately $2 million has been contributed to the escrow account must be at least $0.5; as a result, transfers of additional funds may be required periodically. The court-appointed Director of Medical Monitoringand approximately $1 million has established the program to implement the medical panel's recommendations and the registration process, as well as eligibility screening, is ongoing. Diagnostic screening and testing has begun and associated payments to service providers are beingbeen disbursed from the escrow account; at June 30, 2017 less than $1 has been disbursed. While it is probable that theaccount. The company will incur liabilities related to funding the medical monitoring program, such liabilities cannot be reasonably estimated due to uncertainties surrounding the level of participation by eligible class members and the scope of testing. In addition, under the Leach Settlement Agreement, the companyalso must continue to provide water treatment designed to reduce the level of PFOA in water to six area water districts, including the Little Hocking Water Association, (LHWA), and private well users. While it is probable that the company will incur liabilities related to funding the medical monitoring program and providing water treatment, the company does not expect any such liabilities to be material.

Multi-District LitigationUnder the Leach Settlement, the company funded a series of health studies which were completed in October 2012 by an independent science panel of experts (the "C8 Science Panel"). The C8 Science Panel found probable links, as defined in the Leach Settlement, between exposure to PFOA and pregnancy-induced hypertension, including preeclampsia; kidney cancer; testicular cancer; thyroid disease; ulcerative colitis; and diagnosed high cholesterol.


26

Table of Contents
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)


Leach class members may pursue personal injury claims against DuPont only for the six human diseases for which the C8 Science Panel determined a probable link exists. At June 30, 2017, there wereFollowing the Leach Settlement, approximately 3,550 lawsuits of which about 30 allege wrongful death, pendingalleging personal injury claims were filed in various federal and state courts in Ohio and West Virginia. These lawsuits are consolidated in multi-district litigation (MDL)("MDL") in the U.S. District Court for the Southern District of Ohio (the Court).Ohio.

MDL Settlement
In Februarythe first quarter of 2017, DuPont entered into an agreement in principle with MDL plaintiffs’ counsel providing for a global settlement of all cases and claims in the MDL including all filed and unfiled personal injury cases and claims that are part of the plaintiffs’ counsel’s claim inventory as well as the cases captioned Bartlett v. DuPont, Freeman v. DuPont, Moody v. DuPont and Vigneron v. DuPont,was settled for $670.7 million in cash (the MDL Trial Plaintiffs).


18

Table of Contents
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Dollars in millions, except per share)

In connection with all filed and unfiled personal injury cases and claims that are part of the plaintiffs' counsel's claim inventory, on March 31, 2017, DuPont and MDL plaintiffs’ counsel entered into a definitive agreement covering Leach class members who either, 1) asserted a qualifying claim, not previously settled, withdrawn or dismissed as of February 11, 2017; or 2) claimed to have a qualifying condition and on or before February 11, 2017, had retained counsel for purposes of making a qualifying claim,(the Master Settlement Agreement). The required participation thresholds have been met for each disease category and the parties deemed the Master Settlement Agreement effective on July 6, 2017 (the MSA Effective Date).

Also on March 31, 2017, DuPont and MDL plaintiffs’ counsel entered into a definitive agreement related to the MDL Trial Plaintiffs (the MDL Trial Plaintiffs Settlement Agreement) under which all payments were complete at June 30, 2017 and the individual actions have been or will be dismissed. The Master Settlement Agreement and the MDL Trial Plaintiffs Settlement Agreement (collectively referred to as the MDL Settlement) are not subject to court approval.

The aggregate total settlement amount under the MDL Settlement is $670.7 in cash. DuPont and Chemours have agreed that"MDL Settlement"), half of that amount will bewhich was paid by Chemours and half paid by DuPont. The portion paid by DuPont was recorded, for the three months ended March 31, 2017, within loss from discontinued operations after income taxes in the interim Consolidated Statements of Operations. In 2017, all payments under the settlement agreement were made by both companies. DuPont’s payment wouldwas not be subject to indemnification or reimbursement by Chemours.  In exchange for that payment, DuPont and Chemours will receive a complete releaseare receiving releases of all claims by the settling plaintiffs. The MDL Settlement was entered into solely by way of compromise and settlement and is not in any way an admission of liability or fault by DuPont or Chemours. All of the MDL plaintiffs participated and resolved their claims within the MDL Settlement.

Post MDL Settlement PFOA Personal Injury Claims
The MDL Settlement did not resolve claims of plaintiffs who did not have claims in the MDL or whose claims are based on diseases first diagnosed after February 11, 2017. At March 31, 2018, 34 lawsuits alleging personal injury, including kidney and testicular cancer, from exposure to PFOA in drinking water had been filed against the company in West Virginia and Ohio.

In connectionaddition, three lawsuits are pending in federal court in New York on behalf of five individuals who are residents of Hoosick Falls, New York. The plaintiffs claim personal injuries, including kidney cancer, thyroid disease and ulcerative colitis, from alleged exposure to PFOA discharged into the air and water from nearby manufacturing facilities owned and operated by defendant third parties. Plaintiffs claim that PFOA used at the facilities was purchased from or manufactured by the company and co-defendant, 3M Company.

Water Utility and Related Actions
Actions filed by local water utilities pending in Alabama and New Jersey state court allege contamination from PFOA, and in the case of the Alabama action, perfluorinated chemicals and compounds, including PFOA, (“PFCs”) used in co-defendant manufacturers’ operations. In February 2018, the State of Ohio filed suit in Ohio state court alleging natural resource damages from historical PFOA emissions from the Washington Works site. The plaintiffs in these suits seek monetary damages, remediation and other costs / damages.

While it is reasonably possible that the company could incur liabilities related to the post MDL Settlement PFOA personal injury claims and the water utility and related actions described above, any such liabilities are not expected to be material. Chemours is defending and indemnifying the company in these matters in accordance with the amendment to the Separation Agreement discussed below.

Amendment to Separation Agreement
Concurrent with the MDL Settlement, the company increased the accrual related to the PFOA multi-district litigation to $670.7 at March 31, 2017, (the MDL Settlement Accrual). Due to the first quarter 2017 agreement with Chemours discussed above, the company increased the indemnification asset related to the PFOA multi-district litigation to $335 at March 31, 2017. The remainder of the MDL Settlement Accrual amount was recorded as a charge of $335 ($214 net of tax) which is included in income (loss) from discontinued operations after taxes in the company's interim Consolidated Income Statement during the six months ended June 30, 2017. At June 30, 2017, the MDL Settlement Accrual and related indemnification asset were $640.7 and $320, respectively, a decrease of $30 in the accrual balance from March 31, 2017, and $15 in the indemnification asset from March 31, 2017, related to payment under the MDL Trial Plaintiffs Settlement Agreement described above. The settlement payment for the Master Settlement Agreement is due in the third quarter 2017.

DuPont and Chemours have also agreed, subjectamended the Separation Agreement to and following the MSA Effective Date, toprovide for a limited sharing of potential future PFOA liabilities (i.e., indemnifiable losses, as defined in the Separation Agreement) for a period of 5five years starting on the MSA Effective Date.beginning July 6, 2017. During that five-year period, Chemours wouldwill annually pay future PFOA liabilities up to $25 million and, if such amount is exceeded, DuPont would pay any excess amount up to the next $25 million (which payment will not be subject to indemnification by Chemours), with Chemours annually bearing any further excess liabilities. After the five-year period, this limited sharing agreement wouldwill expire, and Chemours’ indemnification obligations under the Separation Agreement wouldwill continue unchanged.  There have been no charges incurred by DuPont under this arrangement through March 31, 2018. Chemours has also agreed that upon the occurrence of the MSA Effective Date, it will not contest its liability to DuPont under the Separation Agreement for PFOA liabilities on the basis of ostensible defenses generally applicable to the indemnification provisions under the Separation Agreement, including defenses relating to punitive damages, fines or penalties or attorneys’ fees, and waives any such defenses with respect to PFOA liabilities.  Chemours has, however, retained defenses as to whether any particular PFOA claim is within the scope of the indemnification provisions of the Separation Agreement.

Status of MDL Post MDL Settlement
The MDL Trial Plaintiffs cases have been dismissed as a result of the completion of actions under the MDL Trial Plaintiffs Settlement Agreement. Other litigation and judicial proceedingsIt is possible that new lawsuits could be filed against DuPont related to PFOA that may not be within the MDL pending before the Court and U.S. Court of Appeals for the Sixth Circuit have been stayed (the MDL Stay) as a resultscope of the MDL Settlement.

Additional Actions
Since 2006, DuPont has undertaken obligations under agreements with the U.S. Environmental Protection Agency (EPA), including a 2009 consent decree Any such new litigation would be subject to indemnification by Chemours under the Safe Drinking Water Act (the Order), and voluntary commitments to the New Jersey Department of Environmental Protection (NJDEP).  These obligations and voluntary commitments include surveying, sampling and testing drinking water in and around certain company sites and offering treatment or an alternative supply of drinking water if tests indicate the presence of PFOA in drinking water at or greater than the national health advisory level, even if provisional,Separation Agreement, as established from time to time by the EPA. A provisional health advisory level was set in 2009 at 0.4 parts per billion (ppb) for PFOA in drinking water considering episodic exposure. In May 2016, the EPA announced a health advisory level of 0.07 ppb for PFOA in drinking water considering lifetime versus episodic exposure. In January 2017, the EPA announced it had amended the Order to include Chemours, and to make the new health advisory level the trigger for additional actions by the companies, thus expanding the obligations to the EPA beyond the previously established testing and water supply commitments around the Washington Works facility. The company's accrual balance at June 30, 2017, includes $15 related to these obligations and voluntary commitments.amended.


1927

Table of Contents
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(Dollars in millions, except per share)

Fayetteville Works Facility, North Carolina
Prior to the separation of Chemours, the company introduced GenX as a polymerization processing aid and a replacement for PFOA at the Fayetteville Works facility. The facility is now owned and operated by Chemours which continues to manufacture and use GenX. Chemours is responding to ongoing inquiries and investigations from federal, state and local investigators, regulators and other governmental authorities as well as inquiries from the media and local community stakeholders. These inquiries and investigations involve the discharge of GenX and certain similar compounds from the Chemours’ facility at Fayetteville Works into the Cape Fear River in Bladen County, North Carolina.

EnvironmentalIn August 2017, the U.S. Attorney’s Office for the Eastern District of North Carolina served the company with a grand jury subpoena for testimony and the production of documents related to alleged discharges of GenX from the Fayetteville Works facility into the Cape Fear River. In the fourth quarter of 2017, DuPont was served with additional subpoenas relating to the same issue. It is possible that these ongoing inquiries and investigations, including the grand jury subpoena, could result in penalties or sanctions, or that additional litigation will be instituted against Chemours and/or the company.

At March 31, 2018, several actions, filed on behalf of putative classes of property owners and residents in areas near or who draw drinking water from the Cape Fear River, are pending in federal court against Chemours and the company. DowDuPont has been dismissed without prejudice from all such actions in which it was named. These actions relate to the alleged discharge of certain PFCs into the river from the operations and wastewater treatment at the Fayetteville Works facility. The actions, filed in the fourth quarter of 2017 and consolidated into a single purported class action, seek various relief including medical monitoring, property damages and injunctive relief. Separate actions filed by the various North Carolina water authorities including Cape Fear Public Utility Authority and Brunswick County, North Carolina, have been consolidated into a single purported class action seeking actual and punitive damages as well as injunctive relief. In the first quarter of 2018, approximately 70 plaintiffs, who own property near the Fayetteville Works facility, filed an action seeking damages for nuisance allegedly caused by releases of certain PFCs from the site.

Management believes the probability of loss with respect to these actions is remote.

The company has an indemnification claim against Chemours with respect to current and future inquiries and claims, including lawsuits, related to the foregoing. At March 31, 2018, Chemours is also subject to contingencies pursuant to environmental lawsdefending and regulations thatindemnifying the company in the future may require the company to take further action to correct the effects on the environment of prior disposal practices or releases of chemical or petroleum substances by the company or other parties. The company accruespending civil actions.

Environmental
Accruals for environmental remediation activities consistent with the policy as described in the company's 2016 Annual Report in Note 1, "Summary of Significant Accounting Policies." Much of this liability results from the Comprehensive Environmental Response, Compensation and Liability Act (CERCLA, often referred to as Superfund), the Resource Conservation and Recovery Act (RCRA) and similar state and global laws. These laws require the company to undertake certain investigative, remediation and restoration activities at sites where the company conducts or once conducted operations or at sites where company-generated waste was disposed. The accrual also includes estimated costs related to a number of sites identified by the company for whichmatters are recorded when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated based on current law and existing technologies. At March 31, 2018, the company had accrued obligations of $430 million for probable environmental remediation will be required, but whichand restoration costs, including $61 million for the remediation of Superfund sites. These obligations are not currentlyincluded in accrued and other current liabilities and other noncurrent obligations in the subject of enforcement activities.

Remediation activities vary substantially in duration and cost from site to site. These activities, and their associated costs, depend on the mix of unique site characteristics, evolving remediation technologies, diverse regulatory agencies and enforcement policies, as well as the presence or absence of potentially responsible parties. At June 30, 2017, theinterim Condensed Consolidated Balance Sheet included a liabilitySheets. This is management’s best estimate of $490, relatingthe costs for remediation and restoration with respect to theseenvironmental matters and, in management's opinion, is appropriate based on existing facts and circumstances. The average time frame overfor which the company has accrued or presently unrecognized amounts may be paid, based on past history,liabilities, although it is estimated to be 15-20 years. Considerable uncertainty existsreasonably possible that the ultimate cost with respect to these costs and, under adverse changes in circumstances, the potential liability mayparticular matters could range up to $790$885 million above the amount accrued asat March 31, 2018. Consequently, it is reasonably possible that environmental remediation and restoration costs in excess of June 30, 2017. amounts accrued could have a material impact on the company’s results of operations, financial condition and cash flows. It is the opinion of the company’s management, however, that the possibility is remote that costs in excess of the range disclosed will have a material impact on the company’s results of operations, financial condition or cash flows. Inherent uncertainties exist in these estimates primarily due to unknown conditions, changing governmental regulations and legal standards regarding liability, and emerging remediation technologies for handling site remediation and restoration.

Pursuant to the Separation Agreement, discussed in Note 3, the company is indemnified by Chemours for certain environmental matters, included in the liability of $490,$430 million, that have an estimated liability of $261$242 million as of June 30, 2017,March 31, 2018, and a potential exposure that ranges up to approximately $410$430 million above the amount accrued. As such, the company has recorded an indemnification asset of $261$242 million corresponding to the company’s accrual balance related to these matters at June 30, 2017.March 31, 2018, including $42 million related to the Superfund sites.


2028

Table of Contents
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(Dollars in millions, except per share)

Note 12.  Stockholders’NOTE Equity15 - STOCKHOLDERS' EQUITY

Other Comprehensive Income (Loss)
The changes and after-tax balances of components comprising accumulated other comprehensive loss are summarized below:
Cumulative Translation Adjustment1
Net Gains (Losses) on Cash Flow Hedging Derivative InstrumentsPension Benefit PlansOther Benefit PlansUnrealized Gain (Loss) on SecuritiesTotal
(In millions)
Cumulative Translation Adjustment1
Derivative InstrumentsPension Benefit PlansOther Benefit PlansUnrealized Gain (Loss) on InvestmentsTotal
2017 
 
 
 
 
 
   
Balance January 1, 2017$(2,843)$7
$(6,720)$(357)$2
$(9,911)
Balance January 1, 2017 (Predecessor)
$(2,843)$7
$(6,720)$(357)$2
$(9,911)
Other comprehensive income (loss) before reclassifications653
2
(47)
1
609
378
2
(15)
1
366
Amounts reclassified from accumulated other comprehensive income (loss)
(13)244
7
(1)237

(5)124
4
(1)122
Net other comprehensive income (loss)653
(11)197
7

846
378
(3)109
4

488
Balance June 30, 2017$(2,190)$(4)$(6,523)$(350)$2
$(9,065)
Balance March 31, 2017 (Predecessor)
$(2,465)$4
$(6,611)$(353)$2
$(9,423)
   
2018 
 
 
 
 
 
Balance January 1, 2018 (Successor)
$(454)$(2)$128
$(53)$
$(381)
Other comprehensive income before reclassifications957
12
4


973
Amounts reclassified from accumulated other comprehensive loss
(1)


(1)
Net other comprehensive income957
11
4


972
Balance March 31, 2018 (Successor)
$503
$9
$132
$(53)$
$591
1. 
The cumulative translation adjustment gain for the sixthree months ended June 30,March 31, 2017 is primarily driven by the weakening of the U.S. dollar (USD)("USD") against the European Euro (EUR)("EUR") and the Brazilian real ("BRL").

 
Cumulative Translation Adjustment1
Net Gains (Losses) on Cash Flow Hedging Derivative Instruments
Pension Benefit Plans2
Other Benefit PlansUnrealized Gain (Loss) on SecuritiesTotal
2016 
 
 
 
 
 
Balance January 1, 2016$(2,333)$(24)$(7,043)$22
$(18)$(9,396)
Other comprehensive income (loss) before reclassifications73
23
(1,564)(170)(7)(1,645)
Amounts reclassified from accumulated other comprehensive income (loss)
11
309
(49)13
284
Net other comprehensive income (loss)73
34
(1,255)(219)6
(1,361)
Balance June 30, 2016$(2,260)$10
$(8,298)$(197)$(12)$(10,757)
1.
The cumulativecurrency translation adjustment gain for the sixthree months ended June 30, 2016 isMarch 31, 2018 was primarily driven by a modestthe weakening of the USD against the EUR, andas well as the Brazilian real (BRL).
2.
The Pension Benefit Plans loss recognized in other comprehensive (loss) income during the six months ended June 30, 2016 includes the impact of the re-measurement of the principal U.S. pension plan as of June 30, 2016. See Note 14 for additional information.Danish Kroner.

The tax (expense) benefit on the net activity related to each component of other comprehensive income (loss) were as follows:
 Three Months EndedSix Months Ended
 June 30,June 30,
 2017201620172016
Net gains (losses) on cash flow hedging derivative instruments$5
$(11)$6
$(21)
Pension benefit plans, net(54)357
(114)708
Other benefit plans, net(2)58
(4)119
Tax (expense) benefit from income taxes related to other comprehensive income (loss) items$(51)$404
$(112)$806

 SuccessorPredecessor
(In millions)Three Months Ended March 31, 2018Three Months Ended March 31, 2017
Derivative instruments$(4)$1
Pension benefit plans - net(2)(60)
Other benefit plans - net
(2)
Provision for income taxes related to other comprehensive income (loss) items$(6)$(61)


2129

Table of Contents
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(Dollars in millions, except per share)

A summary of the reclassifications out of accumulated other comprehensive lossincome (loss) is provided as follows:
Three Months EndedSix Months EndedConsolidated Statements of Income ClassificationSuccessorPredecessorIncome Classification
June 30,June 30,
2017201620172016
Net gains (losses) on cash flow hedging derivative instruments, before tax:$(13)$7
$(21)$18
See (1) below
Tax expense (benefit)5
(3)8
(7)See (2) below
(In millions)Three Months Ended March 31, 2018Three Months Ended March 31, 2017Income Classification
Derivative Instruments:$(1)$(8)
Tax expense
3
(2)
After-tax$(8)$4
$(13)$11
 $(1)$(5) 
Amortization of pension benefit plans:    



 
Prior service benefit(1)(1)(2)(3)See (3) below
(1)(3)
Actuarial losses189
204
379
376
See (3) below
190
(3)
Curtailment loss
17

66
See (3) below
Settlement loss
37

38
See (3) below
Total before tax$188
$257
$377
$477
 $
$189
 
Tax benefit(68)(91)(133)(168)See (2) below
(65)(2)
After-tax$120
$166
$244
$309
 $
$124
 
Amortization of other benefit plans:    



 
Prior service benefit(18)(36)(35)(75)See (3) below
(17)(3)
Actuarial losses23
18
46
35
See (3) below
23
(3)
Curtailment gain
(3)
(33)See (3) below
Total before tax$5
$(21)$11
$(73) $
$6
 
Tax (benefit) expense(2)8
(4)24
See (2) below
Tax benefit
(2)(2)
After-tax$3
$(13)$7
$(49) $
$4
 
Net realized gains (losses) on investments, before tax:
12
(1)13
See (4) below
Net realized losses on investments, before tax:
(1)(4)
Tax expense



See (2) below

(2)
After-tax$
$12
$(1)$13
 $
$(1) 
Total reclassifications for the period, after-tax$115
$169
$237
$284
 $(1)$122
 
1. 
Cost of goods sold.
2. 
Provision for income taxes from continuing operations.
3. 
These accumulated other comprehensive lossincome (loss) components are included in the computation of net periodic benefit cost of the company's pension and other benefit plans. See Note 1416 for additional information.
4. 
Other (loss)Sundry income - net.



2230

Table of Contents
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(Dollars in millions, except per share)

Note 13. Financial Instruments
Cash, Cash Equivalents and Marketable Securities
The company's cash, cash equivalents and marketable securities as of June 30, 2017 and December 31, 2016 are comprised of the following:
 June 30, 2017December 31, 2016
 Cash and Cash EquivalentsMarketable SecuritiesTotal Estimated Fair ValueCash and Cash EquivalentsMarketable SecuritiesTotal Estimated Fair Value
Cash$1,507
$
$1,507
$1,892
$
$1,892
       
Level 2:      
Certificate of deposit / time deposits1
1,747
2,974
4,721
2,713
1,362
4,075
       
Total cash, cash equivalents and marketable securities$3,254
$2,974
 $4,605
$1,362
 
1.NOTE 16 - PENSION PLANS AND OTHER POST EMPLOYMENT BENEFITS
Represents held-to-maturity investments reported at amortized cost.

The estimated fair value of the company's cash equivalents, which approximates carrying value as of June 30, 2017 and December 31, 2016, was determined using Level 2 inputs within the fair value hierarchy. Level 2 measurements were based on current interest rates for similar investments with comparable credit risk and time to maturity.

The estimated fair valuefollowing sets forth the components of the company's net periodic benefit (credit) cost for defined benefit pension plans and other post employment benefits:
 Defined Benefit Pension PlansOther Post Employment Benefits
 SuccessorPredecessorSuccessorPredecessor
(In millions)Three Months Ended March 31, 2018Three Months Ended March 31, 2017Three Months Ended March 31, 2018Three Months Ended March 31, 2017
Service cost$34
$33
$2
$2
Interest cost190
195
21
22
Expected return on plan assets(303)(308)

Amortization of unrecognized loss
190

23
Amortization of prior service benefit
(1)
(17)
Net periodic benefit (credit) cost - Total$(79)$109
$23
$30
Less: Discontinued operations
1


Net periodic benefit (credit) cost - Continuing operations$(79)$108
$23
$30

In accordance with adopted ASU No. 2017-07, service costs are included in cost of goods sold, research and development expense and selling, general and administrative expenses in the interim Consolidated Statements of Operations. Non-service related components of net periodic benefit (credit) cost are included in sundry income - net in the interim Consolidated Statements of Operations. See Notes 1, 2 and 8 for additional information.

NOTE 17 - FINANCIAL INSTRUMENTS

At March 31, 2018, the company had $3,838 million ($5,205 million at December 31, 2017) of held-to-maturity securities (primarily time deposits and money market funds) classified as cash equivalents, as these securities had maturities of three months or less at the time of purchase; and $246 million ($952 million at December 31, 2017) of held-to-maturity securities (primarily time deposits) classified as marketable securities as these securities had maturities of more than three months to less than one year at the time of purchase. The company’s investments in held-to-maturity securities are held at amortized cost, which approximates carrying value as of June 30, 2017fair value. These securities are included in cash and December 31, 2016, was determined using Level 2 inputs withincash equivalents, marketable securities, and other current assets in the fair value hierarchy. Level 2 measurements were based on current interest rates for similar investments with comparable credit risk and time to maturity. The carrying value approximates fair value due to the short-term nature of the investments.consolidated balance sheets.

Available-for-sale securities are reported at estimated fair value with unrealized gains and losses reported as a component of accumulated other comprehensive loss. There were no sales of available-for-sale securities for the three and six months ended June 30, 2017. The proceeds from the sale of available-for-sale securities for the threeMarch 31, 2018 and six months ended June 30, 2016 were $205 and $465,2017, respectively.

Debt
The estimated fair value of the company's total debt, including interest rate financial instruments, was determined using Level 2 inputs within the fair value hierarchy, as described in the company's 2016 Annual Report in Note 1,Summary of Significant Accounting Policies.Based on quoted market prices for the same or similar issues or on current rates offered to the company for debt of the same remaining maturities, the fair value of the company's debt was approximately $14,060 and $8,890 as of June 30, 2017 and December 31, 2016, respectively. The increase was due primarily to the May 2017 Debt Offering as well as increased borrowings from commercial paper and the Repurchase Facility used primarily to fund seasonal working capital requirements. See Note 10 for further discussion.

Derivative Instruments
Objectives and Strategies for Holding Derivative Instruments
In the ordinary course of business, the company enters into contractual arrangements (derivatives) to reduce its exposure to foreign currency, interest rate and commodity price risks. The company has established a variety of derivative programs to be utilized for financial risk management. These programs reflect varying levels of exposure coverage and time horizons based on an assessment of risk.

Derivative programs have procedures and controls and are approved by the Corporate Financial Risk Management Committee, consistent with the company's financial risk management policies and guidelines. Derivative instruments used are forwards, options, futures and swaps. The company has not designated any nonderivatives as hedging instruments.


23

Table of Contents
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Dollars in millions, except per share)

The company's financial risk management procedures also address counterparty credit approval, limits and routine exposure monitoring and reporting. The counterparties to these contractual arrangements are major financial institutions and major commodity exchanges. The company is exposed to credit loss in the event of nonperformance by these counterparties. The company utilizes collateral support annex agreements with certain counterparties to limit its exposure to credit losses. The company's derivative assets and liabilities are reported on a gross basis in the Condensed Consolidated Balance Sheets. The company anticipates performance by counterparties to these contracts and therefore no material loss is expected. Market and counterparty credit risks associated with these instruments are regularly reported to management.


31

Table of Contents
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)


The notional amounts of the company's derivative instruments were as follows:

June 30, 2017December 31, 2016
Notional AmountsSuccessor
(In millions)March 31, 2018December 31, 2017
Derivatives designated as hedging instruments:   
Commodity contracts$173
$422
$264
$587
Derivatives not designated as hedging instruments:  



Foreign currency contracts9,782
9,896
9,959
10,454
Commodity contracts6
7
34
6

Foreign Currency Risk
The company's objective in managing exposure to foreign currency fluctuations is to reduce earnings and cash flow volatility associated with foreign currency rate changes. Accordingly, the company enters into various contracts that change in value as foreign exchange rates change to protect the value of its existing foreign currency-denominated assets, liabilities, commitments and cash flows.

The company routinely uses forward exchange contracts to offset its net exposures, by currency, related to the foreign currency-denominatedcurrency denominated monetary assets and liabilities of its operations. The primary business objective of this hedging program is to maintain
an approximately balanced position in foreign currencies so that exchange gains and losses resulting from exchange rate changes,
net of related tax effects, are minimized. The company also uses foreign currency exchange contracts to offset a portion of the company's exposure to certain foreign currency-denominated revenues so that gains and losses on these contracts offset changes
in the USD value of the related foreign currency-denominated revenues. The objective of the hedge program is to reduce earnings
and cash flow volatility related to changes in foreign currency exchange rates.

Commodity Price Risk
Commodity price risk management programs serve to reduce exposure to price fluctuations on purchases of inventory such as corn, soybeans, soybean oil and soybean meal. The company enters into over-the-counter and exchange-traded derivative commodity instruments to hedge the commodity price risk associated with agricultural commodity exposures.

Derivatives Designated as Cash Flow Hedges
Foreign Currency Contracts
The company uses foreign currency exchange instruments such as forwards and options to offset a portion of the company's exposure to certain foreign currency-denominated revenues so that gains and losses on these contracts offset changes in the USD value of the related foreign currency-denominated revenues. In addition, the company occasionally uses forward exchange contracts to offset a portion of the company'scompany’s exposure to certain foreign currency-denominated transactions such as capital expenditures.

Commodity Contracts
The company enters into over-the-counter and exchange-traded derivative commodity instruments, including options, futures and swaps, to hedge the commodity price risk associated with agriculture commodity exposures.


24

Table of Contents
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Dollars in millions, except per share)

While each risk management program has a different time maturity period, most programs currently do not extend beyond the next two-year period. Cash flow hedge results are reclassified into earnings during the same period in which the related exposure impacts earnings. Reclassifications are made sooner if it appears that a forecasted transaction is not probable of occurring.

The following table summarizes the after-tax effect of cash flow hedges on accumulated other comprehensive loss for the three and six months ended June 30, 2017 and 2016:loss:
Three Months EndedSix Months EndedSuccessorPredecessor
June 30,June 30,
2017201620172016
(In millions)Three Months Ended March 31, 2018Three Months Ended March 31, 2017
Beginning balance$4
$(7)$7
$(24)$(2)$7
Additions and revaluations of derivatives designated as cash flow hedges
13
2
23
12
2
Clearance of hedge results to earnings(8)4
(13)11
(1)(5)
Ending balance$(4)$10
$(4)$10
$9
$4

32

Table of Contents
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)



At June 30, 2017,March 31, 2018, an after-tax net lossgain of $(2)$4 million is expected to be reclassified from accumulated other comprehensive loss into earnings over the next twelve months.

Derivatives not Designated in Hedging Relationships
Foreign Currency Contracts
The company routinely uses forward exchange contracts to reduce its net exposure, by currency, related to foreign currency-denominated monetary assets and liabilities of its operations so that exchange gains and losses resulting from exchange rate changes are minimized. The netting of such exposures precludes the use of hedge accounting; however, the required revaluation of the forward contracts and the associated foreign currency-denominated monetary assets and liabilities intends to achieve a minimal earnings impact, after taxes. The company also uses foreign currency exchange contracts to offset a portion of the company's exposure to certain foreign currency-denominated revenues so that gains and losses on the contracts offset changes in the USD value of the related foreign currency-denominated revenues.

Commodity Contracts
The company utilizes options, futures and swaps that are not designated as hedging instruments to reduce exposure to commodity price fluctuations on purchases of inventory such as corn, soybeans, soybean oil and soybean meal.

Fair ValuesValue of Derivative Instruments
Asset and liability derivatives subject to an enforceable master netting arrangement with the same counterparty are presented on a net basis in the interim Condensed Consolidated Balance Sheets. The table below presents the fair valuespresentation of the company's derivative assets and liabilities within the fair value hierarchy,is as described in the company's 2016 Annual Report in Note 1, “Summary of Significant Accounting Policies.”follows:
 Fair Value Using Level 2 Inputs Successor
Balance Sheet LocationJune 30, 2017December 31, 2016 March 31, 2018
(In millions)Balance Sheet LocationGross
Counterparty and Cash Collateral Netting1
Net Amounts Included in the Condensed Consolidated Balance Sheet
Asset derivatives:       
Derivatives not designated as hedging instruments:  
   
  
Foreign currency contracts1
Accounts and notes receivable, net$44
$182
Commodity contractsAccounts and notes receivable, net3

Total asset derivatives2
 $47
$182
Cash collateral1
Other accrued liabilities$
$52
Foreign currency contractsOther current assets$33
$(24)$9
Total asset derivatives $33
$(24)$9
       
Liability derivatives:  
   
  
Derivatives not designated as hedging instruments:  
 
  
  
Foreign currency contractsOther accrued liabilities$125
$121
Accrued and other current liabilities$70
$(20)$50
Total liability derivatives2
 $125
$121
Total liability derivatives $70
$(20)$50
1. 
CashCounterparty and cash collateral held as of December 31, 2016 is related to foreign currency derivatives not designated as hedging instruments.
2.
The company's derivative assetsamounts represent the estimated net settlement amount when applying netting and liabilities subject to enforceableset-off rights included in master netting arrangements totaled $39 at June 30, 2017between the company and $114 at December 31, 2016.its counterparties and the payable or receivable for cash collateral held or placed with the same counterparty.


2533

Table of Contents
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(Dollars in millions, except per share)

  Successor
  December 31, 2017
(In millions)Balance Sheet LocationGross
Counterparty and Cash Collateral Netting1
Net Amounts Included in the Condensed Consolidated Balance Sheet
Asset derivatives:    
Derivatives not designated as hedging instruments:  
  
Foreign currency contractsOther current assets$46
$(37)$9
Total asset derivatives $46
$(37)$9
     
Liability derivatives:  
  
Derivatives not designated as hedging instruments:  
  
Foreign currency contractsAccrued and other current liabilities$79
$(32)$47
Total liability derivatives $79
$(32)$47
1.
Counterparty and cash collateral amounts represent the estimated net settlement amount when applying netting and set-off rights included in master netting arrangements between the company and its counterparties and the payable or receivable for cash collateral held or placed with the same counterparty.

Effect of Derivative Instruments
 
Amount of Gain (Loss)
Recognized in OCI1
(Effective Portion)
Amount of Gain (Loss)
Recognized in Income2
 
Three Months Ended June 30,2017201620172016Income Statement Classification
Derivatives designated as hedging instruments:     
Cash flow hedges:     
Commodity contracts$
$21
$13
$(7)Cost of goods sold
 
21
13
(7) 
Derivatives not designated as hedging instruments:     
Foreign currency contracts

(86)(161)
Other (loss) income, net3
Foreign currency contracts

(1)(11)Net sales
Commodity contracts


(10)Cost of goods sold
 

(87)(182) 
Total derivatives$
$21
$(74)$(189) 

Amount of Gain (Loss)
Recognized in OCI
1 
(Effective Portion)
Amount of Gain (Loss)
Recognized in Income
2
 
Amount of Gain Recognized in OCI1 (Effective Portion) - Pre-Tax
Six Months Ended June 30,2017201620172016Income Statement Classification
SuccessorPredecessor
(In millions)Three Months Ended March 31, 2018Three Months Ended March 31, 2017
Derivatives designated as hedging instruments:     
Cash flow hedges:   



Commodity contracts$4
$37
$21
$(18)Cost of goods sold$16
$4
4
37
21
(18) 
Derivatives not designated as hedging instruments:   
Foreign currency contracts

(171)(315)
Other (loss) income, net3
Foreign currency contracts

(1)(15)Net sales
Commodity contracts

4
(10)Cost of goods sold


(168)(340) 
Total derivatives designated as hedging instruments$16
$4
Total derivatives$4
$37
$(147)$(358) $16
$4
1. 
OCI is defined as other comprehensive income (loss).

 
Amount of Gain (Loss) Recognized in Income - Pre-Tax1
 SuccessorPredecessor
(In millions)Three Months Ended March 31, 2018Three Months Ended March 31, 2017
Derivatives designated as hedging instruments:  
Cash flow hedges:



Commodity contracts2
$1
$8
Total derivatives designated as hedging instruments$1
$8
Derivatives not designated as hedging instruments:  
Foreign currency contracts3
(181)(85)
Commodity contracts2
(3)4
Total derivatives not designated as hedging instruments(184)(81)
Total derivatives$(183)$(73)
2.1. 
For cash flow hedges, this represents the effective portion of the gain (loss) reclassified from accumulated OCI into income during the period. For the three and six months ended months ended June 30, 2017 and 2016, thereThere was no material ineffectiveness with regard to the company's cash flow hedges.hedges during the period.
2.
Recorded in cost of goods sold.
3. 
Gain (loss) recognized in other (loss)sundry income - net was partially offset by the related gain (loss) on the foreign currency-denominated monetary assets and liabilities of the company's operations, seeoperations. See Note 58 for additional information.

Note 14. Long-Term Employee Benefits
Defined Benefit Pensions
The workforce reductions in 2016 related to the 2016 global cost savings and restructuring plan triggered curtailments for certain of the company's pension plans, including the principal U.S. pension plan. For the principal U.S. pension plan, the company recorded curtailment losses of $14 and $63 during the three and six months ended June 30, 2016 and re-measured the principal U.S. pension plan as of March 31, 2016 and June 30, 2016. The curtailment loss was driven by the changes in the benefit obligation based on the demographics of the terminated positions partially offset by accelerated recognition of a portion of the prior service benefit. In connection with the re-measurements, the company recognized a pre-tax net loss of $2,352 within other comprehensive income (loss) for the six months ended June 30, 2016. The loss was driven by the decrease in the discount rate from 4.47% at December 31, 2015 to 3.74% as of June 30, 2016. In addition, the company recorded a $31 settlement charge during the three months ended June 30, 2016 related to the company's Pension Restoration Plan which provides for lump sum payments to certain eligible retirees.


26

Table of Contents
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Dollars in millions, except per share)

The following sets forth the components of the company’s net periodic benefit cost for pensions:
 Three Months EndedSix Months Ended
 June 30,June 30,
 2017201620172016
Service cost$34
$42
$67
$89
Interest cost197
206
392
423
Expected return on plan assets(309)(331)(617)(669)
Amortization of loss189
204
379
376
Amortization of prior service benefit(1)(1)(2)(3)
Curtailment loss
17

66
Settlement loss
37

38
Net periodic benefit cost - Total$110
$174
$219
$320
Less: Discontinued operations


(4)
Net periodic benefit cost - Continuing operations$110
$174
$219
$324

During the six months ended June 30, 2017, the company made total contributions of $2,900 to its principal U.S. pension plan funded through the May 2017 Debt Offering; short-term borrowings, including commercial paper issuance; and cash. See Note 10 for further discussion related to the May 2017 Debt Offering.

Other Post Employment Benefits
As a result of the workforce reductions noted above, curtailments were triggered for the company's other post employment benefit plans. The company recorded curtailment gains of $3 and $33 for the three and six months ended June 30, 2016 and re-measured the associated plans as of March 31, 2016 and June 30, 2016. The curtailment gains were driven by accelerated recognition of a portion of the prior service benefit partially offset by the change in the benefit obligation based on the demographics of the terminated positions. In connection with the re-measurements, the company recognized a pre-tax net loss of $265 within other comprehensive income (loss) for the six months ended June 30, 2016. The loss was driven by the decrease in the discount rate from 4.30% at December 31, 2015 to 3.55% as of June 30, 2016.

The following sets forth the components of the company’s net periodic benefit cost (credit) for other post employment benefits:
 Three Months EndedSix Months Ended
 June 30,June 30,
 2017201620172016
Service cost$2
$4
$4
$7
Interest cost23
21
45
44
Amortization of loss23
18
46
35
Amortization of prior service benefit(18)(36)(35)(75)
Curtailment gain
(3)
(33)
Net periodic benefit cost (credit) - Total
$30
$4
$60
$(22)

2734

Table of Contents
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(Dollars in millions, except per share)

Note 15.  Segment InformationNOTE 18 - FAIR VALUE MEASUREMENTS
Segment operating earnings is defined as income (loss) from continuing operations before income taxes excluding significant pre-tax benefits (charges), non-operating pension
The following tables summarize the bases used to measure certain assets and other post employment benefit (OPEB) costs, exchange gains (losses), corporate expenses and interest. Non-operating pension and OPEB costs includes all of the components of net periodic benefit cost from continuing operations with the exception of the service cost component.
Three Months
Ended June 30,
Agriculture1
Electronics &
Communications
Industrial BiosciencesNutrition & Health
Performance
Materials
Protection SolutionsOtherTotal
2017 
 
   
 
 
 
Net sales$3,446
$546
$395
$818
$1,381
$801
$37
$7,424
Operating earnings963
116
76
135
329
191
(53)1,757
         
2016 
 
   
 
 
 
Net sales$3,218
$494
$355
$835
$1,335
$786
$38
$7,061
Operating earnings865
93
62
130
325
188
(50)1,613
liabilities at fair value on a recurring basis:

Six Months
Ended June 30,
Agriculture1
Electronics &
Communications
Industrial BiosciencesNutrition & Health
Performance
Materials
Protection SolutionsOtherTotal
2017 
 
   
 
 
 
Net sales$7,374
$1,056
$763
$1,607
$2,749
$1,548
$70
$15,167
Operating earnings2,199
205
151
256
684
368
(115)3,748
         
2016 
 
   
 
 
 
Net sales$7,004
$946
$707
$1,636
$2,584
$1,515
$74
$14,466
Operating earnings1,966
152
125
234
598
364
(109)3,330
March 31, 2018 (Successor)Significant Other Observable Inputs (Level 2)
(In millions)
Assets at fair value: 
Cash equivalents and restricted cash equivalents1
$3,838
Marketable securities246
Derivatives relating to:2
 
Foreign currency33
Total assets at fair value$4,117
Liabilities at fair value: 
Long-term debt$11,262
Derivatives relating to:2
 
Foreign currency70
Total liabilities at fair value$11,332
1.
As of June 30, 2017, Agriculture netTime deposits included in cash and cash equivalents and money market funds included in other current assets were $10,181, an increase of $3,839 from $6,342 at December 31, 2016. The increase was primarily due to higher trade receivables related to normal seasonality in the sales and cash collections cycle.

Reconciliation to interim Consolidated Income Statements 
 Three Months Ended
June 30,
Six Months Ended
June 30,
 2017201620172016
Total segment operating earnings$1,757
$1,613
$3,748
$3,330
Significant pre-tax (charges) benefits not included in segment operating earnings(160)74
(146)6
Non-operating pension and other post employment benefit costs(104)(133)(208)(207)
Exchange losses(140)(15)(199)(136)
Corporate (expenses) income1,2,3,4,5
(267)(113)(463)160
Interest expense(99)(93)(183)(185)
Income from continuing operations before income taxes$987
$1,333
$2,549
$2,968
1.
Includes transaction costs associated with the planned merger with Dow and related activities of $(216) and $(386) in the three and six months ended June 30, 2017, respectively, and $(76) and $(100) in the three and six months ended June 30, 2016, respectively,interim Condensed Consolidated Balance Sheets are held at amortized cost, which were recorded in selling, general and administrative expenses in the company's interim Consolidated Income Statements. See Note 2 for additional information.approximates fair value.
2.
2.See Note
Includes a $(4) charge recorded in employee separation / asset related charges, net17 for the classification of derivatives in the company's interim Condensed Consolidated Income Statement forBalance Sheets.

December 31, 2017 (Successor)Significant Other Observable Inputs (Level 2)
(In millions)
Assets at fair value: 
Cash equivalents and restricted cash equivalents1
$5,205
Marketable securities952
Derivatives relating to:2
 
Foreign currency46
Total assets at fair value$6,203
Liabilities at fair value: 
Long-term debt$11,560
Derivatives relating to:2


Foreign currency79
Total liabilities at fair value$11,639
1.Time deposits included in cash and cash equivalents and money market funds included in other current assets in the six months ended June 30, 2017, respectively, associated with the 2017 restructuring program. See Note 4 for additional information.interim Condensed Consolidated Balance Sheets are held at amortized cost, which approximates fair value.
2.
3.See Note
Includes a $47 benefit on accrued interest reversals recorded in other (loss) income, net,17 for the classification of derivatives in the company's interim Condensed Consolidated Income Statement for the six months ended June 30, 2017, respectively, related to a reduction in the company’s unrecognized tax benefits due to the closure of various tax statutes of limitations. See Note 6 for additional information.
4.Balance Sheets.
Includes a gain of $369 associated with the sale of DuPont (Shenzhen) Manufacturing Limited entity, which held certain buildings and other assets. The gain was recorded in other (loss) income, net, in the company's interim Consolidated Income Statement for the six months ended June 30, 2016. See Note 3 for additional information.
5.
Includes a $46 and $60 net benefit recorded in employee separation / asset related charges, net in the company's interim Consolidated Income Statements for the three and six months ended June 30, 2016, respectively, associated with the 2016 global cost savings and restructuring plan. See Note 4 for additional information.


28
35

Table of Contents
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Dollars in millions, except per share)

Significant Pre-tax (Charges) Benefits Not Included in Segment Operating Earnings
The three and six months ended June 30, 2017 and 2016, respectively, included the following significant pre-tax (charges) benefits which are excluded from segment operating earnings:
 
Three Months Ended
June 30,
Six Months Ended
June 30,
 2017201620172016
Agriculture1,4,5
$
$35
$
$(38)
Electronics & Communications2,4
(1)8
(6)15
Industrial Biosciences2,4

3
(6)4
Nutrition & Health2,3,4

12
160
13
Performance Materials2,4
(2)9
(13)5
Protection Solutions2,4
(157)7
(281)10
Other4



(3)
 $(160)$74
$(146)$6
1.
Includes $30 of net insurance recoveries recorded in other operating charges in the company's interim Consolidated Income Statements for the three and six months ended June 30, 2016 for recovery of costs for customer claims related to the use of Imprelis® herbicide. Includes $23 for reduction in accrual recorded in other operating charges in the company's interim Consolidated Income Statement for the six months ended June 30, 2016 for customer claims related to the use of the Imprelis® herbicide.
2.
Includes a $(160) and $(308) restructuring charge in employee separation / asset related charges, net in the company's interim Consolidated Income Statements for the three and six months ended June 30, 2017, respectively, associated with the 2017 restructuring program. See Note 4 for additional information.
3.
Includes a $162 gain recorded in other (loss) income, net, in the company's interim Consolidated Income Statement for the six months ended June 30, 2017, associated with the sale of the company's global food safety diagnostic business. See Note 3 for additional information.
4.
Includes a $44 and $28 net restructuring benefit in employee separation / asset related charges, net in the company's interim Consolidated Income Statements for the three and six months ended June 30, 2016, respectively, associated with the 2016 global cost savings and restructuring program. See Note 4 for additional information.
5.
Includes a $(75) restructuring charge recorded in employee separation / asset related charges, net in the company's interim Consolidated Income Statement for the six months ended June 30, 2016, related to the decision not to re-start the insecticide manufacturing facility at the La Porte site located in La Porte, Texas. See Note 4 for additional information.





Item 2.MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Cautionary Statements About Forward-Looking Statements
This reportcommunication contains “forward-looking statements” within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In this context, forward-looking statements which may be identified by their use ofoften address expected future business and financial performance and financial condition, and often contain words like “plans,such as “expect,“expects,“anticipate,” “intend,” “plan,” “believe,” “seek,” “see,” “will,” “anticipates,“would,“believes,“target,“intends,” “projects,” “estimates”similar expressions, and variations or other wordsnegatives of similar meaning. All statements that address expectations or projections about the future, including statements about the company's strategy for growth, product development, regulatory approval, market position, anticipated benefits of recent acquisitions, timing of anticipated benefits from restructuring actions, outcome of contingencies, such as litigation and environmental matters, expenditures, and financial results, forward-looking statements including statements about the consummation of and expected benefits, including synergies, from the planned merger withthese words.

On December 11, 2015, The Dow Chemical Company (Dow)(“Dow”) and E. I. du Pont de Nemours and Company (“DuPont”) announced entry into an Agreement and Plan of Merger, as amended on March 31, 2017, (the “Merger Agreement”) under which the companies would combine in an all-stock merger of equals transaction (the “Merger”). Effective August 31, 2017, the Merger Transaction)was completed and each of Dow and DuPont became subsidiaries of DowDuPont Inc. (“DowDuPont”).

Forward-looking statements by their nature address matters that are, to varying degrees, uncertain, including the proposedintended separation, subject to approval of the combined company’s (DowDuPont)DowDuPont Board of Directors and customary closing conditions, of DowDuPont’s agriculture, business,materials science and specialty products business and material science business through a series of tax-efficientbusinesses in one or more tax efficient transactions on anticipated terms (the Intended“Intended Business Separations), and the FMC Transactions, as defined below, in which, among other things, FMC will acquire the Divested Ag Business, as defined below and DuPont will acquire the Acquired H&N Business, as defined below, and the anticipated benefits thereof. These and other forward-lookingSeparations”). Forward-looking statements including the failure to consummate the Merger Transaction or FMC Transactions or to make or take any filing or other action required to consummate such transactions in a timely manner or at all, are not guarantees of future resultsperformance and are subject to risks, uncertainties and assumptions that could cause actual results to differ materially from those expressed in any forward-looking statements.

Forward-looking statements are based on certain assumptions and expectations of future events which may not be accurate or realized. Forward-looking statements also involve risks and uncertainties, many of which are beyond the company's control.control of DuPont and its parent company. Some of the important factors that could cause DuPont’s actual results to differ materially from those projected in any such forward-looking statements include, but are not limited to: (i) costs to achieve and achieving the successful integration of the respective agriculture, materials science and specialty products businesses of Dow and DuPont, anticipated tax treatment, unforeseen liabilities, future capital expenditures, revenues, expenses, earnings, productivity actions, economic performance, indebtedness, financial condition, losses, future prospects, business and management strategies for the management, expansion and growth of the combined operations; (ii) costs to achieve and achievement of the anticipated synergies by the combined agriculture, materials science and specialty products businesses; (iii) risks associated with the Intended Business Separations, including conditions which could delay, prevent or otherwise adversely affect the proposed transactions, including possible issues or delays in obtaining required regulatory approvals or clearances related to the Intended Business Separations, associated cost, disruptions in the financial markets or other potential barriers; (iv) disruptions or business uncertainty, including from the Intended Business Separations, could adversely impact DuPont’s business or financial performance and its ability to retain and hire key personnel; and (v) risks to DuPont’s business, operations and results of operations from: the availability of and fluctuations in the cost of energy and raw materials; failure to develop and market new products and optimally manage product life cycles; ability, cost and impact on business operations, including the supply chain, of responding to changes in market acceptance, rules, regulations and policies and failure to respond to such changes; delays or failures in obtaining or retaining regulatory approvals, delayed product launches, lack of market acceptance, product discontinuation, changes in the regulatory environment and litigation resulting from concerns and claims regarding the safe use of seeds with biotechnology traits and crop protection products potential impact on health and the environment, and the perceived impacts of biotechnology on health and the environment; impact of unpredictable seasonal and weather factors could impact sales and earnings from agriculture products; outcome of significant litigation, environmental matters and other commitments and contingencies; failure to appropriately manage process safety and product stewardship issues; global economic and capital market conditions, including the continued availability of capital and financing, as well as inflation, interest and currency exchange rates; changes in political conditions, including trade disputes and retaliatory actions; business or supply disruptions; security threats, such as acts of sabotage, terrorism or war, natural disasters and weather events and patterns which could result in a significant operational event for DuPont, adversely impact demand or production; ability to discover, develop and protect new technologies and to protect and enforce the DuPont’s intellectual property rights; failure to effectively manage acquisitions, divestitures, alliances, joint ventures and other portfolio changes; unpredictability and severity of catastrophic events, including, but not limited to, acts of terrorism or outbreak of war or hostilities, as well as management’s response to any of the aforementioned factors. While the listslist of factors presented here and in the Registration Statement (as defined in Note 2 to the interim Consolidated Financial Statements) areis, considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on DuPont’s consolidated financial condition, results of operations, credit rating or liquidity. Some of the important factors that could cause the company's actual resultsDuPont does not assume any obligation to differ materially from those projected inpublicly provide revisions or updates to any such forward-looking statements are:

Risks related to the DowDuPont Merger, the Intended Business Separations and the FMC Transactions including, but not limited to, (i) the completionwhether as a result of the Merger Transaction and the FMC Transactions on anticipated terms and timing, including obtaining regulatory approvals, anticipated tax treatment, unforeseen liabilities,new information, future capital expenditures, revenues, expenses, earnings, synergies, economic performance, indebtedness, financial condition, losses, future prospects, business and management strategies for the management, expansion and growth of the new combined company’s operationsdevelopments or the Acquired H&N Businessotherwise, should circumstances change, except as otherwise required by securities and other conditions to the completion of the Merger Transaction and the FMC Transactions, (ii) the possibility that the Merger Transaction and the FMC Transactions may not close, including because the various approvals, authorizations and declarations of non-objections from certain regulatory and governmental authorities with respect to either the Merger Transaction, including receipt of approvals by certain regulators of the respective purchasers in relation to the FMC Transactions, EAA Transaction, defined below, and the Brazil Seeds Transaction, defined below, or the FMC Transactions may not be obtained, on a timely basis or otherwise, including that these regulatory or governmental authorities may not approve of FMC as an acceptable purchaser of the Divested Ag Business in connection with the FMC Transactions or may impose conditions on the granting of the various approvals, authorizations and declarations of non-objections, including requiring the respective Dow, DuPont and FMC businesses, including the Acquired H&N Business (in the case of DuPont) and the Divested Ag Business (in the case of FMC), to divest certain assets if necessary to obtain certain regulatory approvals or otherwise limiting the ability of the combined company to integrate parts of the Dow and DuPont businesses and/or the DuPont and Health and Nutrition businesses, (iii) the ability of DuPont to integrate the Acquired H&N Business successfully and to achieve anticipated synergies, (iv) potential litigation or regulatory actions relating to the Merger Transaction or the FMC Transactions that could be instituted against DuPont or its directors, (v) the risk that disruptions from the Merger Transaction or the FMC Transactions will harm DuPont’s business, including current plans and operations, (vi) the ability of DuPont to retain and hire key personnel, (vii) potential adverse reactions or changes to business relationships resulting from the announcement or completion of the Merger Transaction or the FMC Transactions, (viii) uncertainty as to the long-term value of DowDuPont common stock, (ix) continued availability of capital and financing and rating agency actions, (x) legislative, regulatory and economic developments, (xi) potential business uncertainty, including changes to existing business relationships, during the pendency of the Merger Transaction or the FMC Transactions that could affect DuPont’s financial performance, (xii) certain restrictions during the pendency of the Merger Transaction or the FMC Transactions that may impact DuPont’s ability to pursue certain business opportunities or strategic transactions and (xiii) unpredictability and severity of catastrophic events, including, but not limited to, acts of terrorism or outbreak of war or hostilities, as well as management’s response to any of the aforementioned factors. These risks, as well as other risks associated with the Merger Transaction

or the FMC Transactions, are more fully discussed in (1) DuPont’s most recently filed Form 10-K, 10-Q and 8-K reports, (2) DuPont’s subsequently filed Form 10-K and 10-Q reports and (3) the joint proxy statement/prospectus included in the Registration Statement filed with the SEC in connection with the Merger Transaction;
Volatility in energy and raw material prices;
Failure to develop and market new products and optimally manage product life cycles;
Outcome of significant litigation and environmental matters, including those related to divested businesses, including realization of associated indemnification assets, if any;
Failure to appropriately manage process safety and product stewardship issues;
Ability to obtain and maintain regulatory approval for its products especially in the Agriculture segment;
Failure to realize all of the expected benefits from cost and productivity initiatives to the extent and as anticipated;
Effect of changes in tax, environmental and other laws and regulations or political conditions in the United States of America (U.S.) and other countries in which the company operates;
Conditions in the global economy and global capital markets, including economic factors such as inflation, deflation, fluctuation in currency rates, interest rates and commodity prices;
Failure to appropriately respond to market acceptance, government rules, regulations and policies affecting products based on biotechnology;
Impact of business disruptions, including supply disruptions, and security threats, regardless of cause, including acts of sabotage, cyber-attacks, terrorism or war, natural disasters and weather events and patterns which could affect demand as well as availability of product, particularly in the Agriculture segment;
Ability to discover, develop and protect new technologies and enforce the company's intellectual property rights; and
Successful integration of acquired businesses and separation of underperforming or non-strategic assets or businesses.applicable laws.

For further discussion of some of the important factors that could cause the company's actual results to differ materially from those projected in any such forward-looking statements, see the Risk Factors discussion set forth under Part I, Item 1A of the company's 20162017 Annual Report.Report and in the section titled "Risk Factors" (Part II, Item 1A of this Form 10-Q).

36

Table of Contents


Recent Developments
DuPont DowDowDuPont Merger of Equals
DowDuPont Inc. ("DowDuPont") was formed on December 9, 2015 to effect an all-stock, merger of equals strategic combination between The Dow Chemical Company ("Dow") and DuPont (the "Merger Transaction"). On December 11, 2015, DuPont and Dow announced entry into anAugust 31, 2017 at 11:59 pm ET, (the "Merger Effectiveness Time") pursuant to the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017 (the Merger Agreement)"Merger Agreement"), under which the companies will combine in an all-stock mergerDow and DuPont each merged with wholly owned subsidiaries of equals (the Merger Transaction) subject to satisfaction of customary closing conditions, including receipt of regulatory approval. The combined company will be named DowDuPont Inc. (DowDuPont). Following the consummation("Mergers") and, as a result of the Mergers, Dow and DuPont became subsidiaries of DowDuPont (collectively, the "Merger"). Prior to the Merger, Transaction, DuPontDowDuPont did not conduct any business activities other than those required for its formation and Dow intendmatters contemplated by the Merger Agreement. DowDuPont intends to pursue, subject to the receipt of approval by the Board of Directors of DowDuPont and customary closing conditions, the separation of the combined company’scompany's agriculture business, specialty products business and materialmaterials science business through a series of tax-efficient transactions (collectively, the Intended"Intended Business Separations)Separations"). DowDuPont anticipates materials science separating by the end of the first quarter of 2019, and expects agriculture and specialty products to separate by June 1, 2019.

On March 27, 2017, DuPontFebruary 26, 2018, DowDuPont announced the corporate brand names that each company plans to assume once the Intended Business Separations occur. Materials science will be called Dow, agriculture will be called CortevaTM Agriscience, and Dow announced thatspecialty products will be the European Commission (EC) granted conditionalnew DuPont.

As a condition of the regulatory clearance in Europeapproval for the Merger Transaction, conditional on DuPont and Dow fulfilling certain commitments. Dow isthe company was required to divest its global Ethylene Acrylic Acid copolymers and ionomers business and has entered into a definitive agreement with SK Global Chemical Co., LTD, (the EAA Transaction) subject to the closing of the Merger Transaction in addition to customary closing conditions, including regulatory approval.

DuPont is required to sell certain assets related to its Crop Protectioncrop protection business and research and development (R&D)("R&D") organization specifically the company’s Cereal Broadleaf Herbicides and Chewing Insecticides portfolios, including Rynaxypyr®, Cyazypyr® and Indoxacarb, as well as the Crop Protection R&D pipeline and organization, excluding seed treatment, nematicides, and late-stage R&D programs. The company will continue to develop and bring to market its late-stage Crop Protection R&D programs and retain the personnel needed to support the Crop Protection marketed products and R&D programs not required to be divested per the EC’s conditional approval.

(the "Divested Ag Business"). On March 31, 2017, DuPontthe company entered into a definitive agreement (the FMC"FMC Transaction Agreement)Agreement") with FMC Corporation (FMC)("FMC"). Under the FMC Transaction Agreement, FMC will acquireand effective upon the Crop Protection business and R&D assets that DuPont is required to divest in order to obtain EC approvalclosing of the Merger Transaction as described above, (thetransaction on November 1, 2017, FMC acquired the Divested Ag Business),Business and DuPont has agreed to acquireacquired certain assets relating to FMC’s Health and Nutrition segment excluding its Omega-3 products, (the Acquired H"H&N Business)Business") (collectively, the FMC Transactions)"FMC Transactions"). Additionally, FMC will pay DuPont $1.2 billion in cash, subject to certain adjustments as set forth inOn November 1, 2017, the company completed the FMC Transaction Agreement, which reflectsTransactions through the difference in value betweendisposition of the Divested Ag Business and the acquisition of the Acquired H&N Business. DuPont will retain accounts receivable and accounts payable associated withSee Note 3 for further information regarding the divestiture. The sale of the Divested Ag Business with an expected net valuemeets the criteria for discontinued operations and as such, earnings are included within income from discontinued operations after income taxes in the interim Consolidated Statements of $425 million at closing. The assets associated with the Divested Ag Business generated revenues in 2016 of about $1.4 billion. The FMC Health and Nutrition business being acquired, which includes texturants as food ingredients and pharmaceutical excipients, generated approximately $700 million in revenues in 2016.Operations for all periods presented.

Tax Reform
On December 22, 2017, the Tax Cuts and Jobs Act (“The divestiture will satisfy DuPont’s commitmentsAct”) was enacted.  The Act reduces the U.S. federal corporate income tax rate from 35 percent to 21 percent, requires companies to pay a one-time transition tax (“transition tax”) on earnings of foreign subsidiaries that were previously tax deferred, creates new provisions related to foreign sourced earnings, eliminates the EC in connection with its conditional regulatory clearance of the merger with Dow. The FMC Transaction is expecteddomestic manufacturing deduction and moves to close ina territorial system. In the fourth quarter of 2017, subjectthe company recorded a net benefit in provision for taxes on continuing operations of $2,001 million, which consisted of a provisional net benefit of $2,716 million due to the closingreduction of the Merger Transaction, in additionU.S. federal corporate income tax rate, partially offset by a provisional charge of $715 million due to customary closing conditions, including regulatory approvalthe transition tax. At March 31, 2018, the company had not yet completed its accounting for the tax effects of enactment of the FMC Transactions.

In the second quarter 2017, Dow and DuPont obtained conditional approval for the Merger Transaction from the antitrust regulatory authoritiesAct; however, in the United States, Brazil, Canada, and China, among others. The conditional approval was granted based onfirst quarter of 2018, the companies fulfilling their commitments to the EC and, in the case of Brazil and China, certain local remedies. The local remedies in Brazil include the divestiture of a select portion of Dow’s corn seed business in Brazil for which Dow has entered a definitive agreement with CITIC Henan Agriculture Industrial Investment Fund, subject to the closing of the Merger Transaction in addition to customary closing conditions, including regulatory approval, (the Brazil Seeds Transaction). In China, DuPont and Dow have made commitments related to the supply and distribution in China of certain herbicide and insecticide ingredients and formulations for rice crops for five years after the closing of the Merger Transaction.

To accommodate the transaction with FMC, DuPont and Dow have amended the Merger Agreement to extend the “Outside Date” to August 31, 2017, and the companies anticipate closing of the merger to occur no sooner than August 1, 2017, subject to satisfaction of customary closing conditions, including receipt of regulatory approvals. The companies still expect the Intended Business Separations, subject to DowDuPont Board approval, to occur within 18 months after closing the Merger Transaction. About $3 billion in aggregate cost synergies are currently expected to be realized on a run-rate basis by the combined businesses within 24 months after consummation of the Merger Transaction, with approximately $1.6 billion from the material science business; approximately $1 billion from the agriculture business; and approximately $0.4 billion from the specialty products business.

See Note 2 to the interim Consolidated Financial Statements for additional information.


Settlement of PFOA MDL
As previously reported, approximately 3,550 lawsuits have been filed in various federal and state courts in Ohio and West Virginia alleging personal injury from exposure to perfluorooctanoic acid and its salts, including the ammonium salt (PFOA), in drinking water as a result of the historical manufacture or use of PFOA at the Washington Works plant outside Parkersburg, West Virginia.  That plant is now owned and/or operated by The Chemours Company (Chemours).  These personal injury lawsuits were consolidated in multi-district litigation in the United States District Court for the Southern District of Ohio (the MDL). In February 2017, DuPont and plaintiffs’ counsel agreed to a settlement in principle of the MDL; the parties executed the definitive settlement agreements in March 2017. The total settlement amount is $670.7 million in cash, half of which will be paid by Chemours and half paid by DuPont. In exchange for that payment, DuPont and Chemours will receive a complete release of all claims by the settling plaintiffs.  The settlement was entered into solely by way of compromise and is not in any way an admission of liability or fault by DuPont or Chemours. The company recorded a charge of $335$48 million ($214 million netto provision for income taxes on continuing operations with respect to the remeasurement of tax) to income (loss) from discontinued operations after taxes in the company's interim Consolidated Income Statementdeferred tax balance. In addition, the company recorded a $16 million charge associated with an indirect impact of The Act related to certain inventory. The company continues to refine its calculations as additional information and guidance becomes available.

DowDuPont Cost Synergy Program
In September and November 2017, DowDuPont and the company approved post-merger restructuring actions to achieve targeted cost synergies under the DowDuPont Cost Synergy Program (the “Synergy Program”), adopted by the DowDuPont Board of Directors. The plan is designed to integrate and optimize the organization following the Merger and in preparation for the six months ended June 30, 2017 forIntended Business Separations.  Based on all actions approved to date under the remainder of the settlement not subjectSynergy Program, DuPont expects to indemnification by Chemours. See Note 11 to the interim Consolidated Financial Statements for additional information.

2017 Restructuring Program
In the first quarter 2017, DuPont committed to take actions to improve plant productivity and better position its businesses for productivity and growth before and after the anticipated closing of the Merger Transaction. In connection with these actions, the company incurredrecord total pre-tax restructuring charges of $312$430 million to $600 million, comprised of $279approximately $320 million of asset-related charges and $33to $360 million inof severance and related benefitbenefits costs; $110 million to $140 million of costs (the 2017 restructuring program) during the six months ended June 30, 2017. The charges, recognized in employee separation /related to contract terminations; and up to $100 million of asset related charges, net,charges. The Synergy Program includes certain asset actions that are reflected in the company's interim Consolidated Income Statement, primarily relatepreliminary fair value measurement of DuPont’s assets as of the merger date. Current estimated total pre-tax restructuring charges could be impacted by future adjustments to the second quarter closurepreliminary fair value of DuPont’s assets. Substantially all of the Protection Solutions segment's Cooper River manufacturing site located near Charleston, South Carolina. Theremaining restructuring charges are expected to be incurred in 2018 and the related actions, including employee separations, associated with this programplan are expected to be substantially complete by the end of 2017.2019.

Future cash payments related to this program are anticipated to be approximately $360 million to $430 million, primarily related to the payment of severance and related benefits and contract termination costs. It is possible that additional charges and future cash payments could occur in relation to the restructuring actions. The company anticipates including savings associated with these actions against the targeted $3within DowDuPont's cost synergy commitment of $3.3 billion of cost synergies associated with the Merger Transaction.

37

Table of Contents


Selected Financial Data
 SuccessorPredecessor
In millions, except per share amountsThree Months Ended March 31, 2018Three Months Ended March 31, 2017
Net sales$6,699
$7,319
 

Cost of goods sold$4,847
$4,152
Percent of net sales72.4 %56.7%
 

Research and development expenses$382
$368
Percent of net sales5.7 %5.0%
 

Selling, general and administrative expenses$959
$1,190
Percent of net sales14.3 %16.3%
   
Effective tax rate on continuing operations(14.3)%14.3%
   
Net (loss) income$(221)$1,121
   
Net income available for common stockholders $1,111
  
Basic earnings per share of common stock from continuing operations $1.35
Diluted earnings per share of common stock from continuing operations $1.34

Results of Operations
Overview
The following is a summaryNote on Financial Presentation
For purposes of DowDuPont's financial statement presentation, Dow was determined to be the accounting acquirer in the Merger and DuPont's assets and liabilities are reflected at fair value as of the results of continuing operations for the three months ended June 30, 2017:

Net sales were $7.4 billion, 5 percent above the same period last year, reflecting a 6 percent volume increase partially offset by a 1 percent decline in local price. Volume grew in all reportable segments, led by Agriculture, Electronics & Communications, and Protection Solutions.

Segment operating earnings increased in all reportable segments driven by higher volumes. Segment operating margins expanded in most reportable segments.

Second quarter results include pre-tax charges of $376 million, comprised of $216 million of costs inMerger Effectiveness Time. In connection with the planned merger with DowMerger and the related activities,accounting determination, the company has elected to apply push-down accounting and $160 millionreflect in its financial statements, the fair value of restructuring charges.

Income from continuing operations after taxes was $0.9 billion versus $1.0 billionits assets and liabilities. DuPont's Consolidated Financial Statements for periods following the close of the Merger are labeled “Successor” and reflect DowDuPont’s basis in the fair values of the assets and liabilities of DuPont. All periods prior to the closing of the Merger reflect the historical accounting basis in DuPont's assets and liabilities and are labeled “Predecessor.” The interim Consolidated Financial Statements and Footnotes include a black line division between the columns titled "Predecessor" and "Successor" to signify that the amounts shown for the same periodperiods prior to and following the Merger are not comparable. In addition, the company has elected to make certain changes in presentation to harmonize its accounting and reporting with that of DowDuPont in the prior year.

The following is a summarySuccessor period. See Note 1, "Summary of the results of continuing operations for the six months ended June 30, 2017:

Net sales were $15.2 billion, 5 percent above the same period last year due to volume growth. Volume grew in most reportable segments led by Agriculture, Performance Materials, and Electronics & Communications.

Segment operating earnings increased in all reportable segments driven by higher volumes.

Agriculture sales increased 5 percent on a 5 percent benefit from volume and a 1 percent benefit from local price, partially offset by a 1 percent negative impact from portfolio. Agriculture operating earnings increased 12 percent on growth in volume and local price.

Year-to-date results include pre-tax charges of $698 million, comprised of $386 million of costs in connection with the planned merger with Dow and related activities and $312 million of restructuring charges, partially offset by a $162 million pre-tax gain from the sale of the global food safety diagnostics business. Year-to-date resultsSignificant Accounting Policies" in the prior year included a pre-tax gaincompany's 2017 Annual Report for further discussion of $369 million fromthese changes and Note 3 for additional information on the sale of the DuPont (Shenzhen) Manufacturing Limited entity partially offset by $100 million in pre-tax costs in connection with the planned merger with Dow and related activities.Merger.


Income from continuing operations after taxes was $2.2 billion versus $2.3 billion for the same period in the prior year.
38

Table of Contents


Net Sales
Net sales were $6.7 billion and $7.3 billion for the three months ended June 30,March 31, 2018 and 2017, were $7.4 billion, up 5 percent versus $7.1 billion in the prior year reflecting 6 percent higher volume, partly offsetrespectively. The change was primarily driven by 128 percent lower local prices. Sales grew 6 percentsales in the U.S. and Canada, mainly driven by increased Agriculture volume, and increased 10 percenttiming in Asia Pacific, primarily driven by volume growth in Electronics & Communications, Agriculture, Performance Materials, and Industrial Biosciences. Volume increased 3 percent in EMEA, led by Protection Solutions and Performance Materials. Net sales in developing markets, which include China, India, and countries in Southeast Asia, Latin America, Eastern and Central Europe, Middle East, and Africa, were $2.1 billion, up 4 percent, driven by higher volume. Volume largely reflects strong growth in Electronics & Communications, Agriculture and Industrial Biosciences in developing Asia Pacific. Sales in developing markets represent 29 percent of total sales, unchanged from prior year.
The table below shows a regional breakdown of net sales based on location of customers and percentage variances from the prior year: 
 Three Months Ended June 30, 2017Percent Change Due to:
 
Net Sales
($ Billions)
Percent
Change vs.
2016
Local
Price and Product Mix
CurrencyVolumePortfolio and Other
Worldwide$7.4
5
(1)
6
U.S. & Canada3.8
6


6
Europe, Middle East & Africa (EMEA)1.4
1

(2)3
Asia Pacific1.7
10
(1)
11
Latin America0.5
(3)(4)2
(1)

Net sales for the six months ended June 30, 2017 were $15.2 billion versus $14.5 billionseed deliveries in the prior year, a 5 percent increase, reflecting 5 percent higher volume. Sales volumeagriculture product line, partly offset by sales increases in the U.S. and Canada increased 3 percent driven by increased volume in Agriculture. A volume increase of 13 percent in Asia Pacific was principally driven by Electronics & Communications, Performance Materials, Agriculture and Industrial Biosciences. Volume increased 6 percent in EMEA, with increased seed sales in Eastern Europe, and higher sales in the Performance Materials and Protection Solutions segments. Net sales in developing markets were $4.6 billion, up 10 percent, driven by higher volume. Volume largely reflects strong growth in Agriculture in developing EMEA and Asia Pacific of 15 percent and Electronics & Communications12 percent, respectively, from higher volume and Performance Materialscurrency benefits in developing Asia Pacific. Sales in developing markets represent 30 percentthose regions.

In the interim Consolidated Statement of total sales versus 29 percent last year.
The table below shows a regional breakdown ofOperations, royalty income is included within net sales basedin the Successor Period and is included in sundry income - net in the Predecessor Periods. Royalty income does not have a significant impact on location of customers and percentage variances from the prior year: any period presented.

SuccessorPredecessor
Six Months Ended June 30, 2017Percent Change Due to:Three Months Ended March 31, 2018Three Months Ended March 31, 2017
Net Sales
($ Billions)
Percent
Change vs.
2016
Local
Price and Product Mix
CurrencyVolumePortfolio and Other
Net Sales
($ Billions)
%Net Sales
($ Billions)
%
Worldwide$15.2
5

5

$6.7
100$7.3
100
U.S. & Canada7.4
3

3

2.5
383.5
48
Europe, Middle East & Africa (EMEA)3.5
31
(3)6
(1)2.2
321.9
26
Asia Pacific3.2
11(1)
13
(1)1.5
231.4
19
Latin America1.1
61
7
(2)
0.5
70.5
7

Cost of Goods Sold (COGS)("COGS")
COGS was $4.8 billion and $4.2 billion for the secondthree months ended March 31, 2018 and 2017, respectively. The change was primarily driven by the amortization of the inventory step-up of $703 million during the first quarter 2017of 2018 as well as increased 5 percentexpenses due to $4.2 billion from $4.0 billionthe elimination of the other operating charges financial statement line item in the prior year. For the six months ended June 30, 2017, COGS increased 4 percent to $8.6 billion versus $8.2 billion in the prior year. The increase in both periods versus prior year is primarilySuccessor period and higher depreciation related to higherthe fair value step up of property, plant and equipment, partially offset by lower sales volume.

COGS as a percentage of net sales decreased to 56was 72 percent for the three and six months ended June 30, 2017 from 57 percent for the three and six months ended June 30, 2016 primarilyMarch 31, 2018 and 2017, respectively. The amortization of the inventory step-up was 10 percent of net sales in the Successor period. The remaining COGS increase as a percentage of net sales in the Successor period is due to favorable mix.the items discussed above.

See Note 3 for additional information regarding the Merger, including the valuation of inventory.

Other Operating Charges
Other operating charges were $176$200 million for the second quarter of 2017 versus $143 million in the prior year, an increase of $33 million, primarily due to the absence of $30 million of insurance recoveries related to Imprelis® herbicide claims in 2016.

For the sixthree months ended June 30, 2017,March 31, 2017. In the Successor period, other operating charges were $380are included primarily in COGS, as well as selling, general and administrative expenses and amortization of intangibles.

Research and Development Expense ("R&D")
R&D expense was $382 million versus $328and $368 million infor the prior year,three months ended March 31, 2018 and 2017, respectively. R&D as a percentage of net sales was 6 percent and 5 percent for the three months ended March 31, 2018 and 2017, respectively. The change was primarily driven by an increase of $52 million, principally due toin R&D expense for the absence of $30 million of insurance recoveriesagriculture and a $23 million reduction in the estimated liability related to the Imprelis® herbicide claims in 2016.health and nutrition product lines.

Selling, General and Administrative Expenses (SG&A)("SG&A")
SG&A expenses were $1.3$1.0 billion and $1.2 billion for the second quarterthree months ended March 31, 2018 and 2017, respectively. In the Successor period, integration and separation costs and amortization of 2017 versus $1.2 billion inintangibles are presented as a line item on the prior year, with the increase primarily driven by costs in connection with the planned merger with Dow and related activities.interim Consolidated Statement of Operations. During the three months ended June 30,March 31, 2017, and 2016, the company incurred $216$170 million and $76 million, respectively, of transaction costs in connection with the planned merger with DowMerger and the Intended Business Separations, including costs relating to integration and separation planning. Separations.

SG&A as a percentage of net sales was approximately 1814 percent and 1716 percent for the three months ended March 31, 2018 and 2017, respectively. Transaction costs were 2 percent of net sales for the three months ended June 30, 2017 and 2016.March 31, 2017.

SG&A expensesAmortization of Intangibles
Intangible asset amortization was $315 million for the sixthree months ended June 30,March 31, 2018. In the Predecessor periods, amortization of intangibles was included within SG&A; other operating charges; R&D; and COGS. See Note 3 for further information regarding the Merger, including the valuation of intangible assets.


39

Table of Contents


Restructuring and Asset Related Charges - Net
Restructuring and asset related charges - net were $97 million and $152 million for the three months ended March 31, 2018 and 2017, were $2.6 billion versus $2.3 billionrespectively. The charges in the prior year, primarily duefirst quarter 2018 related to increasethe DowDuPont Cost Synergy Program. The charges in the first quarter 2017 related to the 2017 restructuring program.

See Note 6 to the interim Consolidated Financial Statements for additional information.

Integration and Separation Costs
Integration and separation costs associated withwere $255 million for the planned merger with Dowthree months ended March 31, 2018. In the Predecessor periods, integration and related activitiesseparation costs were included within SG&A. See Note 1 for further discussion of the changes in presentation.

Sundry Income - Net
Sundry income - net was $47 million and increases in commission expense,$202 million for the three months ended March 31, 2018 and 2017, respectively. The three months ended March 31, 2018 included exchange losses of $132 million, partially offset by cost savings. During the sixa non-operating pension benefit of $92 million. The three months ended June 30,March 31, 2017 and 2016, the company incurred $386included a net exchange loss of $59 million and $100 million, respectivelynon-operating pension costs of transaction costs in connection with the planned merger with Dow and related activities. SG&A was approximately 17 percent and 16 percent of net sales for the six months ended June 30, 2017 and 2016.
Research and Development Expense (R&D)
R&D expense totaled $441 million and $432 million for the second quarter 2017 and 2016, respectively. Year-to-date R&D expense totaled $857 million and $850 million for the six months ended June 30, 2017 and 2016, respectively. The increase in both periods primarily related to increased spend in the Agriculture segment. R&D was approximately 6 percent of net sales for the three and six months ended June 30, 2017 and 2016, respectively.

Other (Loss) Income, Net
Other (loss) income, net totaled $(21) million for the second quarter of 2017 compared to $51 million in the prior year, a decrease of $72 million, primarily due to an increase in net exchange losses. This was partially$104 million. These losses were offset by the absence of prior year losses related to available-for-sale securities and increased licensing income.

For the six months ended June 30, 2017, other (loss) income, net, was $285 million compared to $423 million in the prior year, a decrease of $138 million, primarily due to the change in net gains on sales of business and other assets period over period and an increase in net exchange losses. This was partially offset by the reversal of accrued interest related to unrecognized tax benefits in 2017, absence of prior year losses related to available-for-sale securities and increased licensing income. The six months ended June 30, 2017 included a pre-tax gain of $162 million associated with the sale of the global food safety diagnostic business.diagnostics business, as well as the inclusion of royalty income in the Predecessor period. The six months ended June 30, 2016 includednon-operating pension benefit in the first quarter of 2018 was a pre-tax gainresult of $369 million associated with the saleabsence of DuPont (Shenzhen) Manufacturing Limited entity.the amortization of net losses from accumulated other comprehensive loss.

See Note 58 to the interim Consolidated Financial Statements for additional information.

Interest Expense
Interest expense totaled $99was $80 million inand $84 million for the second quarter 2017 as compared to $93 million in the prior year. The $6 million increase was due primarily to higher debt balances.

For the sixthree months ended June 30,March 31, 2018 and 2017, interest expenserespectively. The change was $183 million versus $185 million inprimarily driven by debt amortization as a result of reflecting the prior year. The $2 million decrease was due primarily to lower interest on long-termcompany's debt prior toat fair value upon the May 2017 Debt Offering,effective date of the Merger, partially offset by higher interest on commercial paper.


Employee Separation / Asset Related Charges, Net
Employee separation / asset related charges, net totaled $160 million for the second quarter 2017 versus a $90 million benefit in the prior year. The charges in the second quarter 2017 relate to the closure of the Protection Solutions segment's Cooper River manufacturing site located near Charleston, South Carolina as part of the 2017 restructuring program. The benefit in the second quarter 2016 relates to a reduction in severance and related benefit costs in the 2016 global cost savings and restructuring plan driven by the elimination of positions at a lower cost than expected as a result of redeployments and attrition, as well as lower than estimated individual severance costs.

Employee separation / asset related charges, net totaled $312 million for the six months ended 2017 versus a $13 million benefit in the prior year. The $312 million charge relates to the 2017 restructuring program. The six months ended June 30, 2016 included an $88 million benefit primarily driven by a reduction in severance and related benefit costs in the 2016 global cost savings and restructuring plan, offset by a $75 million charge in the first quarter related to the decision not to restart the insecticide manufacturing facility at the La Porte site located in La Porte, Texas.

See Note 4 to the interim Consolidated Financial Statements for additional information.debt balances.

Provision for Income Taxes on Continuing Operations
The company'scompany’s provision for income taxes on continuing operations was $27 million for the first quarter 2018 on a pre-tax loss from continuing operations of $189 million, resulting in an effective tax rate for the second quarter 2017 was 13.0 percent as compared to 23.0 percent in 2016.of (14.3) percent. The lower effective tax rate is primarily drivenwas favorably impacted by the reduction of the U.S. federal corporate income tax rate from 35 percent to 21 percent, as well as the tax impact of certain net exchange gains recognized on the re-measurement of the net monetary asset positions which were not taxable in their local jurisdictions. The effective tax rate was unfavorably impacted by non-tax-deductible amortization of the fair value step-up in DuPont’s inventories as a result of the merger, in addition to an incremental net provisional charge of $48 million associated with the enactment of the Act.

The company’s provision for income taxes on continuing operations was $197 million for the first quarter 2017 on pre-tax income of $1,375 million, resulting in an effective tax rate of 14.3 percent. The effective tax rate was favorably impacted by tax benefits associated with a reduction in the company’s unrecognized tax benefits due to the closure of various tax statutes of limitations and other changes in accruals for certain prior year tax positions, the tax impact of certain net exchange gains recognized on the re-measurement of the net monetary asset positions which were not taxable in their local jurisdictions, increased tax benefits on employee separation / asset related charges, as well as the impact of costsnet favorable tax consequences associated with the planned merger with Dow and related activities. These impacts were partially offset by a tax chargeissuance of $29 million related to the elimination of a tax benefit recorded in 2016 due to a second quarter 2017 U.S. discretionary pension contribution.

The company's effective tax rate for the six months ended June 30, 2017 was 13.8 percent as compared to 24.0 percent in 2016. The lower effective tax rate is primarily driven by certain net exchange gains recognized on the re-measurement of the net monetary asset positions which were not taxable in their local jurisdictions. Other factors contributing to the lower effective tax rate include the absence of unfavorable tax consequences of a gain on the sale of an entity in the first quarter 2016, tax benefits related to a reduction in the company's unrecognized tax benefits due to the closure of various tax statutes of limitations, increased tax benefits on employee separation / asset related charges, as well as the impact of costs associated with the planned merger with Dow and related activities. Thesestock compensation. Those impacts were partially offset by the unfavorable tax consequences of non-deductible goodwill associated with the gain on the sale of the company'scompany’s global food safety diagnosticdiagnostics business in the first quarter 2017.

See Notes 5 and 6 to the interim Consolidated Financial Statements for additional information.

Recent Accounting Pronouncements
See Note 12 to the interim Consolidated Financial Statements for a description of recent accounting pronouncements.


Segment Reviews
Summarized below are comments on individual segment net sales and operating earnings for the three and six months ended June 30, 2017 compared with the same period in 2016. Segment operating earnings is defined as income (loss) from continuing operations before income taxes excluding significant pre-tax benefits (charges), non-operating pension and other post employment employee benefit costs, exchange gains (losses), corporate expenses and interest. Non-operating pension and other post employment benefit costs includes all of the components of net periodic benefit costs from continuing operations with the exception of the service cost component. See Note 15 to the interim Consolidated Financial Statements for details related to significant pre-tax benefits (charges) excluded from segment operating earnings. All references to prices are based on local price unless otherwise specified.

A reconciliation of segment operating earnings to income from continuing operations before income taxes for the three and six months ended June 30, 2017 and 2016 is included in Note 15 to the interim Consolidated Financial Statements.

The following table summarizes second quarter and year-to-date 2017 segment net sales and related variances versus prior year:
 Three Months Ended    
 June 30, 2017Percentage Change Due to:
 
Segment
Net Sales
($ Billions)
Percent
Change vs.
2016
Local Price and Product MixCurrencyVolume
Portfolio
and Other
Agriculture$3.4
7
(1)
8
Electronics & Communications0.5
11
(1)(1)13
Industrial Biosciences0.4
11
3
(1)9
Nutrition & Health0.8
(2)(1)(1)1(1)
Performance Materials1.4
3
2
(1)2
Protection Solutions0.8
2
(2)(1)5
 Six Months Ended    
 June 30, 2017Percentage Change Due to:
 
Segment
Net Sales
($ Billions)
Percent
Change vs.
2016
Local Price and Product MixCurrencyVolume
Portfolio
and Other
Agriculture$7.4
5
1

5(1)
Electronics & Communications1.1
12
(1)(1)14
Industrial Biosciences0.8
8
2
(1)7
Nutrition & Health1.6
(2)
(1)(1)
Performance Materials2.7
6
1
(1)6
Protection Solutions1.5
2
(2)(1)5

Agriculture - Second quarter 2017 segment net sales of $3,446 million increased $228 million, or 7 percent, on volume growth, partially offset by declines in local price. Volume growth was due to increased insecticide and fungicide sales, a benefit from the southern U.S. route-to-market change, and higher soybean sales in North America driven by increased soybean area. Reductions in local price were due to price declines in crop protection due to competitive pressure in Latin America and Asia. Operating earnings of $963 million increased $98 million, or 11 percent, on volume growth, partially offset by declines in local price and increased product costs, primarily driven by higher soybean royalties.
Year-to-date segment net sales of $7,374 million increased $370 million, or 5 percent, on growth in volume and local price, partially offset by portfolio changes. Volume growth was driven by a change in the timing of seed deliveries, including the southern U.S. route-to-market change, increased insecticide and fungicide sales, higher soybean sales in North America, and increased sunflower and corn sales in Europe. The change in timing of seed deliveries benefited year-to-date segment net sales by approximately $200 million. These increases were partially offset by lower North America corn seed volumes impacted by an expected decrease in corn area. Pricing growth was realized by double-digit increases in Brazil driven by the continued expansion of Pioneer® brand hybrids with Leptra® insect protection and increases in sunflower seed pricing in Europe, partially offset by price declines in crop protection due to competitive pressure in Latin America and Asia. Operating earnings of $2,199 million increased $233 million, or 12 percent, on growth in volume and local price.

Electronics & Communications - Second quarter 2017 segment net sales of $546 million increased $52 million, or 11 percent, as volume growth more than offset a decline in local price, and a negative impact from currency. Volume growth was due to increased demand in consumer electronics and semiconductor markets, as well as stronger photovoltaic material sales. Operating earnings of $116 million increased $23 million, or 25 percent, as volume growth more than offset declines in local price.

Year-to-date segment net sales of $1,056 million increased $110 million, or 12 percent, on volume growth, partially offset by a decline in local price and a negative impact from currency. Volume growth was due to increased demand in consumer electronics and semiconductor markets, as well as stronger photovoltaic material sales. Operating earnings of $205 million increased $53 million, or 35 percent, primarily on volume growth and the absence of a $16 million prior year litigation expense, partially offset by lower local price. Operating earnings included a gain on the sale of a business offset by costs associated with a legal matter.
Industrial Biosciences - Second quarter 2017 segment net sales $395 million increased $40 million, or 11 percent, as growth in volume and local price was partially offset by a negative impact from currency. Broad-based volume growth was driven by increased demand for biomaterials in apparel and carpeting, bioactives in the grain processing market, and clean technologies. Growth in local price was due to biomaterials in carpeting.Operating earnings of $76 million increased $14 million, or 23 percent, on volume growth and mix enrichment, partially offset by higher costs.

Year-to-date segment net sales of $763 million, increased $56 million, or 8 percent, as volume growth and local price gains were partially offset by a negative impact from currency. Volume growth was driven by increased demand for biomaterials in apparel and carpeting and, bioactives in the grain processing market. Local price gains were due to biomaterials in carpeting. Operating earnings of $151 million increased $26 million, or 21 percent, on volume growth and mix enrichment, partially offset by higher costs.

Nutrition & Health - Second quarter 2017 segment net sales of $818 million decreased $17 million, or 2 percent, as portfolio changes, lower local price and a negative impact from currency, were partially offset by volume growth. The negative impact from portfolio changes was due to the absence of sales related to the global food safety diagnostic business sold in February 2017. Increased demand in probiotics was partially offset by declines in protein solutions and systems and texturants. Operating earnings of $135 million increased $5 million, or 4 percent, on volume growth.

Year-to-date segment net sales of $1,607 million decreased $29 million, or 2 percent on portfolio changes and the negative impact from currency. Volume growth in probiotics was offset by declines in systems and texturants and protein solutions. The unfavorable portfolio impact was due to the absence of sales related to the global food safety diagnostic business sold in February 2017. Operating earnings of $256 million increased $22 million, or 9 percent, on plant productivity, mix enrichment and cost savings, partially offset by portfolio changes.

Performance Materials - Second quarter 2017 segment net sales of $1,381 million increased $46 million, or 3 percent, as increases in local price and volume were partially offset by a negative impact from currency. Higher local price for polymers was driven by price increases to mitigate higher raw material costs. Increased demand for polymers in automotive markets and increased demand for high-performance parts in semi-conductor and aerospace markets drove increased volumes, partially offset by lower ethylene sales due to the planned turnaround of the ethylene cracker in the second quarter. Operating earnings of $329 million increased $4 million, or 1 percent, as increases in volume and local price, and the absence of costs associated with a contractual claim, were largely offset by higher raw material costs.

Year-to-date segment net sales of $2,749 million increased $165 million, or 6 percent, as growth in volume and local price was partially offset by a negative impact from currency. Increased demand for polymers in automotive markets and increased demand for high-performance parts in semi-conductor and aerospace markets drove increased volumes, partially offset by lower ethylene sales due to the planned turnaround of the ethylene cracker in the second quarter. Operating earnings of $684 million increased $86 million, or 14 percent, driven by volume growth, cost savings, and the absence of costs associated with a contractual claim, partially offset by higher raw material costs.

Protection Solutions - Second quarter 2017 segment net sales of $801 million increased $15 million, or 2 percent, as volume growth was partially offset by lower local price, unfavorable mix and the negative impact from currency. Broad-based volume growth was led by improved demand for Tyvek® protective material in medical packaging and protective apparel and Nomex® thermal-resistant fiber in oil and gas markets. Volume growth was partially offset by unfavorable mix in Nomex® and Kevlar®, and lower local price in surfaces due to competitive pressure. Operating earnings of $191 million increased $3 million, or 2 percent, as volume growth more than offset unfavorable mix, lower local price and higher raw material costs.


Year-to-date segment net sales
40

Table of $1,548 million increased $33 million, or 2 percent, as volume growth was partially offset by unfavorable mix and the negative impact from currency. Broad-based volume growth was driven by increased demand for Nomex® in oil and gas markets, Kevlar® for composite structures, Tyvek® in medical packaging and protective apparel, and surfaces. Volume growth was partially offset by the impacts of unfavorable mix in Tyvek® and Nomex®, and lower local price in Kevlar® and surfaces due to competitive pressure. Operating earnings of $368 million increased $4 million, or 1 percent, as volume growth was partially offset by unfavorable mix, lower local price, and higher raw material costs.Contents


Liquidity & Capital Resources
Information related to the company's liquidity and capital resources can be found in the company's 20162017 Annual Report, Part II, Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations, Liquidity and Capital Resources. Discussion below provides the updates to this information for the sixthree months ended June 30, 2017.March 31, 2018.
Successor
(Dollars in millions)June 30, 2017December 31, 2016March 31, 2018December 31, 2017
Cash, cash equivalents and marketable securities$6,228
$5,967
$5,341
$8,202
Total debt13,559
8,536
13,153
13,070

The company's cash, cash equivalents and marketable securities at June 30, 2017March 31, 2018 and December 31, 20162017 are $6.2$5.3 billion and $6.0$8.2 billion, respectively. The decrease of $2.9 billion was primarily due to funding the company's seasonal working capital needs and distributions to DowDuPont.

Total debt at March 31, 2018 and December 31, 2017 was $13.2 billion and $13.1 billion, respectively.

TotalThe company believes its ability to generate cash from operations and access to capital markets will be adequate to meet anticipated cash requirements to fund its working capital, capital spending, debt as of June 30, 2017 was $13.6 billion, a $5.0 billion increase from December 31, 2016. This increase was due primarily to the May 2017 Debt Offeringmaturities as well as increased borrowings fromdistributions and other intercompany transfers to DowDuPont which relies on DuPont and Dow to fund payment of its costs and expenses. DuPont’s current strong financial position, liquidity and credit ratings continue to provide access as needed to the capital markets. The company's liquidity needs can be met through a variety of sources, including cash provided by operating activities, cash and cash equivalents, marketable securities, commercial paper, syndicated credit lines, bilateral credit lines, long-term debt markets, bank financing, committed receivable repurchase facilities and the Repurchase Facility used primarily to fund seasonal working capital requirements.asset sales.

In May 2017, the company completed an underwritten public offering of $1.25 billion of the company's 2.20 percent Notes due 2020 and $750 million of the company's Floating Rate Notes due 2020 (the May"May 2017 Debt Offering)Offering"). The proceeds offrom this offering were used to make a discretionary pension contribution to the company's principal U.S. pension plan, as discussed below. plan.

The company's indenture covenants include customary limitations on liens, sale and leaseback transactions, and mergers and consolidations affecting manufacturing plants, mineral producing properties or research facilities located in the U.S. and the consolidated subsidiaries owning such plants, properties and facilities subject to certain limitations. The outstanding long-term debt also contains customary default provisions. In addition, the company will be required to redeem all of the Notes associated with the May 2017 Debt Offering at a redemption price equal to 100 percent of the aggregate principal amount plus any accrued and unpaid interest upon the announcement of the record date for the separation of either the agriculture or specialty products business, or the entry into an agreement to sell all or substantially all of the assets of either business to a third party.

In March 2016, the company entered into a credit agreement that provides for a three-year, senior unsecured term loan facility in the aggregate principal amount of $4.5 billion (as may be amended, from time to time, the Term"Term Loan Facility). In the first quarter of 2017, the Term Loan Facility was amended to extend the date onFacility") under which the commitment to lend terminates. As a result, DuPont may make up to seven term loan borrowings through July 27, 2018;and amounts repaid or prepaid are not available for subsequent borrowings. The proceeds from the borrowings under the Term Loan Facility matureswill be used for the company's general corporate purposes including debt repayment, working capital and funding a portion of DowDuPont's costs and expenses. The Term Loan Facility was amended in March 20192018 to extend the maturity date to June 2020, at which time all outstanding borrowings, including accrued but unpaid interest, become immediately due and payable. As ofpayable, and to extend the date on which the commitment to lend terminates to June 30, 2017,2019. At March 31, 2018, the company had borrowed $500 millionmade three term loan borrowings in an aggregate principal amount of $1.5 billion and had unused commitments of $4.0$3.0 billion under the Term Loan Facility. DuPont may electIn addition, in 2018 the company amended its $3 billion revolving credit facility to borrow underextend the Term Loan Facilitymaturity date to meet its short-term liquidity needs.June 2020.

The Term Loan Facility and the amended revolving credit facility contain customary representations and warranties, affirmative and negative covenants, and events of default that are typical for companies with similar credit ratings and generally consistent with those applicable to DuPont’s long-term public debt. The Term Loan Facility and the amended revolving credit facility contain a financial covenant requiring that the ratio of Total Indebtedness to Total Capitalization for DuPont and its consolidated subsidiaries not exceed 0.6667. At June 30, 2017,March 31, 2018, the company was in compliance with this financial covenant.

The Term Loan Facility and the revolving credit facility will terminate, and the loans and other amounts thereunder would become due and payable, upon the sale, transfer, lease or other disposition of all or substantially all of the assets of the agriculture product line to DowDuPont, its shareholders or any of its non-DuPont subsidiaries.


41

Table of Contents


In January 2017,February 2018, in line with seasonal agricultural working capital requirements, the company entered into a committed receivable repurchase agreement of up to $1.3 billion (the "2018 Repurchase Facility) thatFacility") which expires on November 30, 2017.in December 2018. From time to time, the company and the banks modify the monthly commitment amounts to better align with working capital requirements. Under the 2018 Repurchase Facility, the company may sell a portfolio of available and eligible outstanding customer notes receivables within the Agriculture segmentagriculture product line to participating institutions and simultaneously agree to repurchase at a future date. See further discussion of this facility in Note 1013 to the interim Consolidated Financial Statements.

The company has access to approximately $7.8$7.9 billion in committed and uncommitted unused credit lines, a decreasean increase of $0.1$1.2 billion from $7.9$6.7 billion as of December 31, 2016.2017. This increase was primarily due to the Repurchase Facility discussed above. These unused credit lines provide support to meet the company'scompany’s short-term liquidity needs and for general corporate purposes which may include funding of discretionary and non-discretionary contributions to certain benefit plans, severance plans in the event of a change in control,payments, repayment and refinancing of debt, working capital, capital expenditures, and repurchases and redemptions of securities.securities, and funding a portion of DowDuPont's costs and expenses.

The Act requires companies to pay a one-time transition tax on earnings of foreign subsidiaries, a majority of which were previously considered permanently reinvested by the company (see Note 9 to the interim Consolidated Financial Statements for further details of The Act). The cash held by foreign subsidiaries for permanent reinvestment is generally used to finance the subsidiaries' operational activities and future foreign investments. A deferred tax liability has been accrued for the estimated U.S. federal tax on all unrepatriated earnings as of December 31, 2017 in accordance with The Act. At March 31, 2018, management believed that sufficient liquidity is available in the U.S. The company previously anticipated making contributionsis currently evaluating the impact of approximately $230 million toThe Act on its principalpermanent reinvestment assertion. In the event that additional foreign funds are needed in the U.S. pension plan in 2017. During the six months ended June 30, 2017,, the company made total contributionshas the ability to repatriate additional funds. The repatriation could result in an adjustment to the tax liability for foreign withholding taxes, foreign and/or U.S. state income taxes and the impact of $2.9 billionforeign currency movements. As such, it is not practicable to its principal U.S pension plan, an increase of approximately $2.7 billion reflecting discretionary contributions. The discretionary contribution was funded throughcalculate the May 2017 Debt Offering, as discussed above; short-term borrowings, including commercial paper issuance; and cash.

unrecognized deferred tax liability on undistributed foreign earnings.

Summary of Cash Flows
Cash used for operating activities was $4.1$2.0 billion for the sixthree months ended June 30, 2017 compared to $1.5March 31, 2018 and $1.6 billion duringfor the same period in 2016.three months ended March 31, 2017. The $2.6 billion increase was due primarily to higher pension contributions, as discussed above.tax payments and higher integration and separation costs.

Cash provided by investing activities was $0.4 billion for the three months ended March 31, 2018 and cash used for investing activities was $1.9$1.3 billion for the sixthree months ended June 30, 2017 compared to $0.4 billion during the same period in 2016.March 31, 2017. The $1.5 billion increasechange was due primarily to increased net purchasesmaturities of marketable securities partially offset by lower net paymentsproceeds from foreign currency contracts.sales of businesses and other assets.

Cash used for financing activities was $0.7 billion for the three months ended March 31, 2018 and cash provided by financing activities was $4.5$1.6 billion for the sixthree months ended June 30, 2017, compared to $1.0 billion during the same period last year.March 31, 2017. The $3.5 billion increasechange was due primarily to the May 2017 Debt Offeringlower borrowings and increased short-term borrowings in commercial paper for seasonal working capital requirements.distributions to DowDuPont to support share repurchases.

As of the consummation of the Merger, shares of DuPont common stock held publicly were redeemed and DuPont's common stock is owned solely by its parent company, DowDuPont. DuPont's preferred stock remains issued and outstanding, and DuPont continues to be responsible for dividends on its preferred stock; however, the obligation is not material to the company's liquidity. Dividend payments to shareholders duringof DuPont preferred stock totaled $2 million in the sixthree months ended June 30,March 31, 2018.

DowDuPont relies on distributions and other intercompany transfers from DuPont and Dow to fund payment of its costs and expenses. In November 2017, totaled $0.7 billion.  In April and July of 2017, theDowDuPont's Board of Directors authorized an initial $4 billion share repurchase program to buy back shares of DowDuPont common stock. In February 2018, the Board declared second and thirda first quarter dividend per share of DowDuPont common stock dividendspayable on March 15, 2018.  In the first quarter of $0.38 per share. The company has2018, DuPont declared and paid quarterly consecutive dividends since the company'sdistributions to DowDuPont of about $830 million, primarily to fund a portion of DowDuPont’s first quarter share repurchases and dividend in the fourth quarter 1904.payment.

Guarantees and Off-Balance Sheet Arrangements
For detailed information related to Guarantees, Indemnifications, and Obligations for Equity Affiliates and Others, see the company's 20162017 Annual Report, Part II, Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations, Off- Balance Sheet Arrangements, and Note 1114 to the interim Consolidated Financial Statements.

Contractual Obligations
Information related to the company's contractual obligations at December 31, 20162017 can be found in the company's 20162017 Annual Report, Part II, Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations, Off-Balance Sheet Arrangements. The company's contractual obligations at June 30, 2017 have increased approximately $2 billion versus prior year end. The increase is driven by the May 2017 Debt Offering. See Note 10 to the interim Consolidated Financial Statements for further discussion of the company's debt offering.

42

Table of Contents


Item 3.
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 

See Note 13The Registrant meets the conditions set forth in General Instruction H(1)(a) and (b) of Form 10-Q (as modified by a grant of no-action relief dated February 12, 2018) and is therefore filing this form with the reduced disclosure format and has omitted the information called for by this Item pursuant to the interim Consolidated Financial Statements. See also Part II, Item 7A. Quantitative and Qualitative Disclosures About Market Risk,General Instruction H(2)(c) of the company's 2016 Annual Report for information on the company's utilization of financial instruments and an analysis of the sensitivity of these instruments.Form 10-Q.

Item 4.  CONTROLS AND PROCEDURES 

a)        Evaluation of Disclosure Controls and Procedures
 
The company maintains a system of disclosure controls and procedures to give reasonable assurance that information required to be disclosed in the company's reports filed or submitted under the Securities Exchange Act of 1934 (Exchange Act)("Exchange Act") is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission. These controls and procedures also give reasonable assurance that information required to be disclosed in such reports is accumulated and communicated to management to allow timely decisions regarding required disclosures.

As of June 30, 2017,March 31, 2018, the company's Chief Executive Officer (CEO)("CEO")" and Chief Financial Officer (CFO)("CFO"), together with management, conducted an evaluation of the effectiveness of the company's disclosure controls and procedures pursuant to Rules 13a-15(e) and 15d-15(e) of the Exchange Act. Based on that evaluation, the CEO and CFO concluded that these disclosure controls and procedures are effective.
 
b)                         Changes in Internal Control over Financial Reporting
 
There has been no change in the company's internal control over financial reporting that occurred during the quarter ended June 30, 2017March 31, 2018 that has materially affected, or is reasonably likely to materially affect, the company's internal control over financial reporting.


43

Table of Contents


PART II.  OTHER INFORMATION


Item 1.LEGAL PROCEEDINGS
The company is subject to various litigation matters, including, but not limited to, product liability, patent infringement, antitrust claims, and claims for third party property damage or personal injury stemming from alleged environmental torts. Information regarding certain of these matters is set forth below and in Note 1114 to the interim Consolidated Financial Statements.

Litigation
PFOA: Environmental and Litigation Proceedings
For purposes of this report, the term PFOA means collectively perfluorooctanoic acid and its salts, including the ammonium salt
and does not distinguish between the two forms. Information related to this matter is included in Note 1114 to the interim Consolidated Financial Statements under the heading PFOA.

Fayetteville Works Facility, Fayetteville, North Carolina
In August 2017, the U.S. Attorney’s Office for the Eastern District of North Carolina served the company with a grand jury subpoena for testimony and the production of documents related to alleged discharges of GenX from the Fayetteville Works facility into the Cape Fear River. In the fourth quarter of 2017, DuPont was served with additional subpoenas relating to the same issue. Additional information related to this matter is included in Note 14 to the interim Consolidated Financial Statements under the heading Fayetteville Works Facility, North Carolina.

La Porte Plant, La Porte, Texas - Crop Protection - Release Incident Investigations
On November 15, 2014, there was a release of methyl mercaptan at the company’s La Porte facility. The release occurred at the site’s Crop Protection unit resulting in four employee fatalities inside the unit. DuPont continues to cooperate with governmental agencies, including the U.S. Environmental Protection Agency (EPA)("EPA"), the Chemical Safety Board and the Department of Justice (DOJ)("DOJ"), still conducting investigations. These investigations could result in sanctions and civil or criminal penalties against the company.

Environmental Proceedings
The company believes it is remote that the following matters will have a material impact on its financial position, liquidity or results of operations. The descriptions are included per Regulation S-K, Item 103(5)(c) of the Securities Exchange Act of 1934.

La Porte Plant, La Porte, Texas - EPA Multimedia Inspection
The EPA conducted a multimedia inspection at the La Porte facility in January 2008. DuPont, EPA and DOJ began discussions in the Fall 2011 relating to the management of certain materials in the facility's waste water treatment system, hazardous waste management, flare and air emissions. These negotiations continue.

Sabine Plant, Orange, Texas - EPA Multimedia Inspection
In June 2012, DuPont began discussions with EPA and DOJ related to a multimedia inspection that EPA conducted at the Sabine facility in March 2009 and December 2015. The discussions involve the management of materials in the facility's waste water treatment system, hazardous waste management, flare and air emissions, including leak detection and repair. These negotiations continue.

La Porte Plant, La Porte, Texas - OSHA Release Incident Citations
In May 2015, the Occupational Safety & Health Administration (OSHA) cited the company in connection with the November 2014 release for fourteen violations (twelve serious, one repeat and one other-than-serious) with an aggregate associated penalty of $99,000. In the second quarter 2017, OSHA and the company settled the Release Incident matter. The company agreed to pay penalties of $106,375 for ten violations (two repeat, seven serious and one other-than-serious). Four violations were withdrawn. The settlement is pending judicial approval and is expected to be finalized in the third quarter.

La Porte Plant, La Porte, Texas - OSHA Process Safety Management (PSM) Audit
In 2015, OSHA conducted a PSM audit of the Crop Protection and Fluoroproducts units at the La Porte Plant. In July 2015, OSHA cited the company for three willful, one repeat and five serious PSM violations and placed the company in its Severe Violator Enforcement Program. OSHA has proposed a penalty of $273,000. In the second quarter 2017, OSHA and the company settled the PSM Audit matter. The company agreed to pay penalties of $285,848 for seven violations (four repeat and three serious). Two violations were withdrawn and all willful violations were reclassified. The settlement is pending judicial approval and is expected to be finalized in the third quarter.



Item 1A. RISK FACTORS 

The following risk factor presentedThere have been no material changes in the company's risk factors discussed in Part I, Item 1A, Risk Factors, in the company's 20162017 Annual Report is updated solely to reflect Amendment No. 1 to the Merger Agreement which, among other things, extends the Merger Agreement to August 31, 2017.

The Merger Agreement may be terminated in accordance with its terms and the Mergers may not be completed.
The completion of the Mergers is subject to the satisfaction or waiver of a number of conditions. Those conditions include: (i) the receipt of certain domestic and foreign regulatory approvals under competition laws, including receipt of approvals by certain regulators of the respective purchasers in relation to the FMC Transactions, EAA Transaction and the Brazil Seeds Transaction; (ii) the absence of certain governmental restraints or prohibitions preventing completion of the DuPont Merger or the Dow Merger; (iii) the approval of the shares of DowDuPont Common Stock to be issued to DuPont stockholders and Dow stockholders for listing on the NYSE; (iv) the reasonable determination by DuPont and Dow that neither the DuPont Merger nor the Dow Merger will constitute an acquisition of a 50 percent or greater interest in Dow or DuPont, under Section 355(e) of the Code; (v) the truth and correctness of the representations and warranties made by both parties (generally subject to certain “materiality” and “material adverse effect” qualifiers); (vi) the performance by DuPont and Dow of their respective obligations under the Merger Agreement in all material respects; and (vii) the receipt by both parties of legal opinions from their respective tax counsels with respect to the tax-free nature of each of the Mergers.

These conditions to the closing may not be fulfilled and, accordingly, the Mergers may not be completed. In addition, if the Mergers are not completed by August 31, 2017, either DuPont or Dow may choose not to proceed with the Mergers, and the parties can mutually decide to terminate the Merger Agreement at any time prior to the consummation of the Mergers. In addition, DuPont or Dow may elect to terminate the Merger Agreement in certain other circumstances. If the Merger Agreement is terminated, Dow and DuPont may incur substantial fees in connection with termination of the Merger Agreement and will not recognize the anticipated benefits of the Mergers.


Item 5. OTHER INFORMATION
In anticipation of and to facilitate the Intended Business Separations post the merger with Dow, DuPont is planning for the internal separation of the three businesses, both domestically and internationally, through a series of transactions that are intended to be tax-efficient from both a United States and foreign perspective (collectively, the DuPont Internal Separations). See Note 2 to the interim Consolidated Financial Statements for more information regarding the merger and the Intended Business Separations. The DuPont Internal Separations are currently expected to consist of two phases: (i) a series of internal transactions undertaken by DuPont to separate the businesses underneath DuPont including multiple distributions intended to qualify as tax-free spinoffs for United States tax purposes under Section 355 of the Internal Revenue Code, followed by (ii) internal distributions by DuPont, as a subsidiary of DowDuPont, to DowDuPont of entities owning collectively the businesses to be owned by the two intended independent companies as opposed to DuPont, which distributions are intended to qualify as tax-free spinoffs for United States tax purposes under Section 355 of the Internal Revenue Code. As part of the DuPont Internal Separations, through transactions that include distributions intended to qualify as tax-free spinoffs for United States tax purposes under Section 355 of the Internal Revenue Code, DuPont also currently expects to separate more fully the internal legal structure of its specialty products businesses (its electronics and communications business, its industrial biosciences business, its nutrition and health business, and its protection solutions business) so that each business is owned by a separate intermediate corporation owned, in turn, by DowDuPont.

The DuPont Internal Separations are expected to occur in the United States and in (or involving entities domiciled in) various jurisdictions, including (but not limited to) Australia, Brazil, Canada, China, Colombia, Hong Kong, India, Japan, Korea, Luxembourg, Mexico, Netherlands, Russia, Singapore, Spain, Switzerland, Taiwan, and Thailand. Following the completion of the DuPont Internal Separations, DuPont expects that DowDuPont will effectuate the Intended Business Separations, pending DowDuPont Board approval, by means of distributions to its public shareholders of the capital stock of two entities each owning businesses currently owned by DuPont, in distributions intended to qualify as tax-free spinoffs for United States tax purposes under Section 355 of the Internal Revenue Code.

The DuPont subsidiaries, or their successors, that are anticipated to be distributing corporations in the DuPont Internal Separations (each in one or more tax-free spinoffs for United States tax purposes under Section 355 of the Internal Revenue Code) include the following: New Asia Holdco B.V.; DuPont China Holding Company Limited; DuPont China, Ltd.; SP International Holding 4 BV; E.I. DuPont India Private Limited; DuPont Kabushiki Kaisha; DuPont Specialty Products KK; DuPont - Toray Company, Ltd; Du Pont Company (Singapore) Pte Ltd; DuPont Taiwan Ltd; DuPont International BV; DuPont Textiles & Interiors Delaware, Ltd; DuPont (Thailand) Co, Ltd; DuPont do Brasil S.A.; DuPont Holdco Spain III SL; DuPont de Colombia, S.A ; DuPont Mexicana, S de RL de CV; DuPont Corporaciones S de RL de CV; DuPont Latin America, Inc; DuPont Science and Technologies LLC ; DuPont Asturias, S.L.; DuPont de Nemours International S.a.r.l; DuPont Technology (Luxembourg) S.a.r.l; DPC (Luxembourg) S.a.r.l; DuPont Contern (Luxembourg) S.a.r.l; DuPont Acquisition (Luxembourg) S.a.r.l; DuPont Holding Netherlands BV; DuPont C.H. (f/k/a DuPont Korea Y.H.; SP Korea, LLC; DuPont Operations Inc; E&C EMEA Holding 2 BV; E&C International Holding; DuPont Chemical and Energy Operations, Inc; Danisco Holding USA Inc; E. I. du Pont de Nemours and Company; PM Diamond, Inc; 1811324 Ontario Limited, Hickory Holdings, Inc.; DuPont Asia Pacific, Inc., and Pioneer Hi-Bred International, Inc.Report.

Item 6.EXHIBITS

Exhibits: The list of exhibits in the Exhibit Index to this report is incorporated herein by reference.


44

Table of Contents


SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 E. I. DU PONT DE NEMOURS AND COMPANY
 (Registrant)
   
 Date:July 25, 2017May 4, 2018
   
   
 By:/s/ Nicholas C. Fanandakis
   
  Nicholas C. Fanandakis
  Executive Vice President and
  Chief Financial Officer
  (As Duly Authorized Officer and
  Principal Financial and Accounting Officer)


45

Table of Contents


EXHIBIT INDEX
 
Exhibit
Number
 Description
   
 Company’s Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 99.23.1 to the company’s Current Report on Form 8-K (Commission file number 1-815) dated JuneSeptember 1, 2015)2017).
   
 Company’s Amended and Restated Bylaws as last amended effective October 22, 2015 (incorporated by reference to Exhibit 3.2 to the company's QuarterlyCurrent Report on Form 10-Q8-K (Commission file number 1-815) for the period ended September 30, 2015)1, 2017).
   
4 The companyCompany agrees to provide the Commission, on request, copies of instruments defining the rights of holders of long-term debt of the company and its subsidiaries.
   
The DuPont Stock Accumulation and Deferred Compensation Plan for Directors, as last amended effective January 1, 2009 (incorporated by reference to Exhibit 10.1 to the company's Annual Report on Form 10-K (Commission file number 1-815) for the year ended December 31, 2013).
10.2*Company’s Supplemental Retirement Income Plan, as last amended effective December 18, 1996 (incorporated by reference to Exhibit 10.2 to the company’s Annual Report on Form 10-K (Commission file number 1-815) for the year ended December 31, 2011).
10.3*Company’s Pension Restoration Plan, as last amended effective June 29, 2015 (incorporated by reference to Exhibit 10.3 to the company's Quarterly Report on Form 10-Q (Commission file number 1-815) for the period ended June 30, 2015).
10.4*Company’s Rules for Lump Sum Payments, as last amended effective May 15, 2014 (incorporated by reference to Exhibit 10.4 to the company's Quarterly Report on Form 10-Q (Commission file number 1-815) for the period ended June 30, 2015).
10.5*Company’s Stock Performance Plan, as last amended effective January 25, 2007 (incorporated by reference to Exhibit 10.5 to the company’s Annual Report on Form 10-K (Commission file number 1-815) for the year ended December 31, 2011).
10.6*Company’s Equity and Incentive Plan, as amended and restated effective March 14, 2016 (incorporated by reference to Exhibit 10.06 to the company's Quarterly Report on Form 10-Q (Commission file number 1-815) for the period ended June 30, 2016).
10.7*Form of 2013 Award Terms under the company’s Equity and Incentive Plan (incorporated by reference to Exhibit 10.7 to the company’s Quarterly Report on Form 10-Q (Commission file number 1-815) for the period ended June 30, 2013).
10.8*Company’s Retirement Savings Restoration Plan, as last amended effective May 15, 2014. (incorporated by reference to Exhibit 10.08 to the company's Quarterly Report on Form 10-Q (Commission file number 1-815) for the period ended June 30, 2014).
10.9*Company’s Retirement Income Plan for Directors, as last amended January 2011 (incorporated by reference to Exhibit 10.9 to the company's Quarterly Report on Form 10-Q (Commission file number 1-815) for the period ended March 31, 2012).
10.10*Company's Senior Executive Severance Plan, as amended and restated effective December 10, 2015 (incorporated by reference to Exhibit 10.10 to the company's Annual Report on Form 10-K (Commission file number 1-815) for the year ended December 31, 2015). The company agrees to furnish supplementally a copy of any omitted schedules to the Commission upon request.
*


Exhibit
Number
Description
10.11*Supplemental Deferral Terms for Deferred Long Term Incentive Awards and Deferred Variable Compensation Awards (incorporated by reference to Exhibit 10.12 to the company's Annual Report on Form 10-K (Commission file number 1-815) for the year ended December 31, 2013).
10.13*Company’s Management Deferred Compensation Plan, as last amended effective April 15, 2014 (incorporated by reference to Exhibit 10.13 to the company's Quarterly Report on Form 10-Q (Commission file number 1-815) for the period ended June 30, 2014).
10.15*Form of 2015 Award Terms under the Company's Equity and Incentive Plan (incorporated by reference to Exhibit 10.15 to the company's Quarterly Report on 10-Q (Commission file number 1-815) for the period ended March 31, 2015).
10.16*Form of 2016 Award Terms under the Company’s Equity and Incentive Plan (incorporated by reference to Exhibit 10.16 to the company’s Quarterly Report on Form 10-Q (Commission file number 1-815) for the period ended March 31, 2017).
10.18** Separation Agreement by and between the Company and The Chemours Company (incorporated by reference to Exhibit 2.1 to the company's Current Report on Form 8-K (Commission file number 1-815) dated July 8, 2015).
   
10.19Amendment No. 1 to Separation Agreement by and between the Company and The Chemours Company, dated August 24, 2017 (incorporated by reference to Exhibit 2.1 to the company's Current Report on Form 8-K (Commission file number 1-815) dated August 25, 2017).
 Tax Matters Agreement by and between the Company and The Chemours Company (incorporated by reference to Exhibit 2.2 to the company's Current Report on Form 8-K (Commission file number 1-815) dated July 8, 2015).
   
10.20*Agreement and Plan of Merger by and between the Company and The Dow Chemical Company, dated as of December 11, 2015 (incorporated by reference to Exhibit 2.1 to the company's Current Report on Form 8-K (Commission file number 1-815) dated December 11, 2015).
10.21** Master Repurchase Agreement by and among Cooperatieve Rabobank, U.A. (New York Branch), The Bank of Tokyo Mitsubishi UFJ Ltd. (New York Branch) and PHI Financial Services, Inc., dated as of January 31, 2017February 13, 2018 (incorporated by reference to Exhibit 10.2110.4 to the company's Annual Report on Form 10-K (Commission file number 1-815) for the yearperiod ended December 31, 2016)2017).
   
10.22* Master Framework Agreement by and among Cooperatieve Rabobank, U.A. (New York Branch), The Bank of Tokyo Mitsubishi UFJ Ltd. (New York Branch) and PHI Financial Services, Inc. dated as of January 31, 2017February 13, 2018 (incorporated by reference to Exhibit 10.2210.5 to the company's Annual Report on Form 10-K (Commission file number 1-815) for the yearperiod ended December 31, 2016)2017).
   
10.23* FormTransaction Agreement, dated as of March 31, 2017, Award Terms underby and between the Company's EquityCompany and Incentive PlanFMC Corporation (incorporated by reference to Exhibit 10.2310.25 to the company’sCompany’s Quarterly Report on Form 10-Q (Commission file number 1-815) for the period ended March 31, 2017).
   
10.24*Amendment No. 1, dated March 31, 2017, to the Agreement and Plan of Merger, dated as of December 11, 2015 by and among the Company, The Dow Chemical Company, Diamond Merger Sub, Inc., Orion Merger Sub, Inc. and Diamond-Orion HoldCo, Inc. (n/k/a DowDuPont Inc.) (incorporated by reference to Exhibit 2.1 to the Company’s current report on Form 8-K (Commission file number 1-815) dated March 31, 2017).
10.25** 
Transaction Agreement, dated as of March 31, 2017, by and between the Company and FMC Corporation (incorporated by reference to Exhibit 10.25 to the company’s Quarterly Report on Form 10-Q (Commission file number 1-815) for the period ended March 31, 2017).
10.26Purchase Price Allocation Side Letter Agreement, dated as of May 12, 2017, by and between the Company and FMC Corporation.Corporation (incorporated by reference to Exhibit 10.26 to the Company’s Quarterly Report on Form 10-Q (Commission file number 1-815) for the period ended June 30, 2017).

   
Employment Agreement by and between the Company and Edward D. Breen, dated as of August 31, 2017, (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K (Commission file number 1-815) dated September 1, 2017).
The E. I. du Pont de Nemours and Company Equity Incentive Plan, incorporated by reference to Exhibit 4.1 to DowDuPont Inc. Registration Statement on Form S-8 filed September 1, 2017.
The E. I. du Pont de Nemours and Company Stock Performance Plan, incorporated by reference to Exhibit 4.2 to DowDuPont Inc. Registration Statement on Form S-8 filed September 1, 2017.
The E. I. du Pont de Nemours and Company Management Deferred Compensation Plan, incorporated by reference to Exhibit 4.3 to DowDuPont Inc. Registration Statement on Form S-8 filed September 1, 2017.
The E. I. du Pont de Nemours and Company Stock Accumulation and Deferred Compensation Plan for Directors, incorporated by reference to Exhibit 4.4 to DowDuPont Inc. Registration Statement on Form S-8 filed September 1, 2017.
DuPont’s Pension Restoration Plan, as last amended effective June 29, 2015 (incorporated by reference to Exhibit 10.3 to the Company’s Quarterly Report on Form 10-Q (Commission file number 1-815) for the period ended June 30, 2015).
DuPont’s Supplemental Retirement Income Plan, as last amended effective December 18, 1996 (incorporated by reference to Exhibit 10.2 to the Company’s Annual Report on Form 10-K (Commission file number 1-815) for the year ended December 31, 2011).
DuPont’s Rules for Lump Sum Payments, as last amended effective May 15, 2014 (incorporated by reference to Exhibit 10.4 to the Company’s Quarterly Report on Form 10-Q (Commission file number 1-815) for the period ended June 30, 2015).
DuPont’s Retirement Savings Restoration Plan, as last amended effective May 15, 2014. (incorporated by reference to Exhibit 10.08 to the Company’s Quarterly Report on Form 10-Q (Commission file number 1-815) for the period ended June 30, 2014).

46

Table of Contents


DuPont’s Retirement Income Plan for Directors, as last amended January 2011 (incorporated by reference to Exhibit 10.9 to the Company’s Quarterly Report on Form 10-Q (Commission file number 1-815) for the period ended March 31, 2012).
DuPont's Senior Executive Severance Plan, as amended and restated effective December 10, 2015 (incorporated by reference to Exhibit 10.10 to the Company’s Annual Report on Form 10-K (Commission file number 1-815) for the year ended December 31, 2015).
 Computation of Ratio of Earnings to Fixed Charges.
   
 Rule 13a-14(a)/15d-14(a) Certification of the company’s Principal Executive Officer.
   
 Rule 13a-14(a)/15d-14(a) Certification of the company’s Principal Financial Officer.

   
 Section 1350 Certification of the company’s Principal Executive Officer. The information contained in this Exhibit shall not be deemed filed with the Securities and Exchange Commission nor incorporated by reference in any registration statement filed by the registrant under the Securities Act of 1933, as amended.
   
 Section 1350 Certification of the company’s Principal Financial Officer. The information contained in this Exhibit shall not be deemed filed with the Securities and Exchange Commission nor incorporated by reference in any registration statement filed by the registrant under the Securities Act of 1933, as amended.
   
101.INS XBRL Instance Document
   
101.SCH XBRL Taxonomy Extension Schema Document
   
101.CAL XBRL Taxonomy Extension Calculation Linkbase Document
   
101.DEF XBRL Taxonomy Extension Definition Linkbase Document
   
101.LAB XBRL Taxonomy Extension Label Linkbase Document
   
101.PRE XBRL Taxonomy Extension Presentation Linkbase Document

*Management contract or compensatory plan or arrangement.
*Management contract or compensatory plan or arrangement.
**DuPont hereby undertakes to furnish supplementally a copy of any omitted schedule or exhibit, and amendments or modifications thereto, to such agreement to the U.S. Securities and Exchange Commission upon request.



4847